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Abstract 
Cells of all known living organisms require a constant energy supply in the form of adenosine 
triphosphate (ATP) for their survival and function. The intracellular transport and diffusion of 
ATP molecules are rather limited and thus, ATP producing mitochondria are directly 
transported to their site of action such as synaptic densities to provide all cellular compartments 
with an adequate amount of ATP. Fast and long-range transport of mitochondria along 
microtubule tracks via kinesin and dynein motor proteins is well established, whereas only little 
is known about actin / myosin functions in mitochondrial transport. There is growing evidence 
that actin filaments and myosin motor proteins play an essential role in the transport of 
mitochondria. A SPIRE formin actin nucleator complex facilitates actin filament generation. In 
addition, SPIRE proteins coordinate myosin 5 (MYO5) motor protein activation at vesicle and 
organelle membranes. Due to alternative splicing of the SPIRE1 gene, mammalian cells 
generate four SPIRE proteins from two SPIRE genes. The SPIRE1 actin / myosin organizer is 
targeted by the alternatively spliced exon 13 towards mitochondrial membranes and the 
corresponding protein is named ‘mitoSPIRE1’. The present thesis quantitatively addressed the 
expression of all SPIRE splice variants including mitoSPIRE1 in distinct organs, showing that 
the brain has the majority of SPIRE expression. In a previous study it was shown that SPIRE1 
mutant mice lacking the expression of all SPIRE1 proteins, including mitoSPIRE1, have 
increased fear in both cued and contextual fear conditioning experiments. To dissect the 
vesicular and mitochondrial SPIRE functions in fear behavior and to analyze the function of 
the mitoSPIRE1 protein in more detail, we generated a novel knockout model by targeted 
deletion of the mouse SPIRE1 exon 13 - the mitoSPIRE1 knockout mouse. Fibroblasts of the 
novel mitoSPIRE1 knockout mouse and the SPIRE1 mutant mouse show increased 
mitochondrial motility in live cell fluorescence microscopy analysis. Colocalization studies 
unraveled that mitoSPIRE1 colocalizes with FMN subfamily formins and MYO5 proteins at 
mitochondria. Subsequent fluorescence-activated mitochondria sorting (FAMS) experiments 
confirmed that SPIRE proteins contribute to target MYO5 actin motor proteins towards 
mitochondrial membranes. Furthermore, FAMS and fluorescence microscopy revealed an 
influence of mitoSPIRE1 on mitochondrial morphology. SPIRE proteins did not influence 
mitochondrial oxygen consumption rate, which was analyzed by a Seahorse Mito Stress Test 
assay. The mentioned function of mitoSPIRE1 in the regulation of mitochondrial motility led 
us to speculate that mitoSPIRE1 might be involved in targeting mitochondria towards synaptic 
terminals and thereby influencing synaptic transmission and possibly fear behavior.  
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Zusammenfassung 
Sämtliche Zellen lebender Organismen benötigen für ihr Überleben und die erfolgreiche 
Ausführung der zellulären Funktion eine ausreichende Menge an Energie in Form von 
Adenosintriphosphat (ATP). Die Diffusion und der Transport von einzelnen Molekülen wie 
ATP, welches hauptsächlich von Mitochondrien synthetisiert wird, ist intrazellulär stark 
eingeschränkt. Aus diesem Grund werden Mitochondrien über ein Transportsystem an ihren 
Einsatzort, beispielsweise synaptische Kontakte, bewegt. In der Literatur ist bereits detailliert 
beschrieben, dass Kinesin- und Dynein-Motoren einen schnellen, weitreichenden und 
bidirektionalen Mitochondrientransport entlang von Mikrotubuli ermöglichen. Gleichzeitig ist 
über einen möglichen mitochondrialen Transport entlang von Aktinfilamenten mittels 
Myosin-Motoren bisher nur wenig bekannt. Dennoch häufen sich die Hinweise, dass 
Aktinfilamente sowie Myosin-Motoren den mitochondrialen Transport beeinflussen. Die 
intrazelluläre Aktinfilament-Bildung wird unter anderem durch den SPIRE / Formin 
Aktinnukleations-Komplex ermöglicht. Zusätzlich koordinieren SPIRE Proteine die 
Aktivierung von Myosin 5 Motoren an Vesikel- und Organell-Membranen. Durch alternatives 
Spleißen entstehen in einer Säugetier-Zelle aus zwei SPIRE Genen insgesamt vier SPIRE 
Proteine. Hierbei wird durch das alternative Spleißen der SPIRE1 mRNA ein Protein 
synthetisiert, welches das alternative Exon 13 des SPIRE1 Genes enthält. Das zusätzliche 
Exon 13 lokalisiert das eigentlich vesikuläre SPIRE1 Protein an die mitochondriale Membran, 
weshalb dieses dementsprechend als „mitoSPIRE1“ bezeichnet wird. In der hier vorliegenden 
Arbeit wurde die Expression aller SPIRE Spleißvarianten inklusive mitoSPIRE1 in 
verschiedenen Organen der Maus quantitativ adressiert. Hierbei konnte gezeigt werden, dass 
das Gehirn der Hauptexpressionsort für SPIRE ist. In der Literatur wurde bereits ein 
Maus-Modell beschrieben, welches keinerlei funktionelle Proteine des SPIRE1 Gens exprimiert 
und ein erhöhtes Angstverhalten in kontextuellen und reiz-induzierten 
Angstkonditionierungs-Experimenten aufweist. Um die Funktion des vesikulären und 
mitochondrialen SPIRE auf das Angstverhalten zu analysieren und die generelle mitoSPIRE1 
Funktion zu untersuchen wurde in dieser Arbeit mittels Deletion des SPIRE1 Exon 13 ein neues 
Knock-out Model erstellt - die mitoSPIRE1 Knock-out Maus. In nachfolgenden 
Fluoreszenz-Mikroskopie-Analysen lebender Zellen zeigen Fibroblasten der neuen 
mitoSPIRE1 Knock-out Maus und der SPIRE1 mutant Maus, welche keinerlei funktionsfähige 
Proteine des SPIRE1 Genes besitzt, eine erhöhte mitochondriale Motilität. Außerdem konnte 
durch eine umfassende Kolokalisations-Studie gezeigt werden, dass das mitochondriale 
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mitoSPIRE1 mit FMN und MYO5 Proteinen an Mitochondrien kolokalisiert. Hierbei wurde 
durch fluorescence-activated mitochondria sorting (FAMS) Experimente bestätigt, dass unter 
anderem SPIRE für die Translokation von MYO5 Proteinen auf mitochondriale Membranen 
benötigt wird. Zusätzlich wurde mittels FAMS und mikroskopischen Analysen gezeigt, dass 
mitoSPIRE1 die mitochondriale Morphologie beeinflusst. Im Gegensatz dazu haben SPIRE 
Proteine des SPIRE1 Genes keinen Einfluss auf die oxygen consumption rate der 
Mitochondrien, was mit einem Seahorse Mito Stress Test Assay festgestellt wurde. Die hier 
gezeigte Funktion von mitoSPIRE1 in der mitochondrialen Motilität impliziert, dass 
mitoSPIRE1 die mitochondriale Verankerung an synaptischen Nervenenden und aus diesem 
Grund die synaptische Transmission und das Angstverhalten beeinflussen könnte. 
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1. Introduction 
1.1 Preamble 
Evolutionary adaption over millions of years generated animals which can rapidly react in 
response to external cues and are able to solve complex tasks. A perfect combination of energy 
consuming organs is required to recognize, evaluate and react to distinct events in time and 
space. In this respect, the analysis of changing environmental allurements is a continuous 
challenge for the organism and desires an adaptable processing system. To process complex 
novel information, neuronal networks of animal brains undergo structural and functional 
alterations induced by external and internal stimuli (Sehgal et al., 2013). In this context, the 
energy consuming structural rearrangement of synapses and dendrites is the cellular correlate 
for the process of learning, memory and cognition (Hamdan et al., 2011; van Bokhofen, 2011). 
To facilitate such adaptive alterations on a molecular level, the eukaryotic cytoskeleton plays a 
fundamental role, with the cytoskeleton serving as a transport system and being used together 
with mitochondria to provide distinct cell areas with energy in the form of ATP (Hollenbeck 
and Saxton, 2005; Mandal and Drerup, 2019). The filamentous components of the cytoskeleton 
build a highly dynamic system, which constantly undergoes alterations and facilitates the cell 
adaptation to distinct environmental influences (Fletcher and Mullins, 2010). 
 
1.2 Mitochondrial dynamics  
Eukaryotic cells require a constant energy supply in the form of adenosine triphosphate (ATP) 
for their survival and proper function (Nicholls and Budd, 2000). Mitochondria work as cellular 
power plants and provide all cell areas with an adequate amount of ATP (Sheng, 2014). In 
addition, these organelles function as Ca2+ storage for neurotransmission (Medler and Gleason, 
2002), produce precursors for macromolecules, such as proteins or lipids, and generate 
metabolic byproducts like reactive oxygen species (Spinelli and Haigis, 2018). Overall 
mitochondrial function is very complex and is facilitated by the specific organelle structure, as 
mitochondria are enveloped by an inner and an outer membrane resulting in the intermembrane 
space and the mitochondrial matrix (Pagliuso et al., 2018). However, mitochondria are highly 
dynamic organelles undergoing processes of fission, fusion and controlled recycling called 
mitophagy (Chen and Chan, 2009). Furthermore, mitochondria migrate along the cytoskeleton 
to distinct cell areas where energy is needed. Fission, fusion and motility are the main 
components of mitochondrial dynamics, and allow these organelles to provide the demanded 
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energy in space and time. As a consequence of these dynamic processes, mitochondria are able 
to adapt to environmental and physiological requirements (Chen and Chan, 2009). In this 
context, mitochondrial fission and fusion events, as well as mitochondrial motility highly 
depend on the cellular subtype and its metabolic activity (Pagliuso et al., 2018). Mitochondrial 
dynamics influence the structure, function and the overall morphology of the organelle, and 
therefore, their functional integrity is of great importance for cellular homeostasis (Figure 1). 
Abnormalities in mitochondrial dynamics often lead to cellular dysfunction and can be lethal 
or result in diseases, particularly neurodegenerative diseases (Chen and Chan, 2009). These 
severe consequences for the organism show the importance of mitochondrial integrity by itself 
and the associated mitochondrial dynamics. 
 
 
Figure 1 - Mitochondrial dynamics is characterized by fission, fusion and motility. A 
change of mitochondrial dynamics influences the function of mitochondria and can alter the 
supply of energy in distinct subcellular areas. (A) In wild type neurons, mitochondria are 
transported along the cytoskeleton to distinct cell areas and are well distributed to provide 
energy all over the cell. Mitochondria are functional and not fragmented or elongated. (B) A 
loss of mitochondrial fusion leads to fragmented mitochondria and a subpopulation of 
fragmented mitochondria becomes dysfunctional (red). In addition, fragmented mitochondria 
show transport defects to distal cell areas. (C) In the absence of mitochondrial fission, the 
mitochondrial population shows extremely elongated mitochondria and a subpopulation is not 
functional anymore (red). The elongated mitochondria show dysfunction in transport and 
cluster around the nucleus. (D) Without functional transport machinery, the mitochondria are 
not distributed throughout the cell but rather cluster in the perikaryon (modified from Chen and 
Chan, 2009). 
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1.2.1 Mitochondrial fission 
The ratio of mitochondrial fission and fusion events determines the length of mitochondria. 
Mitochondrial fission is characterized by the division of a mitochondrion into two daughter 
mitochondria. In the case of excessively frequent fission events, the balance between fission 
and fusion is shifted, resulting in a large number of fragmented mitochondria (van der Bliek et 
al., 2013). Mitochondrial fission is probably required to ensure that a population of organelles 
is available for segregation, to produce smaller organelles that are easier to transport along the 
cytoskeleton, to maintain a healthy population of organelles, and to transfer mitochondrial DNA 
between organelles (Kraus and Ryan, 2017). Mice without effective mitochondrial fission die 
shortly after birth, which shows the necessity of mitochondrial fission in Mammalia (Ishihara 
et al., 2009). Mitochondrial fission is a complex process that requires the interplay of many 
proteins and actin filaments (Korobova et al., 2013, 2014; Hatch et al., 2014; Li et al., 2015; 
Manor et al., 2015; Lee et al., 2016). Mitochondrial fission can be separated into two 
consecutive / sequential stages; in the first stage, the mitochondrial diameter is significantly 
reduced at fission sites. This beginning step involves the endoplasmic reticulum (ER) wrapping 
around the mitochondrial membranes, which marks the fission zones and initiates constriction 
(Friedman et al., 2011). Along these fission zones, actin polymerization occurs and exerts 
pressure on the mitochondrial outer membrane to perform mitochondria constriction, because 
the floppy ER tubules fail to do so (Korobova et al., 2013, 2014; Hatch et al., 2014; Manor et 
al., 2015). The ER associated actin nucleator Inverted formin 2 (INF2) and the mitochondria 
located actin nucleator mitoSPIRE1 (also known as SPIRE1C or SPIRE1-E13) are thought to 
interact, and thus to facilitate actin polymerization at constriction sites (Manor et al., 2015). 
The second stage of mitochondrial fission describes the final mitochondrial membrane scission. 
The scission event is initiated by the GTPase dynamin-related protein 1 (Drp1), which forms a 
polymeric ring after being recruited to fission zones at the outer mitochondrial membrane 
(Smirnova et al., 2001; Lackner and Nunnari, 2009; Archer, 2013). The Drp1 ring is not large 
enough to enclose tubules of human mitochondria, which often have a diameter of ∼ 300 nm. 
For the generation of a Drp1 polymeric ring the mitochondrial diameter should not be larger 
than ∼	150 nm (Friedman et al., 2011). That is why the mitochondrial constriction of the first 
fission stage reduces the diameter at fission zones to the appropriate size so that Drp1 can build 
the polymeric ring (Lackner and Nunnari, 2009; Friedman et al., 2011; Archer, 2013; Manor et 
al., 2015). Like it was done in the first fission stage the Drp1 polymeric ring excerts pressure 
on the mitochondrial fission zone. After the fission zone is narrowed to its maximum, 
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dynamin-2 is recruited to the constricted area and drives the final membrane scission event (Lee 
et al., 2016; Kraus and Ryan, 2017). 
 
1.2.2 Mitochondrial fusion 
The balance between the opposed processes of mitochondria organelle fission and fusion 
regulates mitochondria number and size (Liesa et al., 2009). Mitochondrial fusion is 
characterized by two mitochondria merging into one mitochondrion. An excessive increase of 
mitochondria fusion events brings the equilibrium of mitochondrial fission and fusion out of 
balance, resulting in a large number of hyperfused mitochondria (Pagliuso et al., 2018). Fusion 
of mitochondria is required to mix mitochondrial contents like mitochondrial DNA (mtDNA) 
to maintain a homogenous population of organelles, and to prevent the permanent loss of 
essential components. Consequently, a decreased rate of fusion events results in a 
subpopulation of mitochondria that lack functional mtDNA. Mitochondria with deficient 
mtDNA show respiration defects and can impair the neuronal outgrowth, thereby promoting 
neurodegenerative diseases (Chen and Chan, 2010). Mitochondrial fusion can be separated into 
two stages; The first stage describes the outer mitochondrial membrane (OMM) fusion of two 
mitochondria mediated by the membrane-anchored dynamin GTPase family members 
mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2). In the second step, the inner mitochondrial 
membrane (IMM) fusion is mediated by the optic atrophy 1 (OPA1) protein. In the absence of 
mitofusins, the fusion of both the inner and the outer mitochondrial membrane is abolished 
(Chen and Chan, 2009). The need for mitochondrial fusion is demonstrated by two knockout 
mouse models which lack either Mfn1 or Mfn2. A homozygous knockout of Mfn1 or Mfn2 
results in embryonic lethality. In contrast, heterozygous animals demonstrate full viability and 
fertility (Chen et al. 2003). Interestingly, heterozygous mutations in human Mfn2 cause an 
axonal peripheral neuropathy, known as Charcot-Marie-Tooth disease type 2A (Amiott et al., 
2008). In addition, heterozygous mutations in the human OPA1 gene can cause dominant optic 
atrophy. Patients who suffer from dominant optic atrophy develop a bilateral degeneration of 
the optic nerves, and usually lose their visual sense within the first decade of their life (Lenaers 
et al., 2012).  
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1.2.3 Mitochondrial motility 
Diffusion and transport of intracellular molecules like ATP are rather limited, and therefore 
simple molecule diffusion is not sufficient to provide all cell areas with energy (Kinsey et al., 
2011). A complex transport machinery enables mitochondrial motility, and facilitates transport 
of these cellular power plants to their sites of operation (Hollenbeck and Saxton, 2005). The 
mitochondrial transport system is essential, especially in highly polarized cells, such as neurons, 
to efficiently distribute mitochondria to distal cell compartments (Hollenbeck and Saxton, 
2005; Sheng, 2014). A dysfunction in the mitochondrial transport machinery results in the 
absence of mitochondria in dendrites and axons, leading to neurotransmission defects (Guo et 
al., 2005). In addition, transport defects of mitochondria can influence mitochondrial 
morphology resulting in an imbalance of fission and fusion events (Varadi et al., 2004). 
Mitochondrial trafficking in neurons and thus their distribution depends on synaptic activity, 
certain stress conditions, and mitochondria integrity (Miller and Sheetz, 2004; Chang and 
Reynolds, 2006; Cai et al., 2012; Sheng, 2014). In mature neurons, ∼ 20 - 30 % of axonal 
mitochondria are motile whereas the remaining mitochondria are stationary. Mitochondria are 
specifically docked / anchored to synaptic sites in order to provide a stable ATP supply as 
stationary power plants (Kang et al., 2008). The absence of stationary mitochondria 
significantly influences the synaptic vesicle release due to fluctuations in synaptic ATP levels, 
which are induced by mitochondrial movement (Sheng, 2014). Furthermore, spatially stable 
mitochondrial compartments fuel local translation during synaptic plasticity in neuronal 
dendrites (Rangaraju et al., 2019). As an effect of altered metabolic requirements, the anchored 
stationary mitochondria can become motile and motile mitochondria can become stationary 
(Sheng, 2014). 
The molecular transport of mitochondria in mammalian neuronal cells is well researched and 
allows assumptions to be made about the mitochondrial transport system of other cell types. 
However, there is still uncertainty concerning the exact mechanism of mitochondrial targeting. 
It is known that mitochondria are transported along cytoskeletal components mediated by motor 
and adapter proteins (Hollenbeck and Saxton, 2005). The transport of axonal mitochondria is 
modulated by microtubule- and actin-dependent mechanisms, in which the majority of 
mitochondria are transported on fast tracks along microtubules via kinesin and dynein motor 
proteins (Hollenbeck and Saxton, 2005; Pathak et al., 2010; Sheng, 2014). Microtubules are 
polarized along the axonal processes, which makes it possible to study bidirectional 
mitochondrial transport (Heidemann et al., 1981; Baas et al., 1988, 1989). Dynein motor 
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proteins mediate a retrograde (towards the cell body) movement of mitochondria, whereas 
kinesin motor proteins drive an anterograde (towards axonal termini) mitochondria transport. 
KIF5, a member of the kinesin-1 family, is described as a key motor protein of neuronal 
mitochondrial transport (Hurd and Saxton, 1996; Tanaka et al., 1998; Górska-Andrzejak et al., 
2003; Cai et al., 2005; Glater et al., 2006; Pilling et al., 2006; Sheng, 2014). In line with all 
other mitochondria-associated motor proteins, KIF5 does not bind directly to mitochondria, but 
rather interacts with the adapter protein complex Miro1-Trak2 to be finally connected to 
mitochondria and facilitate transport along microtubules (MacAskill et al., 2009; van Spronsen 
et al., 2013; Sheng, 2014). A large number of adapters between motor proteins and 
mitochondria have already been identified, but it is often unclear how exactly they influence 
mitochondrial motility and how they are regulated (Sheng, 2014). However, the adapter protein 
syntaphilin immobilizes motile axonal mitochondria by anchoring them to microtubules, which 
results in stationary pools of mitochondria (Sheng, 2014). Compared to the 
microtubule-associated mitochondrial transport, only little is known about the role of 
actin / myosin forces in mitochondrial transport. The actin / myosin transport machinery might 
be used to move mitochondria to cell regions where there is a lack of microtubules or it could 
be used to recouple mitochondria to microtubules after kinesin or dynein motor proteins are 
disengaged (Hollenbeck and Saxton 2005). Further research into Drosophila melanogaster 
shows an increase of mitochondrial movement and velocity following myosin 5 depletion in 
neuronal cells. These data indicate that myosin 5 activity opposes microtubule-based axonal 
transport of mitochondria (Pathak et al., 2010). However, the role of actin / myosin in 
mitochondrial transport has not been investigated sufficiently and is not well understood. In 
contrast to KIF5, it is still unknown how myosin motor proteins interact with mitochondria, or 
which proteins might mediate their connection.  
 
1.3 Actin nucleators facilitate actin polymerization 
Actin filaments are highly dynamic and function in diverse cellular processes (Rottner et al., 
2017). They provide mechanical stability and regulate cell shape, enable cell membrane 
dynamics and facilitate intracellular transport processes (Dominguez and Holmes, 2011; 
Pollard and Goldman, 2016; Rottner et al., 2017). Actin filaments are generated by the 
polymerization of actin monomers (G-actin) into double helical filaments (F-actin). Actin 
dimers and trimers are relatively unstable, and therefore a spontaneous polymerization of actin 
monomers into actin filaments is possible, but insufficient and rare. In addition, actin monomer 
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binding proteins like profilin and ß-thymosin further inhibit spontaneous actin polymerization 
in cells (Sept and McCammon, 2001; Pollard und Cooper, 2009; Xue and Robinson, 2013). A 
well-regulated initiation of actin polymerization in cells in space and time is thus essential and 
is controlled by a large set of actin nucleators. These actin nucleators bind actin monomers and 
stabilize an actin nucleus (dimer, trimer, tetramer), which enables further polymerization 
(Firat-Karalar and Welch, 2011). There are three major classes of actin nucleators; namely the 
Arp2/3 complex, the formin superfamily and the Wiskott-Aldrich-Syndrome protein homology 
2 (WH2) domain containing nucleators, including the SPIRE proteins. These actin nucleators 
differ in their molecular mechanisms to initiate actin polymerization (Robinson et al., 2001; 
Quinlan et al., 2005; Kerkhoff, 2006; Schönichen and Geyer, 2010; Carlier et al., 2011). 
 
1.3.1 SPIRE proteins 
SPIRE proteins were first identified in 1999 / 2000 and were shown to play a role in Drosophila 
oocyte maturation (Wellington et al., 1999; Otto et al., 2000). Twenty years later, modern 
technology traced back the origin of SPIRE to be at least a holozoan invention, because SPIRE 
proteins were found in Ichthyosporea, Choanoflagellida, and Metazoa (Kollmar, Welz, Straub 
et al., 2019). Mammals have two SPIRE genes, namely SPIRE1 and SPIRE2. The mammalian 
SPIRE1 gene locus contains two alternatively spliced exons - exon 9 and exon 13. In contrast, 
the SPIRE2 gene locus encodes only a single transcript (Figure 2A). As a result, the two 
mammalian SPIRE genes encode a total of four different SPIRE proteins: SPIRE1, SPIRE1-E9, 
mitoSPIRE1 and SPIRE2, which are highly similar proteins regarding their domain 
organization. The primary structure of the mouse SPIRE1 and SPIRE2 proteins show an 
identity of 37 % and a similarity of 50 % (Kerkhoff, 2006). SPIRE1 and SPIRE2 proteins do 
not contain alternatively spliced exons and have similar subcellular localization at vesicular 
membranes (Kollmar, Welz, Straub et al., 2019). The vesicle located SPIRE1-E9 contains the 
alternatively spliced exon 9, a unique 14 amino acid spanning sequence. The alternatively 
spliced exon 13, which encodes a sequence of 58 amino acids, is part of the mitoSPIRE1 
protein, which is localized at mitochondria. A SPIRE protein containing both the exon 9 and 
the exon 13 was not detected (Kollmar, Welz, Straub et al., 2019). 
All SPIRE proteins contain highly conserved regions in their structural protein organization 
(Figure 2, B, C). The SPIRE proteins consist of an N-terminal kinase non-catalytic C-lobe 
domain (KIND) for FMN subgroup formin interaction (Pechlivanis et al., 2009), and a cluster 
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of four Wiskott-Aldrich-Syndrome protein homology 2 (WH2) domains for actin monomer 
binding and nucleation (Quinlan et al., 2005). The globular tail domain binding motif (GTBM) 
in the central linker region of SPIRE proteins mediates a direct interaction between SPIRE and 
myosin 5 (MYO5) proteins (Pylypenko, Welz et al., 2016). The C-terminal SPIRE-box (SB) 
shows sequence homology to the Slp homology domain (SHD) of RAB GTPase interacting 
proteins like rabphilin 3A (Kerkhoff, et al. 2001; Fukuda 2013). In this context, the C-terminal 
SPIRE SHD-like sequences mediate the interaction between SPIRE1 and RAB27A/B 
(Alzahofi, Robinson, Welz et al., 2018). Furthermore, SPIRE1 and SPIRE2 interact with 
comparable affinity with RAB8A (Kollmar, Welz, Straub et al., 2019). This indicates the 
opportunity of the SPIRE-box to interact with different RAB family GTPases. The C-terminal 
FYVE-type zinc-finger (FYVE) domain contains a hydrophobic turret loop which integrates 
into lipid bilayers, enabling intracellular membrane localization of the whole protein (Misra 
and Hurley, 1999; Dumas et al., 2001; Kerkhoff et al., 2001; Tittel et al., 2015). 
In situ hybridization in mouse brains revealed a high expression of SPIRE1 in the hippocampus, 
dentate gyrus, and the cerebellum (Schumacher et al., 2004; Pleiser et al., 2010). Expression 
analysis in mice show that SPIRE mRNA is most abundant in oocytes and in the brain (Pfender 
et al., 2011; Pleiser, 2012). As a conclusion of the expression studies, the overall SPIRE 
expression levels seem to be low, which complicates the study of endogenous SPIRE functions. 
Nevertheless, in several studies, the function of SPIRE has been addressed. SPIRE nucleated 
actin filaments mediate long-range transport of vesicles in mouse oocytes (Schuh, 2011) and 
are essential for asymmetric oocyte cell division (Pfender et al., 2011). In addition, SPIRE1 
function influences fear expression (Pleiser et al., 2014) and contributes to the regulation of 
melanosome transport in melanocytes (Alzahofi, Robinson, Welz et al., 2018). 
  Introduction 
 
 9 
 
Figure 2 - Structure of mouse SPIRE genes and proteins. (A) Schematic drawing of the 
mouse SPIRE1 protein and the predicted gene structure of mouse SPIRE1 and SPIRE2. 
Conserved domains of the SPIRE1 protein are highlighted in color and are assigned to their 
respective exon sequence. Dark and light grey boxes indicate exons and introns, respectively. 
Introns have been scaled down for a better presentation of the gene structures as denoted. (B) 
Overview on functional SPIRE protein domains and the specific interactions they mediate. 
KIND, kinase non-catalytic C-lobe domain; WH2, Wiskott-Aldrich-Syndrome protein 
homology 2; GTBM, globular tail domain binding motif; FYVE, FYVE-type zinc-finger. (C) 
Overview on mouse SPIRE proteins and their respective domain organizations. Numbers 
indicate amino acids. The SPIRE1 gene encodes for three different proteins, SPIRE1, 
SPIRE1-E9 and mitoSPIRE1. The SPIRE2 gene encodes for one protein, SPIRE2. E9, exon 9; 
E13, exon 13; SB, SPIRE-box; aa, amino acids. Figure 2 was already published in Kollmar, 
Welz, Straub et al., 2019. 
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1.3.2 mitoSPIRE1 
The alternatively spliced actin nucleator protein mitoSPIRE1 was first described in 2015. Until 
recently, the protein was named SPIRE1C, because it includes the alternatively spliced exon 13 
also known as exon C. Unfortunately, Drosophila already encodes a SPIRE protein isoform 
which is called SPIREC. To avoid misunderstandings, in 2019 we renamed the mammalian 
SPIRE1C protein in agreement with its discoverer Uri Manor into mitoSPIRE1. We chose this 
name, because mitoSPIRE1 is localized at mitochondria, and is a splice variant of the SPIRE1 
gene. The 58 amino acid sequence of the alternatively spliced exon 13 binds to the outer 
mitochondrial membrane, and targets the mitoSPIRE1 protein towards mitochondria (Manor et 
al., 2015). Manor and colleagues describe a role of mitoSPIRE1 in mitochondrial fission. In 
their current model, a dimer of mitoSPIRE1 is expected to interact with the endoplasmic 
reticulum (ER)-localized inverted formin 2 (INF2) to form an actin nucleation complex during 
ER initiated mitochondrial constriction. The subsequent nucleation and elongation of actin 
filaments along fission zones by the mitoSPIRE1 / INF2 complex might exert pressure on the 
mitochondrial outer membrane, and therefore cause constriction of the mitochondrial 
membrane. The mitoSPIRE1 / INF2 complex could be necessary for mitochondrial fission 
(Manor et al., 2015). Additional functions of mitoSPIRE1 remain unknown thus far. 
 
1.4 Cooperation of SPIRE and formin proteins 
Initial findings of the association between the two actin nucleators SPIRE and formin were 
already provided in the late 1980s. A mutation in the gene locus of the Cappuccino protein (a 
Drosophila melanogaster FMN2 ortholog) revealed the same phenotype in oocytes of 
Drosophila melanogaster as a mutated SPIRE gene (Manseau and Schüpbach, 1989). Years 
later, the identical oocyte phenotype was explained. SPIRE and Cappuccino cooperate to 
assemble a cytoplasmic mesh of actin filaments that controls a distinct microtubule organization 
during oocyte development (Dahlgaard et al., 2007). In addition to this functional cooperation, 
further studies also revealed a physical interaction between formins and SPIRE proteins 
(Quinlan et al., 2007; Pechlivanis et al., 2009). The mammalian FMN subgroup formins 
(FMN1, FMN2) and SPIRE proteins (SPIRE1, SPIRE2) interact directly with each other in 
order to form a functional actin nucleator complex (Pechlivanis et al., 2009; Pfender et al., 
2011). The very C-terminal end of FMN1/2 contains a basic amino acid cluster in the so called 
formin-SPIRE Interaction (FSI) sequence, which binds to an acidic cluster in the N-terminal 
KIND of SPIRE proteins (Pechlivanis et al., 2009; Zeth et al., 2011). 
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FMN subfamily formins contain, like all formins, two formin homology domains which are 
termed formin homology domain 1 (FH1) and formin homology domain 2 (FH2). Formin 
proteins dimerize which results in a dimeric ring of the two FH2 domains that encircles and 
processively moves with the growing plus end of an actin filament, therefore, facilitating its 
elongation (Schönichen and Geyer, 2010). The FH1 domains of the formin dimer contain 
multiple clusters of poly-proline stretches, which enable the binding of profilin-actin and 
providing it to the FH2 dimer for actin filament elongation (Romero et al., 2004; Otomo et al., 
2005; Paul and Pollard, 2008; Schönichen and Geyer, 2010). The actin nucleation activity of 
FMN formins and the binding of FH2 to barbed ends of actin filaments is inhibited by the 
formation of the SPIRE-FMN complex. However, the formation of the SPIRE-FMN actin 
nucleator complex significantly increases the overall actin nucleation in comparison to the 
single nucleator proteins acting alone (Vizcarra et al., 2011; Montaville et al., 2014). The 
SPIRE-formin complex facilitates both actin nucleation via the WH2 domains of SPIRE and 
actin filament elongation via FMN (Figure 3; Quinlan and Kerkhoff, 2008; Kerkhoff, 2011). 
It has been shown that the four WH2 domains of SPIRE are sufficient to nucleate actin 
polymerization in vitro, but these domains are not able to nucleate actin polymerization of 
profilin bound actin, being the most abundant source of actin monomers in cells (Quinlan et al., 
2005; Montaville et al., 2014; Pollard, 2016). Thus, for SPIRE actin nucleation actin monomers 
have to be provided as a non-coupled actin monomer directly or by other proteins, which are 
able to process profilin-actin (Quinlan et al., 2005; Montaville et al., 2014). A present model of 
the SPIRE-formin complex explains that SPIRE WH2 domains nucleate actin monomers and 
passes over to an FMN dimer which elongates the newly synthesized SPIRE nucleated 
filaments (Quinlan and Kerkhoff, 2008; Kerkhoff, 2011). This model accumulates evidence for 
the theory that FMN subfamily formins provide SPIRE with actin monomers, because FMN 
processes profilin-actin with its FH1 domains and as a consequence, could supply actin 
monomers to SPIRE (Figure 3). However, in a current model, the building of the SPIRE-formin 
complex leads to the dimerization of SPIRE proteins at the membrane and initiates actin 
nucleation (Quinlan and Kerkhoff, 2008). The increase of SPIRE WH2 domains could be an 
explanation for higher actin nucleation activity of SPIRE in the complex. 
A further model shows that SPIRE proteins exist in two distinct states: a potentially 
auto-inhibited inactive state and an unfolded, membrane-bound active state (Figure 4). In the 
inactive state, the SPIRE protein is cytosolic and might adopt a backfolded structure by an 
intramolecular interaction between the C-terminal FYVE domain and the N-terminal KIND. In 
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this state membrane-binding of the FYVE domain is inhibited and KIND is not accessible for 
binding to FMN subfamily formins. In the active state, the SPIRE protein gets unfolded, is 
targeted to intracellular membranes and is now able to recruit FMN subfamily formins through 
the accessible KIND. The intramolecular FYVE / KIND and the trans-regulatory 
FMN-FSI / KIND interactions are competitive and couples the membrane binding of SPIRE to 
the recruitment of FMN subfamily formins (Tittel et al., 2015). A distinct mechanism which 
drives SPIRE protein activation and membrane targeting is still not completely understood. In 
this context, the interaction of SPIRE proteins and myosin 5 actin motors might contribute to 
the SPIRE activation process (Pylypenko, Welz et al., 2016). 
 
Figure 3 - Model of SPIRE / FMN subfamily formin cooperation in efficient actin 
nucleation and filament elongation. For actin nucleation SPIRE proteins need monomeric 
unbound actin molecules, whereas FMN subfamily formins can process profilin bound actin 
monomers which are the most abundant form of actin monomers in eukaryotic cells. In the 
current model SPIRE WH2 domains nucleate actin monomers and passes over to an FMN dimer 
which elongates the novel synthesized SPIRE nucleated filaments. (A) Activated SPIRE 
proteins are targeted at subcellular membranes by the interaction of the SPIRE FYVE-type 
zinc-finger with negatively charged lipids of the membrane. Specific subcellular localization of 
SPIRE proteins could be determined by the interaction of the SPIRE-box with small G-proteins 
like RAB27 and the localization might be influenced by dimerization of SPIRE proteins. After 
SPIRE dimerization FMN subfamily formins are translocated to SPIRE and FH2 domains of 
FMN formins form a dimer as well, whereas each FSI motif interacts directly with a single 
N-terminal SPIRE KIND. In addition, each WH2 domain of the SPIRE dimer is used to interact 
with an unbound actin monomer to facilitate actin nucleation. It is not verified but in the 
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following functional cooperation of SPIRE and FMN formins, the proline rich region of FMN 
FH1 could process profilin bound actin monomers to provide SPIRE WH2 domains with 
non-bound actin monomers for actin nucleation (indicated by the arrow). If FMN does not 
provide unbound actin monomers to the WH2 domains, the SPIRE dimer is mainly dependent 
on cytosolic unbound actin monomers. (B) After SPIRE mediated actin nucleation, the novel 
actin filament is released from WH2 domains and the dimerized donut shaped FH2 domains of 
FMN elongate the growing actin filament by processive addition of actin monomers. Actin 
monomers for the FH2 mediated elongation of the actin filament are provided by the FH1 
domains, processing profilin bound actin monomers. The FSI domain is highlighted in green 
(modified from Kerkhoff, 2011). 
 
 
Figure 4 - Model for the different molecular states of the SPIRE / FMN actin nucleation 
complex at vesicle membranes. In this model cytosolic SPIRE proteins are primarily inactive 
(closed conformation) as backfolded monomers, but after transient membrane binding SPIRE 
proteins are activated (open conformation), able to dimerize and interact with FMN subfamily 
formins to build a functional unit as SPIRE / FMN actin nucleator complex. (A) The cytosolic 
backfolded SPIRE monomer is inactive due to interaction by FYVE / KIND with itself. The 
KIND is blocked by FYVE which is why the protein is not able to interact with FMN subfamily 
formins. (B) After transient interaction of the SPIRE C-terminus in a non-specific pattern with 
negatively charged intracellular membranes, the protein is unfolded. The accessible KIND is 
able to interact with FMN-FSI to initiate formation of a functional SPIRE / FMN actin nucleator 
complex. (C) A donut shaped FMN subfamily dimer interacts with two SPIRE proteins. The 
FMN subfamily formin and SPIRE build a functional unit to nucleate and elongate actin 
filaments. Additional factors (X) may specify targeting of SPIRE at vesicle membranes 
(modified from Tittel et al., 2015). 
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1.5 The SPIRE and myosin 5 interaction 
Myosin actin motor proteins are molecular motors that are involved in a variety of cellular and 
sub-cellular mechanisms including cell migration and adhesion, muscle contraction, 
cytokinesis and signal transduction (Vicente-Manzanares et al., 2009; Hartman and Spudich, 
2012). Furthermore, motor proteins are essential for intracellular transport of distinct cargos 
(Hartman and Spudich, 2012). In particular, neurons depend on these transport mechanisms as 
they synthesize most axonal and synaptic proteins in the cell body. These proteins need to be 
transported to their respective places of action for instance in large neurites and therefore, they 
require a molecular transport system (Hirokawa et al., 2010). In this context, myosin motors 
transport cargos along actin filaments, which facilitate a slow but precise transport system to 
subcellular target regions (Ross et al., 2008; Hirokawa et al., 2010; Welz et al., 2014). 
Myosin superfamily motor proteins are actin binding ATPases. ATP hydrolysis induces an 
intramolecular conformational change within the motor. This conformational change is used to 
generate forces along actin filaments in order to induce morphological changes of cells, to 
mediate muscle contractions or to transport distinct cargos along actin tracks (Hartman and 
Spudich, 2012; Houdusse and Sweeney, 2016). Myosin motor proteins are divided into 
conventional myosins (myosin 2 family) and unconventional myosins (all other myosins; 
Venkatesh et al., 2019). To date, 38 different myosin genes have been identified in humans, 
which are grouped into distinct classes. In general, myosins consist of three different regions: 
An N-terminal motor domain, a neck region, and a tail region (Hammer and Sellers, 2011; 
Figure 5). The motor domain, which is also known as the head, harbors the ATPase activity and 
binds to actin filaments (Hammer and Sellers, 2011).  
In the present thesis, myosin 5 motor proteins are of great interest because these motor proteins 
serve as cargo transporters (Hammer and Sellers, 2011). In humans, there are three different 
myosin 5 genes: myosin 5A, 5B and 5C, encoding myosin 5A (MYO5A), myosin 5B (MYO5B) 
and myosin 5C (MYO5C) proteins, respectively (Mercer et al., 1991; Zhao et al., 1996; Berg 
et al., 2001; Rodriguez et al., 2002). In gene expression studies, MYO5A, MYO5B and MYO5C 
are found in the brain (Espreafico et al., 1992; Cheney et al., 1993; Rodriguez et al., 2002; 
Tilelli et al., 2003; Lisé et al., 2006). Myosin motor proteins like MYO5 assemble as a dimer 
to form a two-headed motor and work as a unit to allow the dimer to ‘walk’ along actin filaments 
(Hammer and Sellers, 2011). The neck region of MYO5 contains six IQ motifs and each IQ 
repeat binds to calmodulin or a related light chain (Espindola et al., 2000). As a consequence, 
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the MYO5 neck region builds the lever arm required for processive movement of the whole 
protein. In the case of MYO5, the tail region contains a proximal coiled coil domain to form a 
dimerization of heavy chains and a C-terminal globular tail domain (GTD). The GTD of MYO5 
has an important role in cargo binding because it enables the motor protein to bind to adapter 
proteins, which mediate vesicle or organelle targeting (Wu et al., 1998; Reck-Peterson et al., 
1999; Hammer and Sellers, 2011; Syamaladevi et al., 2012). In 2016, it was demonstrated that 
the GTDs of MYO5A, 5B and 5C, interact directly with an evolutionarily conserved sequence 
motif termed globular tail domain binding motif (GTBM) of the SPIRE actin nucleator. 
Through the interaction of MYO5 with RAB11, the SPIRE GTBM facilitates the formation of 
a tripartite complex at vesicle membranes made of SPIRE, MYO5 and RAB11. In summary, 
this complex could explain how RAB11 vesicles coordinate actin filament nucleation and 
myosin force generation at RAB11 vesicle membranes to regulate transport processes 
(Pylypenko, Welz, et al., 2016). Human homozygous mutation of MYO5A is known as 
Griscelli syndrome type 1, which is characterized by partial albinism and primary neurological 
defects (Thomas et al., 2009; Cağdaş et al., 2012). Mutations of MYO5B are also found in 
humans, and cause microvillus inclusion disease, a rare genetic disorder of the small intestine 
(Knowles et al., 2014). 
 
Figure 5 - Schematic overview of a vertebrate 
myosin 5 motor protein. The myosin 5 motor 
protein is organized into three different 
functional units, facilitating processive 
movement and consequently transport of cargos 
along actin filaments. The N-terminal motor 
domain provides ATPase activity and binds to 
actin filaments. The following lever arm / neck 
carries six calmodulin binding IQ motifs. Given 
the elongated nature of the neck region compared 
to other myosin motors the ATP hydrolysis 
induced conformational change is translated into 
a large step size of the motor which allows for 
processive movements. The C-terminal tail is 
divided into two functional and structural parts: 
the coiled-coil region necessary for dimerization 
of two myosin 5 heavy chains and at the very end 
of the protein the globular tail domain (GTD) 
which mediates as cargo binding domain cargo 
interaction of the motor and direct interaction 
with SPIRE proteins (modified from Pylypenko, Welz et al., 2016; Welz, 2018). 
  Introduction 
 
 16 
1.6 Cellular functions of SPIRE proteins 
As mentioned previously, SPIRE proteins are expressed at very low levels but still have a 
significant impact on several cell biological mechanisms, including oocyte maturation, 
transport of RAB11 vesicles and peripheral transport of melanosomes in melanocytes (Pfender 
et al., 2011; Schuh et al., 2011; Pleiser, 2012; Alzahofi, Robinson, Welz et al., 2018; Kollmar, 
Welz, Straub et al., 2019). The ability of SPIRE to directly interact with FMN subfamily 
formins and MYO5 actin motors suggests a much wider spectrum of SPIRE function in vesicle 
and organelle transport (Pechlivanis et al., 2009; Pylypenko, Welz, et al., 2016). Further 
investigations are necessary to unravel the diversity of SPIRE functions. 
 
1.6.1 SPIRE actin nucleators drive oocyte maturation  
The maturation of oocytes into eggs is a complex differentiation program that is initiated early 
on in embryonic development. During early meiosis, the diploid precursor cells termed 
‘oocytes’ are arrested at prophase I and wait for their chance to mature into pregnable eggs. 
During sexual maturity, mostly a single oocyte per menstrual cycle matures into a haploid egg 
and becomes ovulated from its surrounding follicle. The maturation of an oocyte into an egg is 
dependent on asymmetric cell division, including a reduction to half of the oocyte chromosomes 
(Mogessie et al., 2018). The process of asymmetric meiotic cell division can be described by 
two different stages. In the first stage, an asymmetric positioning of the meiotic spindle takes 
place in order to move excessive chromosomes for a haploid egg into a small cell termed the 
polar body. In this context, the dense chromosomes must first be aligned to the spindle 
apparatus, which is necessary to separate chromosomes in space (Kirschner et al., 1986; 
Kline-Smith et al., 2004). After chromosomes are aligned to the spindle, the whole spindle has 
to be moved to the cell cortex to initiate the second stage of asymmetric cell division. Spindle 
positioning is dependent on a dynamic actin meshwork, which is generated by FMN2 and 
SPIRE actin nucleators (Leader et al., 2002; Dumont et al., 2007; Pfender et al. 2011). For that 
matter, SPIRE and FMN interact as a functional unit in which both actin nucleators depend on 
each other. Interestingly, a single depletion of either SPIRE1 or SPIRE2 compared to a double 
depletion does not affect spindle positioning, indicating that the protein similarity allows a 
mutual rescue of both proteins. Finally, the extrusion of polar bodies describes the second stage 
of the asymmetric meiotic division. A loss of SPIRE proteins not only inhibits proper spindle 
positioning, but consequently impairs polar body extrusion as well. In summary, SPIRE 
proteins are important for flawless oocyte maturation (Pfender et al., 2011). Interestingly the 
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corresponding Drosophila melanogaster (Dm) SPIRE and Cappuccino (a Dm FMN2 ortholog) 
produce a similar actin meshwork in fly oocytes, which is necessary to facilitate the maturation 
of the oocyte into an egg (Dahlgaard et al., 2007). Errors in the maturation of oocytes may result 
in aneuploidy, hypofertility, and genetic disorders in offspring (Leader et al., 2002; Zhai et al., 
2018). 
 
1.6.2 SPIRE actin nucleators drive vesicular transport processes  
Intracellular transport of cargo and organelles is essential for communication, organization and 
polarity of mammalian cells (Pylypenko, Welz et al., 2016). In this respect, cargo, such as 
proteins, lipids, or even RNA molecules, have to be transported to their target areas, and 
especially proteins are therefore wrapped into membrane enclosed carriers termed vesicles. 
Transport of intracellular cargo is generally mediated by microtubules and actin filaments. 
Polarized microtubules serve as long bidirectional transport tracks and provide a fast but 
constricted path used by kinesin and dynein motor proteins (Schliwa and Woehlke, 2003; 
Hirokawa et al., 2009; Welz et al., 2014). Actin filament-based transport processes are much 
slower but more dynamic than microtubule-based transports and are mostly important for 
precise short-range movements of vesicles, facilitated by myosin motor proteins (Hirokawa et 
al., 2009; Kneussel and Wagner, 2013; Welz et al., 2014). Typical intracellular transport 
processes including microtubule- and actin-based transport systems for cargo are commonly 
described as the highways and local roads model (Figure 6). In this controversial discussed 
model, vesicles are transported quickly along microtubules to the cell periphery. Here, vesicles 
are detached from microtubules and begin to move slowly along actin filaments to their final 
destinations (Langford, 1995; Ross et al., 2008; Woolner and Bemet, 2009; Welz et al., 2014). 
The dynamic actin cytoskeleton facilitates transport of vesicles to areas which are not reached 
and therefore supplied with cargos by the coarse microtubule network (Welz et al., 2014). 
Already in 2001, it was found that the actin nucleator SPIRE is targeted to intracellular 
membranes and involved in vesicle transport processes (Kerkhoff et al., 2001). Years later, in 
mouse metaphase oocytes, SPIRE was identified to contribute to a microtubule-independent 
long-range transport of RAB11 vesicles (Schuh et al., 2011). In this context, SPIRE and FMN 
proteins cooperate in nucleating actin filaments originating from vesicle membranes to 
facilitate the formation of a cytoplasmic actin mesh and to allow a myosin 5B 
(MYO5B)-dependent RAB11 vesicle transport. A lack of SPIRE1 and SPIRE2 results in a loss 
of directed transport of RAB11 vesicles to the oocyte cortex (Schuh et al., 2011). SPIRE 
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function in oocytes therefore presents two interesting facts: SPIRE can be necessary for the 
movement of vesicles, and actin filaments are used as alternative routes for distinct long-range 
transport processes. 
 
Figure 6 - Schematic overview of the highways and local roads model for intracellular 
transport. Microtubules serve as fast transport tracks for cargo and organize a coarse transport 
structure, which enables a bidirectional transport of cargos between the center and the periphery 
of the cell. The more dynamic actin cytoskeleton localizes in more cortical areas of the cell and 
facilitates a slower but more precise transport system of cargos to subcellular target regions, 
which are not connected to the microtubule tracks. In this model, vesicles are first transported 
from the cell center to the periphery along microtubules (highways) and then the slower, but 
dynamic actin filament system (local roads) take over the transportation of the cargo to its 
specific target site (modified from Ross et al., 2008; Welz et al., 2014; Welz, 2018). 
 
1.6.3 SPIRE1 / FMN1 / MYO5A cooperate in cytoplasmic melanosome dispersion  
Melanosomes produce, store and transport the natural pigment melanin required for tissue 
coloration and photoprotection. In mammals, melanosomes are synthesized in skin-located 
melanocytes, choroidal melanocytes and retinal pigment epithelial cells (RPE cells), which 
supply surrounding tissues with an adequate number of melanosomes (Wasmeier et al., 2008). 
In general, the transport and release of melanosomes into distinct tissues provide the 
melanosome receiving cells with the photoprotective and dark-colored melanin. As a 
consequence, melanin colors mammalian skin, hair and eyes. In addition, the pigment prevents 
cellular DNA damages caused by ultraviolet irradiation (Raposo and Marks, 2007; Wasmeier 
et al., 2008; D`Orazio et al., 2013). Consequently, a loss of melanosome function is associated 
with albinism and is linked to the pathogenesis of skin melanoma (Wasmeier et al., 2008; 
Oberhofer et al., 2017). 
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Skin melanocytes distribute melanosomes via dendrites to provide keratinocytes with an 
adequate amount of melanin. In this process, the intra- and intercellular transport mechanisms 
of melanosomes play an important role in facilitating melanin supply to a specific area 
(Alzahofi, Robinson, Welz et al., 2018). In the 1990s, it was described that melanosomes are 
transported along microtubules and actin filaments, but only the actin-based transport 
mechanism was investigated in more detail (Wei et al., 1997; Wu et al., 1997). In this context, 
an old model hypothesized that melanosomes are transported in a fast microtubule-dependent 
long-range distance transport to the tip of melanocyte dendrites where they are captured by a 
MYO5-based mechanism at actin filaments (Wu et al., 1998).  
In dendrites of melanocytes, the intracellular melanosome transport along actin filaments is 
facilitated by a tripartite complex containing RAB27A, melanophilin (MLPH) and MYO5A. 
The melanosome bound RAB27A associates with MLPH, which acts as an adapter between 
RAB27A and MYO5A to finally target MYO5A towards melanosomes (Hume et al., 2001; 
Matesic et al., 2001; Wu et al., 2001; Fukuda et al., 2002; Hume et al., 2002; Nagashima et al., 
2002; Provance et al., 2002; Wu et al., 2002; Oberhofer et al., 2017). In the old melanosome 
transport model, the tripartite complex therefore facilitates the association of melanosomes to 
actin filaments in dendrites of melanocytes, enables the detachment of melanosomes from 
microtubules, and facilitates positioning of melanosomes close to the plasma membrane. The 
tripartite complex is therefore required for the retention of melanosomes in the dendrites of skin 
melanocytes (Wasmeier et al., 2008). In RPE cells, transport of melanosomes along actin 
filaments is organized by a tripartite complex containing RAB27A, the myosin- and 
RAB-interacting protein MYRIP and MYO7A. This complex is similar to the 
RAB27A / MLPH / MYO5A tripartite complex of skin melanosomes and appears to perform 
the same function in RPE cells as its corresponding complex at skin cell melanosomes (Lopes 
et al., 2007; Ramalho et al., 2009). 
In contrast to the intracellular melanosome transport system described herein, a recent study 
revealed that the distribution of melanosomes seems to be determined by the balance of two 
different mechanisms: An actin dependent long-range dispersion and a microtubule based 
perinuclear clustering, but not peripheral dispersion of melanosomes (Alzahofi, Robinson, 
Welz et al., 2018). It was previously shown in 2014 that microtubule depletion by nocodazole 
had little effect on pigment distribution, while disruption of the actin cytoskeleton by 
latrunculin A resulted in significant perinuclear clustering of melanosomes (Evans et al., 2014). 
In the recently published model, the small GTPase RAB27A recruits SPIRE1 to melanosomes 
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and the actin nucleator cooperates in a complex with FMN1 organizing a 
melanosome-originated actin meshwork to drive MYO5A dependent peripheral melanosome 
transport in mouse melanocytes. A lack of FMN1 or SPIRE leads to the loss of peripheral 
melanosome dispersion in melanocytes, and results in a perinuclear clustering of melanosomes 
(Alzahofi, Robinson, Welz et al., 2018). The experiments of the recent publication indicate that 
SPIRE1 / FMN1 / RAB27A are important to produce a dynamic actin meshwork for 
melanosome transport, while the tripartite complex of RAB27A / MLPH / MYO5A uses the 
actin meshwork to transport melanosomes (Figure 7). In addition to mouse oocytes, the 
publication also shows a long-range transport mechanism along dynamic actin filaments 
mediated by SPIRE / FMN-nucleated actin filaments (Alzahofi, Robinson, Welz et al., 2018). 
The importance of the RAB27A / MLPH / MYO5A complex is underscored by the fact that 
gene mutations within any member of the complex result in a rare disease - the Griscelli 
syndrome (GS). The autosomal recessive hereditary GS is classified into three different 
subtypes, of which GS type 3 represents the mildest form of the disease. All known patients 
suffering from any subtype of GS have hypopigmentation of skin and hair (characteristically 
silvery gray hair), and show a perinuclear accumulation of melanosomes in melanocytes, 
caused by a transport failure of melanosomes (Huizing et al., 2008; van Gele et al., 2009). GS 
type 1 is caused by specific mutations in the MYO5A gene and patients show severe 
impairments of brain function, primary neurological symptoms and hypopigmentation. In 
contrast, GS type 2 is associated with immune system abnormalities in addition to 
hypopigmentation, but is not associated with brain dysfunctions. Mild GS type 3 patients only 
show hypopigmentation of skin and hair (Huizing et al., 2008). 
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Figure 7 - Model how RAB27A 
could regulate actin filament 
driven melanosome transport 
in melanocytes by recruiting 
SPIRE1 / FMN1 and MLPH / 
MYO5A towards 
melanosomes. In this model 
RAB27A recruits SPIRE1 / 
FMN1 and MLPH / MYO5A to 
melanosomes. The SPIRE1 / 
FMN1 / RAB27A complex is 
important to produce a dynamic 
actin meshwork for melanosome 
transport, while the tripartite 
complex of RAB27A / MLPH / 
MYO5A uses the actin 
meshwork to ultimately transport 
melanosomes. In this context, 
SPIRE1 and MLPH proteins 
recruited by RAB27A could 
translocate MYO5A towards melanosomes, facilitating transport along actin filaments 
(modified from Alzahofi, Robinson, Welz et al., 2018).  
 
1.7 Knockout mouse models of the actin nucleators SPIRE and FMN subgroup 
formins 
The low expression levels of the actin nucleators SPIRE and FMN subgroup formins make it 
complicated to investigate the intracellular functions of these proteins at endogenous levels. In 
order to explain the cell biological mechanisms to which the proteins contribute, mouse models 
have been established. 
 
1.7.1 The SPIRE1 mutant mouse  
To gain a deeper insight into the cellular functions of the SPIRE1 protein, a mutant mouse 
model lacking the expression of any functional SPIRE1 protein was generated. A DNA 
gene-trap insertion following the fifth exon inhibits the translation of the SPIRE1 mRNA 
immediately after N-terminal SPIRE1 KIND. As a result, the expression of all three SPIRE1 
isoforms is abolished, i.e. neither a functional SPIRE1 nor SPIRE1-E9 nor mitoSPIRE1 protein 
is synthesized. The N-terminal SPIRE1 domain of SPIRE1 mutant mice can be translated as a 
single truncated protein containing a functional KIND. In this context, the presence of the single 
KIND domain could influence SPIRE / FMN interaction in a dominant negative effect (Pleiser 
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et al., 2014). However, SPIRE2 protein expression is not affected by the SPIRE1 inserted 
gene-trap, because the SPIRE2 gene locus is located on a different chromosome (Pleiser et al., 
2014; Kollmar, Welz, Straub et al., 2019). SPIRE proteins affect the spindle positioning and 
polar body extrusion of maturating oocytes and therefore their maturation into eggs (Pfender et 
al., 2011). The redundant function of SPIRE2 is sufficient to compensate SPIRE1 functions for 
oocyte maturation that SPIRE1 mutant mice are still fertile (Pleiser et al., 2014). Interestingly, 
SPIRE1 mutant mice do not show any anatomical abnormalities. However, on a cellular level, 
cortical neurons of SPIRE1 mutant mice show a reduced number of dendritic spines. 
Phenotyping of SPIRE1 mutant mice revealed an increased fear expression in contextual and 
cued fear conditioning experiments of male mice. The fear expression phenotype indicates a 
highly specific function of proteins expressed from the SPIRE1 gene in fear learning (Pleiser et 
al., 2014). A human correlate to the SPIRE1 mutant mouse model with a functional loss of 
SPIRE1 or SPIRE2 has not yet been discovered. 
 
1.7.2 The FMN1 knockout mouse 
In 2009, a mouse model lacking the expression of functional FMN1 proteins was established - 
the FMN1Pro mouse model. The FMN1Pro mouse has a genetic disruption at the proline-rich 
FH1 domain of FMN1, which is why these mice fail to synthesize any full-length FMN1 
proteins. The loss of functional FMN1 splice variants causes kidney aplasia and limb 
development defects (oligodactyly phenotype) in mice, but FMN1Pro mice are still viable and 
fertile (Zhou et al., 2009). Until now the FMN1Pro mouse model has not been characterized in 
fear conditioning experiments. 
 
1.7.3 The FMN2 knockout mouse 
In 2002, a knockout mouse model for the SPIRE interacting FMN2 was established. The 
knockout mice neither show abnormalities of anatomic structures nor obvious defects in the 
central nervous system. Nevertheless, metaphase I oocytes of female FMN2 knockout mice fail 
in spindle positioning and polar body extrusion. As a consequence, female FMN2 knockout 
mice are hypo-fertile and fertilization of FMN2 knockout oocytes results in a polyploid embryo 
formation. In contrast fertility of male knockout animals is not affected by the absence of FMN2 
(Leader et al., 2002; Dumont et al., 2007). A more recent study shows that the absence of FMN2 
causes a reduced number of dendritic spines in neuronal cells (Law et al., 2014). In addition, 
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the loss of FMN2 induces mild deficits in neuronal plasticity (Agís-Balboa et al., 2017). 
Phenotyping of these knockout mice revealed an impairment of fear extinction and an age 
dependent loss of fear memory (Peleg et al., 2010; Agís-Balboa et al., 2017). 
 
1.8 Mutations of the human FMN2 protein 
As the maturation of mouse oocytes is dependent on FMN2 function, it might be obvious that 
the fertility of women is also affected by defects of the FMN2 protein. For this reason, a study 
analyzed the FMN2 gene for women with unexplained infertility. Only six patients with 
unexplained infertility were investigated, but none of these patients showed an abnormality in 
the FMN2 gene. To figure out if FMN2 also affects human fertility, women with unexplained 
infertility and meiosis I arrest of oocytes, as shown for the FMN2 knockout mouse, have to be 
analyzed for FMN2 mutations (Ryley et al., 2005). 
Homozygous FMN2 truncations in two independent and consanguineous families show 
offsprings with an intellectual disability (ID). An ID is defined by cognitive deficits, which 
means an IQ lower than 70, and limitations in adaptive behavior. One consanguineous family 
originates from Pakistan and the other one from Egypt. The healthy Pakistani parents have 6 
offspring, three of which are affected by ID. On the other hand, two of the six children of the 
healthy Egyptian parents are affected. All individuals affected by ID, regardless of which family 
they’re from, harbored a homozygous frameshift mutation in the FMN2 gene, which suggests 
a recessive inheritance. Fibroblasts from an affected individual and a non-affected littermate 
were reprogrammed to neuronal cells and the synaptic density was determined. Synaptic density 
in diseased cells was nearly reduced by half in comparison to the healthy control (Law et al., 
2014). The culmination of these studies demonstrates the importance of the actin nucleator 
FMN2 for neuronal systems.  
 
1.9 Aim of the thesis  
This thesis aims to explain on a molecular level the increased fear-related behavior in contextual 
and cued fear conditioning experiments of SPIRE1 mutant mice, lacking the expression of any 
functional SPIRE proteins from the SPIRE1 gene. 
SPIRE actin nucleators organize local actin / myosin networks at vesicle membranes, which 
mediate the cortical transport of RAB11 vesicles in oocytes and the cytoplasmic dispersion of 
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melanosomes (Schuh et al., 2011; Alzahofi, Robinson, Welz et al., 2018). In this context, 
mitochondrial motility seems to be influenced by actin-associated myosin motor proteins and 
actin filaments (Hollenbeck and Saxton, 2005; Pathak et al., 2010; Gutnick et al., 2019). 
Recently, the mitochondrial targeting of a splice variant of the SPIRE1 actin nucleator was 
discovered and the corresponding protein was named ‘mitoSPIRE1’ (Manor et al., 2015). The 
localization of mitoSPIRE1 is most likely unique to SPIRE proteins, and might therefore not 
be compensated by SPIRE2 proteins expressed from the SPIRE2 gene. Knowledge of the 
intracellular expression and function of mitoSPIRE1 could help to interpret the fear 
conditioning phenotype of SPIRE1 mutant mice.  
Accordingly, the work presented here addresses the expression, localization and the specific 
function of the mouse mitoSPIRE1 protein. As a basic tool to differentiate the mitochondrial 
from vesicular SPIRE1 functions, a mitoSPIRE1 knockout mouse has been generated. 
Following the hypothesis that mitoSPIRE1, in analogy to its vesicular homologs, organizes 
actin / myosin networks at mitochondria membranes, I have analyzed if mitoSPIRE1 influences 
mitochondrial morphology, function and motility. Overall these studies provide basic cell 
biological knowledge to resolve the function of SPIRE1 in fear learning. Based on the theory 
that mitoSPIRE1 influences fear behavior, it is indispensable to understand the molecular 
function of mitoSPIRE1, which could potentially be used in the future as a medical treatment 
for patients suffering from anxiety disorders. 
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2. Materials and methods 
Parts of the materials and methods section were already published in Alzahofi, Robinson, Welz 
et al., 2018 and in Kollmar, Welz, Straub et al., 2019. These materials and methods sections are 
written by myself and generated for the mentioned publications and my dissertation. 
 
2.1 Primer design  
Primer pairs for polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) to 
amplify specific genomic DNA and cDNA sequences were designed using the web-based tool 
Primer3 (http://primer3.ut.ee). The sequence specificity of each primer pair was checked by 
performing a Primer-BLAST search against the genomic DNA database 
(www.ncbi.nlm.nih.gov/blast). Primer oligonucleotides consist of 18 to 30 nucleotides and 
have a GC content of 40 - 60 %. qPCR primer pairs were chosen to amplify exon specific 
sequences less than 150 base pairs and flank a region that contains at least one intron. PCR 
primer pairs were mostly chosen to amplify fragments less than 1000 base pairs. All primers 
were synthesized by Sigma-Aldrich (St. Louis, USA) and purified by HPLC. Lyophilized 
primers were resuspended in DEPC-H2O and stored at -20 °C. Prior to use in qPCR all primers 
were tested to amplify a specific band in PCR and agarose gel separation (method written as 
presented in Kollmar, Welz, Straub et al., 2019). 
 
2.2 Agarose gel electrophoresis  
Agarose gel electrophoresis was used to visualize the fragment lengths of amplified PCR 
products or digested vectors and DNA inserts. By heating and shaking a specific amount of 
ultrapure agarose (Thermo Fisher Scientific Inc. (ThermoFisher), Waltham, USA) was solved 
in 0.5x TBE buffer. For subsequent visualization of DNA in UV light 10 mg/ml 
ethidiumbromide (Carl Roth, Karlsruhe, Germany) was added to the hot mixture and the 
mixture was finally poured into a sealed gel casting tray. Here we generated agarose gels with 
an agarose concentration between 1 % (used for separation of DNA fragments longer than 1000 
bp) and 2.5 % (used for separation of DNA fragments shorter than 1000 bp). DNA samples 
were mixed with 6x DNA loading dye, filled into gel pockets of the agarose gel and separated 
at 120 V for 30 min in 0.5x TBE buffer. As a molecular length marker one pocket of each gel 
was loaded with a 1 kb or 100 bp (ThermoFisher) -standard, which allows the identification of 
DNA samples in size by comparison with the utilized size standard. 
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2.3 Agarose gel clean-up  
For further processing of DNA fragments, which are separated by fragment length in an agarose 
gel, electrophoresis DNA bands were extracted from the agarose gel and purified with the 
NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel, Düren, Germany). The kit was used 
according to the manufactures protocol. In general, the kit is based on the binding of DNA to a 
silica membrane, followed by multiple washing steps and finally DNA is eluted with 30 μl 
elution buffer (5 mM Tris-HCl, pH 8.5). The concentration and purity of extracted DNA was 
analyzed by spectrophotometric analysis.  
 
2.4 RNA isolation 
2.4.1 RNA isolation of mouse organs 
Male C57BL/6J mice were ordered from Charles River Laboratories (Sulzfeld, Germany) at an 
age of 6 weeks. Immediately after arrival mice were killed by cervical dislocation and organs 
of interest were isolated. Organs were weighted and stored in an adequate amount of RNA later 
(Qiagen, Hilden, Germany) at 4 °C, which inhibits RNA degradation. For total RNA 
preparations of organs, the RNeasy Midi Kit (Qiagen) was used according to manufacturer’s 
recommendation. Disruption and homogenization of organs was done with the TissueRuptor 
(Qiagen). Isolated RNA was stored in the freezer at -20 °C (method written as presented in 
Kollmar, Welz, Straub et al., 2019). 
 
2.4.2 Total RNA isolation from eukaryotic cultured cells 
Mammalian cells were cultured until they are 80 - 90 % confluent. Total RNA from cells of 
interest was isolated according to the manufacturer´s protocol of the NucleoSpin RNA Kit from 
Macherey-Nagel. Following the protocol genomic DNA is eliminated and RNA is isolated by 
binding to a silica membrane. After isolation the amount and purity of total RNA was directly 
determined by spectrophotometric analysis. Isolated RNA was stored in the freezer at -20 °C. 
 
2.4.3 Analysis of RNA / DNA purity and concentration 
In order to determine the yield and purity of isolated RNA spectrophotometric analysis by a 
Nanophotometer® (Implen GmbH, Munich, Germany) spectrophotometer was done. Nucleic 
acid concentration measurements in the Nanophotometer® are based on absorbance at a 
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wavelength of 260 nm. A volume of 1 μl isolated total RNA was used to determine RNA 
concentration as well as purity and measured in triplicates per sample. 260/280 absorbance ratio 
was obtained and used in assessment of sample purity. In this context a value of ~ 1.8 describes 
pure DNA and a value of ~ 2.0 indicates pure RNA. In this thesis only isolated total RNA and 
DNA with a high purity were used. 
 
2.4.4 RNA quality 
Sample integrity of isolated total RNA from mouse organs was measured with the QIAxcel 
(Qiagen) using the QIAxcel RNA QC Kit v2.0 (Qiagen) according to the manufacturer´s 
protocol. For each organ the quality of isolated total RNA from a single organ was determined 
vicariously for all isolated organs from the same type. QIAxcel instruments determine the RNA 
Integrity Score by capillary gel electrophoresis of nucleic acids, which allows interpretation of 
sample integrity. In this context the highest RNA Integrity Score of 10 describes a completely 
intact RNA, whereas the lowest RNA Integrity Score of 1 indicates a high degradation of the 
RNA sample. An RNA Integrity Score above 6 still indicates a high quality of RNA, why in 
this thesis isolated total RNAs were only used if they have an RNA Integrity Score higher than 
6. 
 
2.5 PCR techniques 
The belonging sections (2.5.2 - 2.5.4) of the chapter ‘PCR techniques’ are written as described 
in standard protocols of the Kerkhoff laboratory and as presented in Welz, 2018. 
 
2.5.1 Reverse transcription (synthesis of cDNA) 
Using isolated total RNA as template cDNA was generated by reverse transcription employing 
the QuantiNova Reverse Transcription Kit (Qiagen) according to the manufacturer´s protocol. 
In this method, the ability of the enzyme reverse transcriptase enables the synthesis of DNA 
from an RNA template. The QuantiNova Reverse Transcription Kit includes a genomic DNA 
removal step, which excludes the abundance of false positive cDNA fragments made from 
genomic DNA. For cDNA used in qPCR we used an internal control RNA provided by the kit 
to verify successful and efficient reverse transcription. After successful cDNA generation, 
cDNA was used for PCR and qPCR and stored in -20 °C. 
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2.5.2 Amplification of cDNA fragments 
Standard qualitative PCR amplification of cDNA fragments was performed to check for general 
gene expression from specific mouse tissues or cultured cells. PCR was done in 200 μl 
PCR-SoftTubes (Biozym Scientific GmbH, Hessisch Oldendorf, Germany) using Q5 
High-Fidelity DNA Polymerase (New England Biolabs (NEB), Frankfurt am Main, Germany) 
employing 50 - 200 ng cDNA or 1 ng plasmid DNA as a control. In addition, 10 mM of each 
dNTP, the Mg2+ containing Q5 Reaction Buffer, 10 μM of the reverse and forward primer, and 
upon need the GC Enhancer (all from NEB), which enables better amplification of GC-rich 
sequences, were mixed and added gently to the PCR reaction tube. For each PCR the elongation 
time for DNA synthesis (tE) was calculated individually for the length of the amplified fragment 
(30 sec per 1000 bp) and extension temperature was set to 72 °C. The primer annealing 
temperature (TA) was set 5 °C lower than the primers melting temperature (Tm) of the lower 
primer Tm. To generate a sufficient product yield 30 - 35 amplification cycles were used. The 
specific length of PCR products was analyzed by agarose gel electrophoresis. The cycling 
protocol is shown in Table 1. 
(i) 
Reagent Volume 
5X Q5 Reaction Buffer 5 μl 
10 mM dNTPs (each) 0.5 μl 
10 μM forward primer 1.25 μl 
10 μM reverse primer 1.25 μl 
template cDNA 50 - 200 ng 
Q5 DNA Polymerase 0.25 μl 
(5X Q5 High GC Enhancer) (5 μl) 
nuclease-free water to 25 μl 
total 25 μl 
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(ii) 
Step  Temperature Time 
Initial Denaturation 98 °C 30 sec 
Denaturation 98 °C 8 sec 
Annealing              30 - 35 cycles 50 - 72 °C (TA) 25 sec 
Extension 72 °C  30 sec/kb (tE) 
Final Extension 72 °C  120 sec 
Storage 4 °C hold 
Table 1 - Protocol for routine PCR using defined components (i) and thermocycling 
conditions (ii) for DNA fragment amplification by Q5 High-Fidelity DNA Polymerase. 
Annealing temperature (TA) = 5 °C less than melting temperature (Tm) of the lower Tm from 
used primer pair. Elongation time (tE) = 30 sec for 1000 bp. 
 
2.5.3 Amplification of genomic DNA fragments (genotyping of mice) 
General PCR amplification was performed in 200 μl PCR-SoftTubes (Biozym Scientific 
GmbH) using up to 50 ng template DNA mixed with Taq DNA Polymerase (NEB) and Standard 
Taq Buffer (NEB). This method was used besides others to genotype wild type, SPIRE1 mutant 
and mitoSPIRE1 knockout mice. For each PCR the elongation time for DNA synthesis (tE) was 
calculated individually for the length of the amplified fragment (60 sec per 1000 bp) and 
extension temperature was set to 72 °C. The primer annealing temperature (TA) was set 5 °C 
lower than the primers melting temperature (Tm) of the lower primer Tm. For generation of a 
sufficient product yield 35 amplification cycles were used. The specific length of PCR products 
was analyzed by agarose gel electrophoresis. The cycling protocol is shown in Table 2. 
(i) 
Reagent Volume 
template DNA 0.1 - 50 ng 
25 mM dNTPs (each) 0.3 μl 
10 μM forward primer 0.3 μl 
10 μM reverse primer 0.3 μl 
Standard Taq Buffer 3 μl 
Taq DNA Polymerase 0.3 μl 
nuclease-free water to 30 μl 
total 30 μl 
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(ii) 
Step  Temperature Time 
Initial Denaturation 95 °C 180 sec 
Denaturation 95 °C 20 sec 
Annealing               35 cycles TA °C 30 sec 
Extension 68 °C  60 sec/kb (tE) 
Final Extension 68 °C  300 sec 
Storage 4 °C hold 
Table 2 - Protocol for routine PCR using defined components (i) and thermocycling 
conditions (ii) for DNA fragment amplification by Taq DNA Polymerase. Annealing 
temperature (TA) = 5 °C less than melting temperature (Tm) of the lower Tm from used primer 
pair. Elongation time (tE) = 60 sec for 1000 bp. 
 
2.5.4 Amplification of cDNA fragments for cloning 
DNA fragment amplification for cloning was performed in 200 μl PCR-SoftTubes (NEB) using 
50 ng template DNA (plasmid DNA) and the Pfx DNA Polymerase (ThermoFisher). For each 
PCR the elongation time for DNA synthesis (tE) was calculated individually for the length of 
the amplified fragment (60 sec per 1000 bp) and extension temperature was set to 68 °C. The 
primer annealing temperature (TA) was set 5 °C lower than the primers melting temperature 
(Tm) of the lower primer Tm. For generation of a sufficient product yield 35 amplification cycles 
were used. The cycling protocol is shown in Table 3. 
(i) 
Reagent Volume 
template DNA 50 ng 
10 μM forward primer 3 μl 
10 μM reverse primer 3 μl 
10X Pfx Buffer 5 μl 
Pfx DNA Polymerase 1 μl 
nuclease-free water to 50 μl 
total 50 μl 
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(ii) 
Step  Temperature Time 
Initial Denaturation 95 °C 300 sec 
Denaturation 95 °C 60 sec 
Annealing               35 cycles TA °C 30 sec 
Extension 68 °C  60 sec/kb (tE) 
Final Extension 68 °C  300 sec 
Storage 4 °C hold 
Table 3 - Protocol for routine PCR using defined components (i) and thermocycling 
conditions (ii) for DNA fragment amplification by Pfx DNA Polymerase. Annealing 
temperature (TA) = 5 °C less than melting temperature (Tm) of the lower Tm from used primer 
pair. Elongation time (tE) = 60 sec for 1000 bp. 
 
2.5.5 Quantitative real-time PCR 
Expression vectors encoding mouse SPIRE1, SPIRE1-E9, mitoSPIRE1 and SPIRE2 cDNAs 
(see Table 18) were used as positive controls. The absolute gene quantification by quantitative 
real-time PCR (qPCR) was performed with the Rotor-Gene Q thermocycler (Qiagen) and the 
QuantiNova SYBR Green PCR Kit (Qiagen). Each reaction was set up in triplicates and cycle 
threshold (CT) values were calculated by the Qiagen Rotor-Gene Q Series Software. Reactions 
were pipetted with Filter pipette tips (Sarstedt, Nümbrecht, Germany; and Greiner Bio-One, 
Frickenhausen, Germany). For absolute quantification of sample mRNA copy numbers specific 
expression vectors encoding mouse SPIRE1, SPIRE1-E9, mitoSPIRE1 and SPIRE2 cDNAs (see 
Table 18) were used to generate a standard curve with known copy number concentrations. 
Therefore, plasmid DNA was linearized by restriction digest and then serially diluted in water. 
The copy number of standard DNA molecules was then determined by the following formula 
(from the script ‘Critical Factors for Successful Real Time PCR’, Qiagen):  
 
#	 X	 gµl 	DNA[plasmid	length	in	basepairs	 × 	660]< × 	6.022	 ×	10@A 	= 	Y	moleculesµl  
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CT values of the samples were compared to those of the standard curve with known 
concentrations to calculate the sample mRNA copy numbers. The primer pairs used for 
quantitative PCRs are shown in Table 15. The primer pair for ‘SPIRE1’ amplifies all three 
splice variants from the SPIRE1 gene whereas the primer pairs for ‘SPIRE1-E9’ and 
‘mitoSPIRE1’ are specific for the distinct splice variant. To determine the exact copy number 
of SPIRE1 mRNA, the calculated copy numbers of SPIRE1-E9 and mitoSPIRE1 were 
subtracted from the calculated total SPIRE1 copy number (method written as presented in 
Kollmar, Welz, Straub et al., 2019). 
 
2.6 Cloning 
Most of the used DNA constructs (plasmids with specific DNA inserts) in the present thesis 
were generated by Annette Samol-Wolf and Dr. Tobias Welz from the Kerkhoff laboratory (see 
Figure 9, 10). In the following chapter the general procedure for cloning is described as it is 
performed in the Kerkhoff laboratory. Point mutants were generated using the In-Fusion HD 
cloning kit (TakaraBio, Kusatsu, Japan). The belonging sections (2.6.1 -  2.6.4) of the chapter 
‘Cloning’ are written as described in standard protocols of the Kerkhoff laboratory and as 
presented in Welz, 2018. 
 
2.6.1 Restriction digest and ligation of DNA vectors 
A commercial DNA vector (plasmid) like pAcGFP1-C1 (Clontech, Kusatsu, Japan) have been 
chosen to finally integrate a DNA fragment of interest. For successful integration of a novel 
DNA fragment 2 μg of plasmid DNA was first digested with specific restriction endonucleases 
(NEB) in the appropriate buffer for 2 hours at 37 °C. In general, a combination of two restriction 
endonucleases was chosen, each cutting the plasmid only once, resulting in a truncated vector 
and a belonging inlay. Therefore, the digested plasmid shows two DNA bands in agarose gel 
electrophoresis - a digested vector and the cut insert. Indeed, the cut insert has mostly only a 
few bp why it is hard to see it in the agarose gel. As a conformation for successful plasmid 
digestion two controls were used: an undigested vector and a vector which was only digested 
with one of the two restriction endonucleases. Calf Intestinal Alkaline Phosphatase (CIP; NEB) 
removes the phosphate groups at the 5´ends of DNA and inhibits therefore the religation of the 
digested plasmid, why CIP was added 60 and 90 min after the start of the restriction digest. The 
DNA fragment of interest was amplified by PCR, separated by agarose gel electrophoresis, 
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purified and finally digested with identical restriction endonucleases (NEB) as the plasmid. 
After separation by gel electrophoresis and DNA purification a ligation from the digested 
plasmid and the digested DNA fragment of interest was performed using T4 DNA Ligase 
(NEB) at 16 °C over night. 
 
2.6.2 Transformation of Escherichia coli bacterial cells 
For amplification of newly generated DNA plasmids the chemo-competent NEB10-beta 
competent E. coli (Δ(ara-leu) 7697 araD139 fhuA ΔlacX74 galK16 galE15 
e14-φ80dlacZΔM15 recA1 relA1 endA1 nupG rpsL (StrR) rph spoT1 Δ(mrr-hsdRMS-mcrBC); 
NEB) were used. Bacteria were transformed with the ligated plasmid from 2.6.1 to finally 
produce and purify plasmid DNA in a high demand. For transformation 100 μl competent E. 
coli were thawed on ice and the ligation mixture was subsequently added to the thawed E. coli. 
After 1 h incubation on ice the mixture of E. coli cells and the ligated plasmid were treated with 
a heat shock (42 °C) in a water bath for 55 seconds, which facilitates plasmid uptake for 
bacterial cells. Following incubation on ice for 2 min, 900 μl LB0 medium (Carl Roth) was 
added to bacteria and the suspension was incubated for at least 1 h at 37 °C while shaking. After 
centrifugation (10 min; 4600 × g; room temperature) 800 μl of the supernatant was discarded 
and bacteria are resuspended in the remaining supernatant and were plated and cultured on 
respective agar selection plates over night at 37 °C. 
 
2.6.3 Plasmid DNA extraction and purification from bacterial cells 
After successful transformation of E. coli bacteria with newly generated plasmid DNA or 
existing plasmid DNA for re-transformations, single bacterial colonies on selective agar plates 
from 2.6.2 are used to extract plasmid DNA and check for its correctness. Therefore, single 
colonies were picked, and each bacterial colony is transferred into its own reaction vessel 
containing LB0 medium, including respective antibiotics, and incubated over night at 37 °C 
while shaking. On the following day, LB0 medium turned into a turbid suspension which 
indicates that bacteria have been replicated, why plasmid DNA was extracted and purified from 
bacterial cells at this day. Extraction and purification of lower plasmid amounts for control 
digests and control DNA sequencing of plasmids was performed by Plasmid-Mini-Purification 
(MiniPrep). After confirmation of the correct plasmid DNA sequence a higher yield of plasmids 
for usage in different experiments was generated by Plasmid-Maxi-Purification (MaxiPrep). 
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MiniPrep was performed using the QIAprep Spin Miniprep Kit (Qiagen), while the QIAGEN 
Plasmid Maxi Kit (Qiagen) was used for MaxiPrep. Both plasmid purification kits were used 
according to the manufacturer´s protocol. Concentration of purified plasmids was measured by 
spectrophotometric analysis and plasmids were subsequently stored in the fridge at 4 °C upon 
usage. 
 
2.6.4 Control digests and DNA sequencing of plasmids 
Extracted and purified plasmids by MiniPrep were used to perform control digests and DNA 
sequencing of plasmids. First purified plasmids were used to perform a control digest to confirm 
successful DNA fragment insertion in the plasmid. Therefore, plasmid solution was treated for 
2 h at 37 °C with respective endonucleases and resulting DNA bands were separated by agarose 
gel electrophoresis. The presence of a digested vector and a released insert in the gel confirmed 
the successful DNA fragment insertion into the plasmid. As a second control step the correct 
DNA sequence of the plasmid was confirmed by DNA sequencing. Here, plasmid DNA was 
diluted to a concentration of 100 ng/μl and sent to the commercially available sequencing 
service of LGC Genomics (LGC Genomics, Berlin, Germany). Primers for cloning as well as 
standard primers provided by LGC Genomics were used for DNA sequencing. The resulting 
sequence was checked for correctness by DNA nucleotide sequence alignments (Nucleotide 
BLAST; NCBI) in comparison to the respective cDNA sequence from the DNA fragment of 
interest. In addition, the correct reading frame of the cDNA sequence in relation to the vector 
sequences was verified using the Serial Cloner software (SerialBasics, Franck Perez). 
 
2.7 Cell culture techniques 
HEK293, HeLa cells (both from ATCC, Manassas, Virginia, USA), immortalized mouse 
embryonic fibroblasts (iMEFs) and primary mouse embryonic fibroblasts (pMEF) were 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; ThermoFisher) supplemented with 
10 % (v/v) fetal calf serum (FCSIII; GE Healthcare Life Sciences, Chalfont St Giles, UK), 
2 mM L-glutamine (ThermoFisher), penicillin (100 units/ml; ThermoFisher) and streptomycin 
(100 μg/ml; ThermoFisher) at 37 °C, 5 % CO2, 95 % humidity and were passaged regularly at 
80 % confluency. Passaging of cells was performed by washing cells once with 1x PBS 
(Sigma-Aldrich), detaching cells using 0.05 % Trypsin-EDTA solution (ThermoFisher) and 
inactivating Trypsin-EDTA with an appropriate amount of Full Medium (DMEM, 10 % FCSIII, 
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2 mM L-glutamine, 100 units/ml Penicillin, 100 μg/ml Streptomycin). Finally, a fraction of the 
cell suspension was transferred to a new culture dish containing fresh Full Medium. The chapter 
‘Cell culture techniques’ and the belonging sections (2.7.1 - 2.7.3) are written as described in 
standard protocols of the Kerkhoff laboratory and as presented in Welz, 2018. 
 
2.7.1 Thawing cells 
A cryovial of HEK293, HeLa cells, immortalized mouse embryonic fibroblasts (iMEFs) or 
primary mouse embryonic fibroblasts (pMEF) was taken out of long-term liquid nitrogen 
storage and frozen cells were thawed rapidly (< 1 minute) in a 37 °C water bath. Thawed cells 
were transferred into a 50 ml centrifuge tube containing 15 ml prewarmed Full Medium and 
centrifugated for 6 min at 800 × g, room temperature. Supernatant was discarded, and cell pellet 
was gently resuspended in 1 ml of Full Medium. Finally, the cell suspension was transferred 
into a new 10 cm culture dish (Greiner Bio-One) containing prewarmed Full Medium and cells 
were cultured at 37 °C, 5 % CO2. 
 
2.7.2 Freezing cells 
For long-term storage eukaryotic cells are kept in liquid nitrogen and thawed upon request. 
Cells were frozen in a special Freezing Medium containing Full Medium supplemented with 
FCSIII and the cryoprotective agent dimethylsulfoxide (DMSO). In this context, DMSO allows 
a slow cooling of the Freezing Medium by reducing the freezing point of the medium and 
therefore avoids the risk of ice crystal formation, which can cause cell damages and cell death. 
The specific Freezing Medium is prepared with DMEM supplemented with 10 % DMSO, 20 % 
FCSIII, 2 mM L-Glutamine, penicillin (100 units/ml) and streptomycin (100 μg/ml). Cultured 
cells from eight 10 cm culture dishes were washed with 1x PBS, detached using Trypsin-EDTA 
and Trypsin-EDTA was inactivated by adding Full Medium. Cell suspension was transferred to 
a 50 ml centrifuge tube containing 5 ml Freezing Medium and centrifuged for 6 min at 800 × g, 
room temperature. Supernatant was discarded, cell pellet gently resuspended in 18 ml Freezing 
Medium and 1 ml aliquots were transferred into cryovials (ThermoFisher). Aliquots were 
transferred in a cryo-box filled with isopropanol, which allows a slow cooling at -80 °C of the 
aliquots at a rate of 1 °C/h and therefore inhibits formation of intracellular ice crystals causing 
cell damage and cell death. At the next day the aliquots are transferred into liquid nitrogen for 
extended storage periods. 
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2.7.3 Seeding cells 
For most experiments a certain number of cells were seeded on 6-well plates (Greiner Bio-One), 
microscope cover glasses (A. Hartenstein, Würzburg, Germany) or WillCo dishes 
(WillCo-Dish, 40 mm; WillCo Wells B.V., Amsterdam, The Netherlands). Therefore, cells 
from a 10 cm culture dish were detached using Trypsin-EDTA (as described for passaging cells) 
and the number of cells in the cell suspension was determined by using a Neubauer counting 
chamber (Paul Marienfeld GmbH & Co. KG, Lauda-Königshofen, Germany). To distinguish 
between dead and living cells 10 μl Trypan Blue solution (0.4 %; Sigma-Aldrich) were mixed 
with 10 μl of the cell suspension and mixture was transferred to the Neubauer counting 
chamber. Viable cells in the four independent quadrants, each with an area of 1 mm2 and a 
height of 0.1 mm, were counted and the mean value was calculated. The cell suspension was 
diluted in a 1:1 ratio with Trypan Blue solution, why the mean value was multiplied by 2 to 
equal the dilution factor. Finally, this value represented the number of cells in a volume of 
0.1 μl from the cell suspension, because 1 mm2 (quadrant area) × 0.1 mm (quadrant height) = 
0.1 mm3 (quadrant volume) = 0.1 μl. The total number of cells was calculated for the cell 
suspension and by determining the appropriate volume of a certain cell number, a certain cell 
number was seeded in appropriate culture vessels containing pre-warmed Full Medium. Cells 
were cultured at 37 °C, 5 % CO2. 
 
2.7.4 Staining of mitochondria in eukaryotic cells 
In order to fluorescently label mitochondrial membranes in living HeLa cells and fibroblasts 
the cell permeable compound MitoTracker Orange (ThermoFisher) was used. Cells were 
seeded on glass-bottom cell culture dishes (WillCo-Dish, 40 mm; WillCo Wells B.V.) 20 h 
prior to the experiment. On the next day cells were washed in Opti-MEM (ThermoFisher) and 
incubated with 2 ml of a 5 nM MitoTracker Orange solution diluted in Opti-MEM for 20 min 
at 37 °C, 5 % CO2. Cells were washed again with Opti-MEM to get rid of excess staining 
solution and covered with Opti-MEM for subsequent fluorescence live cell imaging (method 
written as presented in Kollmar, Welz, Straub et al., 2019). 
In addition, the cell-permeable dye tetramethylrhodamine-methylester (TMRM; ThermoFisher) 
was used to stain specifically functional mitochondria. In this context, the staining procedure 
was done to the manufacturer’s protocol. In the present thesis, mitochondria are stained with 
100 nM TMRM. 
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2.7.5 Transfection of eukaryotic cells using Lipofectamine2000 reagent 
Transfections with plasmid DNA were performed using Lipofectamine2000 reagent 
(ThermoFisher) according to manufacturer’s recommendation. In case of low transfection rates, 
the plasmid concentration and / or the amount of Lipofectamine2000 reagent was adjusted. 
 
2.8 Colocalization studies 
The extent of colocalization from SPIRE1 with SPIRE1-E9, mitoSPIRE1 or SPIRE2, 
respectively, at vesicle surfaces or of mitoSPIRE1 or isolated exon 13 with MYO5, formins or 
MitoTracker at mitochondrial membranes as well as the extent of all other colocalization studies 
was analyzed using the ImageJ (V2.0.0) plug-in Coloc2 (National Institute of Health, Bethesda, 
USA). Here, the colocalization rate is indicated by the Pearson’s Correlation Coefficient (PCC) 
as a statistical measure to unravel a linear correlation between the intensity of different 
fluorescent signals. A PCC value of 1 indicates a perfect colocalization, 0 indicates a random 
colocalization and a PCC value of -1 indicates a mutually exclusive localization of the analyzed 
signals. To take the noise of each image into account and to gain an objective evaluation of 
PCC significance, a Costes significance test was performed. To do so, the pixels in one image 
were scrambled randomly and the correlation with the other (unscrambled) image was 
measured. Significance regarding correlation was observed when at least 95 % of randomized 
images show a PCC less than that of the original image, meaning that the probability for the 
measured correlation of two colors is significantly greater than the correlation of random 
overlap (Costes et al., 2004; Pompey et al., 2013). PCC values > 0.2 which failed Costes 
significance test (Costes p-value < 0.95) were excluded from the belonging experiment and not 
used for further statistical analysis (method written as presented in Pylypenko, Welz et al., 
2016). 
 
2.9 Immunostaining 
HeLa cells were seeded on microscope cover glasses and transfected to transiently express 
fluorescently tagged SPIRE, FMN, INF2 and MYO5 proteins as well as Myc-epitope tagged 
SPIRE1 proteins, respectively. Cells were fixed with paraformaldehyde (3.7 % in 1x PBS; Carl 
Roth) for 20 min at 4 °C and subsequently permeabilized using 0.2 % Triton X-100 (in 1x PBS; 
Sigma-Aldrich) for 3.5 min, room temperature. In one experiment 20 μM Digitonin 
(ThermoFisher) for 3 min, room temperature, was used to permeabilize only the cell membrane. 
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Digitonin is a mild permeabilizer which specifically targets cholesterol-rich membranes such 
as the plasma membrane, whereas the mitochondria membranes are not affected due to their 
low concentration of cholesterol. Respective cells were incubated with anti-c-Myc (9E10, 
sc-40, 2 μg/ml, mouse monoclonal; Santa Cruz Biotechnology, Dallas, USA), 
anti-cytochrome C (33-8200, 5 μg/ml, mouse monoclonal, ThermoFisher) and anti-SPIRE1 
(SA-2133, 50 μg/ml, rabbit polyclonal; Schumacher et al., 2004) antibodies, respectively, for 1 
hour at room temperature, and conjugated anti-mouse TRITC (715-025-151, 9.75 μg/ml, from 
donkey; Dianova, Hamburg, Germany) and anti-rabbit Cy5 (711-175-152, 9.75 μg/ml, from 
donkey, Dianova) secondary antibodies, respectively, for 1 h at room temperature avoiding 
exposure to light. Finally, cells were mounted on microscope slides with Mowiol (Merck, 
Darmstadt, Germany), dried at room temperature in the dark and stored at 4 °C. 
 
2.10 Microscopy  
2.10.1 Microscopy of in situ hybridization experiments 
Brain slices from in situ hybridization experiments were analyzed with a Leica DMR 
microscope, equipped with a Leica PL Fluotar 10x/0.30 objective and a Leica DFC320 digital 
camera (2,088 × 1,550 pixels (~ 3.3 MP); 3.45 μm × 3.45 μm pixel size; all from Leica, Wetzlar, 
Germany). Images were recorded using the Leica LASX software and further processed with 
Adobe Illustrator. 
 
2.10.2 Fluorescence microscopy of fixed and immunostained cells 
Fixed cells were analyzed with a Leica AF6000LX fluorescence microscope, equipped with a 
Leica HCX PL APO 63x/1.3 GLYC objective and a Leica DFC7000 GT digital camera 
(1,920 × 1,440 pixel (~ 2.8 MP); 4.54 μm × 4.54 μm pixel size; all from Leica). 3D stacks were 
recorded and processed with the Leica deconvolution software module. Images were recorded 
using the Leica LASX software and further processed with Adobe Illustrator. 
 
2.10.3 Fluorescence microscopy of viable cells 
Live cell imaging for the analysis of moving mitochondria was done with a Leica AM total 
internal reflection fluorescence (TIRF) MC microscope equipped with a Leica HCX PL APO 
100x/1.47 oil objective (all from Leica) and a Hamamatsu EM-CCD C9100-02 digital camera 
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(1000 × 1000 pixel (~ 4.2 MP); 8 μm × 8 μm pixel size; Hamamatsu Photonics, Herrsching am 
Ammersee, Germany). For experiments in this thesis only the epifluorescence mode of the 
TIRF microscope was used. Movies were recorded using the Leica LASX software and further 
processed and analyzed with the IMARIS software (Bitplane, Zürich, Switzerland). 
 
2.11 Quantification of mitochondrial length using microscopy and ImageJ 
Mitochondria of primary mouse embryonic fibroblasts (pMEFs) from wild type, SPIRE1 
mutant and mitoSPIRE1 knockout mice were stained as described above with MitoTracker 
Orange. In fluorescence live cell microscopy, cells with stained mitochondria were recorded 
using the Leica AM TIRF MC microscope equipped with a Leica HCX PL APO 100x/1.47 
oil objective (all from Leica) and a Hamamatsu EM-CCD C9100-02 digital camera 
(1000 × 1000 pixel (~ 4.2 MP); 8 μm × 8 μm pixel size; Hamamatsu Photonics). In this context, 
a randomly chosen section including ~ 10 cells was imaged to record cells with all kinds of 
mitochondria sizes, which reduced a bias caused by unconscious picking single cells with a 
specific mitochondrial length by the experimenter. Images were then transferred to ImageJ 
(National Institute of Health) and the scale was set. The maximal length of each mitochondrion 
was traced with the tool freehand line, followed by length measurement of the drawn line, 
which therefore represented the length of the mitochondrion. For comparison all measured 
mitochondrial lengths of a specific genotype were taken together and the mean was calculated. 
Evaluated means were blotted in a graph and statistics was done. Imaging and analysis of 
mitochondrial length was blinded. 
 
2.12 Quantification of mitochondrial motility 
Mitochondrial motility of primary mouse embryonic fibroblasts (pMEFs) from wild type, 
SPIRE1 mutant and mitoSPIRE1 knockout mice was evaluated with IMARIS (Bitplane). First 
mitochondria were stained with MitoTracker Orange as described above and recorded in a live 
cell imaging with a Leica AM TIRF MC microscope equipped with a Leica HCX PL APO 
100x/1.47 oil objective (all from Leica) and a Hamamatsu EM-CCD C9100-02 digital camera 
(1000 × 1000 pixel (~ 4.2 MP); 8 μm × 8 μm pixel size; Hamamatsu Photonics). Imaged cells 
were picked randomly and mitochondria movement from these cells was recorded for 20 sec 
(1 image/500 ms). Movies of motile mitochondria were transferred as Leica project files to 
IMARIS and movies were processed with the integrated Matlab background subtraction (The 
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MathWorks, Natick, USA). In the following step mitochondria were tracked with the surface 
tool (Max Distance: 1.5 μm; Max Gap Size: 3 μm) of IMARIS. Mitochondria movement was 
difficult to track automatically, because mitochondria crossed each other and sometimes moved 
fast, because of which IMARIS lost tracks or generated incorrect tracks. For this reason, 
automatically tracked mitochondria by the surface tool of IMARIS were checked manually and 
in case of missing or wrong tracks, tracks were corrected manually. Based on the measured 
tracks IMARIS calculated parameters like track length, maximal track length or maximal 
velocity of mitochondria and these results were exported and saved as Excel-files. Data were 
used to determine the percentage of moving, wiggling and stationary mitochondria in pMEFs 
from wild type, SPIRE1 mutant and mitoSPIRE1 knockout mice. Here, moving mitochondria 
were determined as mitochondria which had a track length > 4 μm/20 sec, while wiggling 
mitochondria had a track length of 1.5 - 4 μm/20 sec, and stationary mitochondria moved less 
than 1.5 μm/20 sec. The calculated parameters from IMARIS were defined as follows; ‘Track 
length’ describes the covered distance of moving mitochondria per time interval. ‘Maximal 
track length’ defines the largest covered distance by a moving mitochondrion of a cell per time 
interval. ‘Maximal velocity’ determines the highest speed reached by moving mitochondria 
while transportation. Each parameter was calculated for all moving mitochondria of a cell. Data 
were summarized in Excel (Microsoft Corporation, Albuquerque, USA) and further processed 
to generate means of parameters per cell. For the presentation of parameters in a bar diagram, 
the average of all mean values calculated per cell was evaluated. The same procedure was used 
to measure mitochondrial motility when mitoSPIRE1 was transiently overexpressed in pMEFs. 
Transiently overexpression of AcGFP1 was used as a control and all transfections were 
performed as described above. Results were finally summarized in graphs and statistics were 
determined. 
 
2.13 Analysis of MYO5A positive mitochondria and mitochondrial sizes using 
FAMS 
Fluorescence-activated mitochondria sorting (FAMS) is based on the principle of a standard 
fluorescence-activated cell sorting (FACS) machine. FAMS allows to identify mitochondrial 
surface molecules and to determine size of fluorescent stained mitochondria. For FAMS 
cultured cells were detached and collected by centrifugation (300 × g for 5 minutes). The cell 
pellet was resuspended in FACS buffer (1x PBS pH 7.2, 0.5 % BSA, 2 mM EDTA) at a cell 
density of 1 × 106 cells/ml. Cells were incubated with 100 nM MitoTracker Red CMXRos 
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(MTR; ThermoFisher) at 37 °C, 5 % CO2 for 15 minutes. Cell suspensions were pelleted at 
300 × g and resuspended in 1 ml of ice-cold hypo-osmotic buffer (RSB Hypo Buffer, Cold 
Spring Harbor Protocols; 10 mM NaCl, 1.5 mM MgCl2, 10 mM Tris-HCl (pH 7.6)). Following 
a ten-minute swelling period at 4 °C, samples were subjected to 35 strokes of dounce 
homogenization. Cell lysates were centrifuged at 12,000 × g for 5 minutes at 4 °C. Supernatant 
was aspirated, and pellets were resuspended in blocking buffer (0.2 % BSA and 2 % fetal bovine 
serum in 1x PBS) and incubated at room temperature for 20 minutes. Samples were centrifuged 
at 12,000 × g for 5 minutes and then incubated with anti-myosin 5A antibody (G-4, sc-365986, 
0.75 μg/ml, mouse monoclonal, Santa Cruz Biotechnology) conjugated to PE-Cy7 (Abcam, 
Cambridge, UK). Samples were pelleted at 12,000 × g and resuspended in buffered blood bank 
saline (0.85 % (w/v) isotonic solution; ThermoFisher) for analysis via nanoscale flow cytometry 
as described in MacDonald et al., 2019. Briefly, assessment of mitochondria was performed 
using a special ordered BD FACS Aria III, fitted with a photomultiplier tube detector for 
forward light scatter of a 488 nm laser. Mitochondria were identified by size and positive 
fluorescence using mitochondrial-specific dye (MTR) in comparison to unstained negative 
control samples, allowing up to 0.5 % false positive events versus controls. Spectral overlap 
from MTR in PE-Cy7 channel was corrected manually using single color samples. For each 
sample, 50,000 events in total were analyzed. Data were acquired using BD FACSDiva 
software (version 8.0.2; Becton Dickinson, Franklin Lakes, USA) and analysis performed using 
FlowJo (version 10; FlowJo LLC, Ashland, USA). Method was described and performed in 
collaboration with Hannah (Sheehan) Alberico and Prof. Dr. Dori Woods at Northeastern 
University. 
 
2.14 Software  
2.14.1 Statistical analysis  
For all statistical analysis the software SPSS (IBM, Armonk, USA) or SigmaPlot (Systat 
Software GmbH, Erkrath, Germany) was used. To compare more than two groups on one level 
a One-way analysis of variance (ANOVA) was performed, while the comparison of more than 
two groups on two levels was employed by a Two-way ANOVA. If ANOVA revealed a 
significant difference and data are distributed normally a Tukey-Kramer test was used as 
post-hoc analysis, while for data which failed normality test a Mann-Whitney-U-test was 
performed. Statistical analysis between two groups was performed if normality test was passed 
by t-test and if normality test failed by Mann-Whitney-U-test. A difference between groups was 
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determined as significant if the alpha level of post-hoc analysis was < 0.05. For groups with 
n > 25 the effect size was determined as well. In this context, for One-way ANOVA analysis 
eta squared (η²) was calculated to determine the effect size (η2 > 0.01 - 0.06, describes a small 
effect size; η2 > 0.06 - 0.14, describes a medium effect size; η2 > 0.14 describes a large effect 
size). For Two-way ANOVA analysis partial eta squared (η²P) was calculated to determine the 
effect size (η²P > 0.1 - 0.3, describes a small effect size; η²P > 0.3 - 0.5, describes a medium 
effect size; η²P > 0.5 describes a large effect size). 
 
2.14.2 Graphs and cartoons  
In general, diagrams were generated in SigmaPlot (Systat Software GmbH, Erkrath, Germany), 
while FAMS graphs were employed in FlowJo (FlowJo LLC). The online tool Protein 
Homology / analogY Recognition Engine V 2.0 (PHYRE; Structural Bioinformatics Group, 
London, UK) was used to predict the secondary protein structure of the alternatively spliced 
exon 13 from the SPIRE1 gene and the resulting raw structure was further processed in PyMOL 
(Schrödinger LLC, New York, USA). Diagrams and graphs from all software mentioned above 
were further processed in Adobe Illustrator (Adobe Inc., San José, USA). In addition, all 
cartoons in the present thesis were designed with Adobe Illustrator and Adobe Illustrator was 
finally used to organize colors, lettering and layout of figures. 
 
2.14.3 Written work  
The present thesis and all other written work during my PhD such as progress reports were 
performed with Microsoft Word (Microsoft Corporation). 
 
2.14.4 Identification of protein domains 
The online tool ‘Simple Modular Architecture Research Tool’ (SMART; 
http://smart.embl-heidelberg.de) allows the identification of domain organizations and the 
belonging amino acid boundaries from specific amino acid sequences. These informations were 
used to draw proteins with their belonging domains in the here presented cartoons in scale. The 
amino acid sequence from the protein of interest was analyzed using the normal SMART tool. 
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2.14.5 DNA and cDNA sequences 
Respective DNA / cDNA sequences were obtained from the NCBI Gene database 
(https://www.ncbi.nlm.nih.gov). The Serial Cloner software was used to translate cDNA in 
amino acid sequences. 
 
2.15 Mitochondrial respiration 
The mitochondrial respiration of primary mouse embryonic fibroblasts (pMEFs) from wild type 
and SPIRE1 mutant mice was studied by analyzing the oxygen consumption rate (OCR) using 
the Seahorse Flux Analyzer (Agilent Technologies, Santa Clara, USA). 25 × 103 wild type or 
SPIRE1 mutant pMEFs were grown for 24 hours in XFp 8 well miniplates (Agilent 
Technologies) at 37 °C, 5 % CO2. Cartridges were prepared according to manufacturer’s 
recommendation and the OCR from different metabolic stages of mitochondria was analyzed 
using the XFp Cell Mito Stress Kit (Agilent Technologies) containing the mitochondrial stress 
compounds oligomycin (1 μM), carbonilcyanide p-triflouromethoxyphenylhydrazone (FCCP; 
2 μM) and antimycin A / rotenone (1 μM). The OCR was measured by means of a XFp Seahorse 
Flux Analyzer (Agilent Technologies). 
 
2.16 Isolation of pMEFs from mouse embryos 
For successful isolation of primary mouse embryonic fibroblasts (pMEFs) from homozygous 
mitoSPIRE1 knockout and wild type embryos heterozygous mitoSPIRE1 knockout mice were 
crossbred. Furthermore, heterozygous SPIRE1 mutant mice were crossbred to isolate pMEFs 
from homozygous SPIRE1 mutant and wild type embryos. In this thesis only pMEFs from 
mother mice which gave birth to heterozygous and to both homozygous genetic possibilities 
were used. At embryonic day 14.5 pregnant mice were killed by cervical dislocation. The uterus 
was removed from the mouse, embryos were isolated and stored in a petri dish with cold sterile 
1x PBS. Two limbs of each embryo were collected and used for following genotyping of the 
embryos by PCR. Each embryo was handled individually and within 60 minutes after death of 
the mother animal. After removing all red organs from the embryo, the belonging embryonal 
body was washed with 1x PBS to remove as much blood as possible. In the next step the embryo 
was sliced into fine pieces with the help of two scalpels (Megro, Wesel, Germany) and 
transferred into a 15 ml conical tube containing 3 ml of ice-cold 0.05 % Trypsin-EDTA solution 
(ThermoFisher). Conical tubes were stored over night at 4 °C to allow the trypsin to diffuse 
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into the tissue. Between preparation of different embryos scissors (Megro), forceps (Dumont, 
Montignez, Switzerland) and scalpels were washed with 70 % ethanol and water to avoid 
cross-contamination between different genotypes. At the next day the Trypsin-EDTA 
supernatant was discarded and the tubes containing the embryonal tissue were incubated for 
15 min at 37 °C in a water bath. Adding 3 ml Full Medium to each embryo inactivated 
Trypsin-EDTA and facilitated a gentle homogenization of tissue clumps by pipetting gently up 
and down with a 1000 μl pipette tip (Axygen, Corning, USA) and a 200 μl pipette tip (Sarstedt). 
The cell suspension of each embryo contained pMEFs and was finally transferred into four 
10 cm tissue culture plates containing 10 ml of Full Medium. pMEFs were cultured at 37 °C, 
5 % CO2, 95 % humidity and were passaged regularly at 80 % confluency. pMEFs were frozen 
for long-term storage and thawed as required for experiments. All experiments with pMEFs 
were done with cells not older than passage five, because proliferation rate of pMEFs in culture 
decreases dramatically after five passages (method written as described in the standard protocol 
of the Kerkhoff laboratory). 
 
2.17 In situ hybridization 
In situ hybridization allows to visualize the distribution of specific nucleic acid sequences in 
cells within a tissue section or in an entire organ. The mentioned technique is based on the 
principle that two complementary strands of nucleic acids bind to each other. In this thesis we 
visualized the abundance of SPIRE1 and mitoSPIRE1 mRNA in the mouse brain. In this 
context, we used a Digoxigenin (DIG)-labeled single stranded RNA probe to detect expression 
of the SPIRE splice variants of interest in paraffin embedded sections. 
For mouse brain paraffin embedded block preparation wild type and mitoSPIRE1 knockout 
mice were euthanized by cervical dislocation and intracardially perfused with first 20 ml of 
1x PBS and then with 20 ml of 3.7 % paraformaldehyde. Immediately after perfusion mouse 
brains were dissected, rinsed in 1x PBS and post fixed over night at 4 °C in 3.7 % 
paraformaldehyde. At the next day the fixed mouse brain tissue was washed for 60 minutes in 
1x PBS and as described below embedded in a paraffin block. After washing with 1x PBS the 
brain tissue was dehydrated with 50 %, 70 %, 80 %, 96 % and pure ethanol. The dehydrated 
mouse brain tissues were then immersed for 90 min in acetone / ethanol (1:1) and for 60 min in 
acetone at room temperature. Finally, the prepared brain tissues were embedded in prewarmed 
paraffin (63 °C) for 3 hours and cooled at room temperature. 
  Materials and methods 
 
 45 
Paraffin sections later used for in situ hybridization were prepared by cutting brain paraffin 
embedded block with a microtome at a thickness of 6 μm. Paraffined brain sections were placed 
on Poly-L-lysine (Sigma-Aldrich) covered slides. Slides were deparaffinized in a vertical 
position by incubation at 68 °C for 45 min and Xylol (Carl Roth; 2 times for 10 min) treatment. 
The brain sections were then rehydrated in a decreasing concentration of ethanol. Here we used 
a pure ethanol bath for 2 min (2 times) and a single 100 %, 95 %, 70 %, 50 % ethanol bath each 
for 1 min, followed by two DEPC-H2O water baths (30 seconds each). 
For prehybridization rehydrated brain sections were then incubated first with 1x PBS / DEPC 
(pH 7.4; 2 times for 5 min) and successively two times for 5 min with 1x PBS / DEPC 
containing 100 mM Glycine. Sections were then incubated with 1x PBS / DEPC containing 
0.3 % Triton X-100 for 15 min. After washing the brain sections two times with 1x PBS / DEPC 
brain sections are incubated for antigen retrieval in TE-Buffer containing 20 μg/ml proteinase 
K for 30 min at 37 °C. After treatment with 1x PBS / DEPC containing 100 mM Glycine 
(2 times for 5 min) brain sections were washed with 1x PBS / DEPC and post-fixed with 
3.7 % PFA in 1x PBS / DEPC for 5 min at room temperature. After washing with 
1x PBS / DEPC the brain sections were incubated with prehybridization buffer (50 % deionized 
formamide, 1x Denhardt´s solution, 10 mM DTT, 4x SCC, 10 % Dextran sulfate, 1 mg/ml yeast 
t-RNA and 1 mg/ml salmon sperm DNA) at 37 °C for 3 hours to block non-specific nucleic 
acid interactions and reduce background noise. The prehybridization buffer was denaturized at 
95 °C for 3 min and chilled on ice before it was added to the brain sections. 
For hybridization of brain sections 15 μl of specific DIG-labeled RNA probe was added to 
prehybridization buffer to obtain a final concentration of 2 ng/μl and used as hybridization mix. 
The hybridization mix was denaturized at 95 °C for 3 min and chilled on ice before it was added 
to the brain sections. With hybridization mix extended covered brain sections were engulfed 
with parafilm and incubated over night at 60 °C in a humid chamber. DIG-labeled RNA probes 
for mitoSPIRE1 and SPIRE1 were generated by DIG RNA Labeling Kit (Merck) according to 
manufacturer’s recommendation. 
During posthybridization it was not necessary to work RNase free. Slides with brain sections 
were immersed in 2x SSC to remove parafilm and then washed 3 times (each for 20 min) with 
2x SSC at room temperature. Subsequently slides were washed 40 min with 0.5x SSC/20 % 
formamide (Carl Roth) at 50 °C and 20 min with 0.5x SSC/20 % formamide at 37 °C. To digest 
any single stranded RNAs in the brain section slides were first treated for 15 min with NTE 
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buffer and then for 30 min with NTE buffer containing 20 μg/ml RNase A (Qiagen) both at 
37 °C. Afterwards slides were washed with 0.5x SSC/20 % formamide at 50 °C and 
subsequently with 2x SSC/20 % formamide at room temperature both for 30 min. 
Immunological detection of hybridized DIG-labeled RNA probes was facilitated by an alkaline 
phosphatase conjugated anti-Digoxigenin antibody (11093274910, 1:5000 ≙ 0.1646 units/ml, 
sheep polyclonal; Merck-Millipore, Darmstadt, Germany). First the brain sections were 
blocked with blocking buffer for 1 hour at room temperature. Subsequently mentioned antibody 
was diluted in blocking buffer (1:5000) and sections were incubated over night at 4 °C. At the 
next day slides were washed four times (each 5 min) with TBST, three times (each 15 min) 
with TBST, two times (each 10 min) with NTMT buffer and at least for 10 min with NTMT 
buffer containing 2 mM levamisole, which inhibits the endogenous alkaline phosphatase 
activity. Finally, alkaline phosphatase activity was visualized by incubating the sections with 
BM purple (Roche, Basel, Switzerland) for six days at 4 °C in the dark. The BM purple solution 
on the slides was changed every two days by a fresh one. After color development has finished, 
slides were washed two times (each 15 min) with NTMT buffer, a single time (10 min) with 
1x PBS and for 1 min with Millipore-H2O. Tissue sections were analyzed and recorded using a 
Leica DMR microscope (method written as presented in Pleiser, 2012). 
 
2.18 Protein work 
The belonging sections (2.18.1 - 2.18.3) of the chapter ‘protein work’ are written as presented 
in Pylypenko, Welz et al., 2016 and as presented in Welz, 2018. 
 
2.18.1 Recombinant protein expression and purification 
Recombinant GST-mm-FMN2-eFSI (GST-FMN2-eFSI) proteins were expressed in 
Escherichia coli Rosetta bacterial cells (Merck Millipore). Bacteria were cultured in LB 
medium (100 mg/l ampicillin, 34 mg/l chloramphenicol) at 37 °C until an OD600nm of 0.6 - 0.8. 
Protein expression was induced by 0.2 mM Isopropyl-b-D-thiogalactopyranoside 
(Sigma-Aldrich) and continued at 20 °C for 20 h. Bacteria were harvested and lysed by 
ultra-sonication. Soluble proteins were purified in two consecutive steps. GSH-Sepharose 4B 
beads (GE Healthcare Life Sciences) were used first for an affinity-based batch purification 
process which was followed by size exclusion chromatography using an ÄKTApurifier system 
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and a High Load 16/60 Superdex 200 SEC column (both GE Healthcare Life Sciences). Proteins 
were concentrated by ultrafiltration using Amicon Ultra centrifugal filters (Merck Millipore) 
with 50 kDa cut off. The final protein purity was estimated by SDS-PAGE and Coomassie 
staining. Purification of GST-FMN2-eFSI was done by Dr. Tobias Welz from the Kerkhoff 
laboratory. 
 
2.18.2 GST-pulldown from wild type and mitoSPIRE1 knockout fibroblast lysates 
For GST-pulldowns eight 10 cm cell culture dishes of primary mouse embryonic fibroblasts 
(pMEFs) from each, wild type and mitoSPIRE1 knockout mice were cultured. When cells 
reached a confluency of 80 % cells were lysed in lysis buffer (25 mM Tris-HCl pH 7.4, 
150 mM NaCl, 5 mM MgCl2, 10 % (v/v) glycerol, 0.1 % (v/v) Nonidet P-40, 1 mM PMSF, 
protease inhibitor cocktail) and centrifuged at 20,000 × g, 4 °C, 20 min to remove insoluble 
debris. For GST-pulldown assays 40 µg GST-FMN2-eFSI and 20 µg GST protein as control 
was coupled to GSH-Sepharose 4B beads for 1 hr, 4 °C on a rotating wheel. Beads were washed 
twice with pulldown buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl2, 10 % (v/v) 
glycerol, 0.1 % (v/v) Nonidet P-40) and subsequently incubated with the cell lysates for 2 h at 
4 °C on a rotating wheel. Beads were washed four times with pulldown buffer and bound 
proteins were eluted with 1x Laemmli buffer, denatured at 95 °C for 10 min and then analyzed 
by immunoblotting. 
 
2.18.3 Immunoblotting 
Immunoblotting was performed using Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) to separate proteins and Western blotting to visualize the 
presence of specific proteins. 
Protein samples were mixed with SDS sample buffer (Laemmli buffer) containing the anionic 
detergent sodium dodecyl sulfate (SDS) and denatured at 95 °C for 10 min in a heat block. SDS 
charges the proteins negatively, which allowed in the following process to separate the proteins 
under voltage solely by their molecular weight in a polyacrylamide gel, regardless of their 
individual charges. Here we used an 7.5 % SDS gel and separation was done at 50 mA per gel 
in 1x SDS-PAGE-buffer. Negatively charged proteins move towards the positively charged 
anode. In this context, in the polyacrylamide gel smaller proteins move faster than larger 
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proteins towards the positively charged pole, why they were separated from each other. All gel 
pockets are loaded with the same sample volume.  
In the Western blotting technique separated proteins are transferred from the polyacrylamide 
gel onto a nitrocellulose membrane (Protran Nitrocellulose Transfer Membrane, 0.45 μm pore 
size; GE Healthcare Life Sciences) by use of the Mini Trans-Blot Cell system (Bio-Rad 
Laboratories, Inc (Bio-Rad), Hercules, USA) in 1x Transfer buffer (containing 20 % methanol). 
Proteins are transferred at 150 mA, room temperature for 2 h. Subsequently a Ponceau S 
staining was performed to confirm a successful protein transfer to the nitrocellulose membrane 
and to check for equal loading in all lanes. Here, the nitrocellulose membrane was incubated 
for 5 min in Ponceau S staining solution (Sigma-Aldrich) and then washed with de-ionised 
water until all background coloring was gone and protein bands were well defined. Finally, the 
membrane was completely de-stained by repeated washing with 1x PBST. 
In the next step proteins on the nitrocellulose membrane were visualized by specific antibodies. 
In order to prevent unspecific antibody binding, the membrane was blocked in 5 % milk powder 
solution (Carl Roth) in 1x PBST at 4 °C over night. At the next day the membrane was incubated 
with an anti-SPIRE1 primary antibody (SA-2133, 0.5 µg/ml, rabbit polyclonal; Schumacher et 
al., 2004; 1x PBST, 3 h, room temperature) and a horse-radish-peroxidase (HRP) linked 
anti-rabbit secondary antibody (NA934-1ML, 1:5000, from donkey, GE Healthcare Life 
Sciences; 1.6 % milk, 1 h, room temperature). The protein signal was detected by 
chemiluminescence (Luminata Forte Western HRP substrate; Merck Millipore) and recorded 
with an Image Quant LAS4000 system (GE Healthcare Life Sciences). Recorded images were 
processed in Adobe Photoshop and assembled in Adobe Illustrator. 
 
2.19 Generation of the mitoSPIRE1 knockout mouse  
The mitoSPIRE1 knockout mouse was generated by our collaboration partners Prof. Dr. Cord 
Brakebusch and Dr. Javier Martín Gonzalez from the University of Copenhagen. After an initial 
meeting at the University of Copenhagen, they generated the knockout mouse and finally 
transferred it 18 months later to our laboratory in Regensburg. Here we confirmed by PCR and 
RT-PCR the successful knockout of the alternatively spliced exon 13 from the SPIRE1 gene 
(chapter 3.7). By means of GST-pulldown assays we further confirmed that SPIRE proteins 
from the SPIRE1 gene are still expressed (chapter 3.7). The following method sections 
  Materials and methods 
 
 49 
(2.19.1 - 2.19.6) were written by our collaboration partners who did the experimental 
procedures for the generation of the knockout mouse. 
 
2.19.1 Overview of generating the mitoSPIRE1 knockout mouse 
We have generated the mitoSPIRE1 knockout mice through the use of CRISPR / Cas9 gene 
editing technology. In here we have designed two targeting constructs (pX458-gRNA-1 and 
pX458-gRNA-2) that each express both the gRNA (guide RNA) and the Cas9 nuclease protein. 
Upon expression of these two components in the cells, the gRNA directs the Cas9 nuclease to 
the genomic regions of interest which, upon its interaction with the genome, results in a double 
strand break that is then repaired by the cell DNA repair mechanism.  
Both gRNAs used here targeted Cas9 nuclease to two distinct locations that lay right before and 
after the exon 13 of the SPIRE1 gene. Upon nuclease activity a DNA sequence of approximately 
179 bp is deleted. Figure 8 shows a schematic representation of the targeting strategy that was 
used to generate the mitoSPIRE1 knockout mouse model. 
 
 
Figure 8 - Schematic representation of the CRISPR / Cas9 targeting strategy used to 
generate the mitoSPIRE1 knockout mouse model. For simplicity purposes, here are 
represented only 3 exons from the SPIRE1 gene. Both gRNAs flank exon 13; upon expression 
of these two gRNAs in the cell, Cas9 protein is directed to the sequences of interest where it 
introduces a double strand break on either side of the exon 13. The cell DNA repair mechanism 
excises the exon 13 and ligates both free ends of the DNA back together in a process called 
Non-homologous end joining. 
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2.19.2 Guide selection and cloning of CRISPR constructs 
Potential gRNAs were screened using CRISPOR tool (www.crispor.tefor.net) and two of them 
were selected according to the following parameters: cutting site proximity to the location of 
interest, off target score and Doench score (Doench et al., 2016). The analysis resulted in two 
gRNAs (gRNA-1: TAGGAACCTGAACAATGGAAGGG and gRNA-2: 
CAGCAGGTGGAAACCCTCAAAGG; protospacer adjacent motif (PAM) sequence 
underlined) that were satisfactory to our requirements. These particular gRNAs have a 
Specificity Score of 66 and 79 which is a value that ranges from 0 to 100 and measures the 
uniqueness of a gRNA in the genome. Any gRNA with a specificity value above 50 is generally 
considered to be good (Hsu et al., 2013). Both gRNAs were individually cloned into the pX458 
plasmid (Addgene, Watertown, USA), as described in Ran et al., 2013. 
 
2.19.3 Embryonic Stem Cell targeting 
F1.129S2; C57BL/6N embryonic stem cells (ES cells) were transfected with the above 
mentioned gRNAs and donor templates, following the protocol described in Yang et al., 2014. 
1 × 106 ES cells were plated in two 10 cm petri dishes coated with gelatine and cultured in 
N2B27+2i+LIF medium. 4 hours later the cell culture was transfected with a mixture of 5 µg 
pX458-gRNA-1 + 5 µg pX458-gRNA-2 + 15 µl FuGene following the vendor ́s instructions. 
48 h later, GFP-positive cells were sorted by FACS and re-plated in gelatine-coated 10 cm Petri 
dishes (25,000 cells / dish). After one week in culture, 192 individual ES cell colonies were 
picked manually, disaggregated and plated on a feeder cell layer in 96-well plates. This clone 
set was split in triplicates: two of the copies were frozen and the third was expanded up to 
confluent 24-well plate wells for DNA extraction and genotyping. 
 
2.19.4 Genotyping and targeting efficiency  
ES cell clones were genotyped by PCR reaction using the following primers: genomito 
SPIRE1-FW: TCCCTCCAACCAAAAATGTC and genomito SPIRE1-REV: 
TCAGCAGTCAAAAGCAAAGTG. Electrophoresis analysis showed a band size of 749 bp 
corresponding to the wild type allele while the mutated allele shows a band size of 570 bp. The 
total number of ES cell clones genotyped was 96, of which 28 showed a band size that could 
correspond to the mutated allele. From those 28 positive clones, the first 10 were sent for 
sequencing where 5 of them clearly show the mutation of interest, where the others were 
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inconclusive due to the amount of sequencing background noise. Those 5 clones that were 
validated for a homozygous knockout by sequencing were: # 4, # 8, # 26, # 27 and # 28. 
 
2.19.5 Off target screening 
Off target sites were not screened. However, the gRNA-1 shows a total of 225 off targets where 
204 of them have 4 mismatches, 19 have 3 mismatches and 2 have 2 mismatches. The gRNA-2 
shows a total of 159 off target sites where 144 of them have 4 mismatches, 14 have 3 
mismatches and 1 has 2 mismatches. Regarding the mismatches location, whether in the seed 
region of the gRNA (seed region is the proximal region to the PAM sequence where the 
presence of mismatches more significantly reduces the likelihood of targeting), the gRNA-1 
has a total of 8 potential off target sites where 2 have 3 mismatches and the other 6 have 4 
mismatches; whether the gRNA-2 has a total of 6 potential off target sites where 3 have 3 
mismatches and the other 3 have 4 mismatched. None of the most likely 3 off target sites for 
each gRNA are located in the same chromosome of SPIRE1, which means that even in the 
unlikely event of off targeting those mutations will be diluted in the breeding generations. 
 
2.19.6 Chimeric mice generation and breeding  
Once the ES cell clones carrying the deletion were identified by PCR, one of the two frozen 
clone-set replicas were thawed and the selected clones were put in culture on a feeder cell layer 
in 96-well plates with N2B27+2i+LIF medium. Subsequently, these clones were then expanded 
in the same culture conditions transferred to 6-well plate wells. Cells were disaggregated to 
single cell suspension and microinjected into morula stage C57BL6/N embryos, at a ratio of 
3 - 5 cells per morula. The injected embryos were transferred to pseudo-pregnant recipient CD1 
females to be carried to term.  
ES cell clones # 4 and # 27 were injected, each of them into 36 morulas. Clone # 4 gave rise to 
8 newborns, but 3 of them died after birth; all of the other five turned out to be chimeric. Clone 
# 27 resulted in 10 newborns, but only 6 survived; out of those, 5 were chimeras. The 
contribution of the ES cells to the embryo was very high as all of the 10 chimeric pups generated 
(5 + 5) turned out to be male and 100 % ES cell-derived, assessed by coat color. 
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3. Results 
A variety of eukaryotic expression vectors encoding fluorescent tagged SPIRE, MYO5, FMN 
and INF2 proteins were used to analyze the cellular functions and localization of mitoSPIRE1. 
To provide an orientation among constructs throughout the results section, all proteins encoded 
by expression vectors used are shown in Figure 9 and Figure 10. Detailed information regarding 
each expression vector is listed in the supplement. 
 
 
Figure 9 - Schematic overview of used SPIRE proteins encoded by expression vectors. 
Shown fluorescent tagged proteins encoded by expression vectors were used for single or 
multiple experiments. For a better overview, fluorescence tags (GFP and mStrawberry) are 
visualized in half of their amino acid size. Numbers indicate amino acids. KIND, kinase 
non-catalytic C-lobe domain; WH2, Wiskott-Aldrich-Syndrome protein homology 2; E9, 
exon 9; GTBM, globular tail domain binding motif; E13, exon 13; SB, SPIRE-box; FYVE, 
FYVE-type zinc-finger; GFP, green fluorescent protein; FL, full-length; Hs, Homo sapiens; 
Mm, Mus musculus; aa, amino acids. 
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Figure 10 - Schematic overview of used MYO5, FMN and INF2 proteins encoded by 
expression vectors. Shown fluorescent tagged proteins encoded by expression vectors were 
used for single or multiple experiments. Numbers indicate amino acids. FH1, formin homology 
domain 1; FH2, formin homology domain 2; FSI, formin-SPIRE Interaction; GBD, 
GTPase-binding domain; FH3, formin homology domain 3; WH2, Wiskott-Aldrich-Syndrome 
protein homology 2; GFP, green fluorescent protein; FL, full-length; Hs, Homo sapiens; Mm, 
Mus musculus; aa, amino acids. 
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3.1 Expression of SPIRE splice variants in mouse tissues  
The mammalian genome encodes two SPIRE actin nucleator genes. In addition, the SPIRE1 
gene contains two alternatively spliced exons (exon 9 and exon 13). As a result, the two SPIRE 
genes encode for four different proteins, SPIRE1, SPIRE1-E9, mitoSPIRE1 and SPIRE2. A 
SPIRE protein which contains both the exon 9 and the exon 13 is not expressed (Figure 2; 
Kollmar, Welz, Straub et al., 2019). The existence of four distinct mouse SPIRE proteins which 
are very similar, but not identical, allows us to speculate that each protein might have a specific 
function, and that the expression might differ in tissues of distinct functions. Individual 
expression patterns of SPIRE splice variants provide the first insight into the role of these 
proteins in specific tissues. For this reason, the first step of this work was to unravel the mRNA 
expression patterns of all SPIRE splice variants in distinct mouse tissues by using quantitative 
real time PCR (qPCR). The highly sensitive qPCR method enables us to determine the absolute 
mRNA copy numbers, by using a known concentration of a corresponding reference plasmid 
encoding identical cDNA sequences. The expression levels of the four splice variants showed 
considerable differences in all tested tissues, with highest SPIRE copy numbers in the brain 
(21692 mRNA copies / 50 ng total RNA; Figure 11). The brain is not only the organ with the 
highest overall SPIRE expression, it is also the main expression tissue for SPIRE1. However, 
the expression of SPIRE2 in brain (6528 mRNA copies / 50 ng total RNA) was remarkably 
lower than that of SPIRE1 (13242 mRNA copies / 50 ng total RNA). Interestingly, the intestine, 
testicle and the liver showed an overall higher expression of SPIRE2 compared to the total 
number of all SPIRE1 splice variants. The highest amount of SPIRE2 was measured in testis 
(12832 mRNA copies / 50 ng total RNA). The liver was the only organ analyzed which does 
not express SPIRE1. All investigated tissues except the kidney and the liver displayed a 
prominent decrease in SPIRE1-E9 (1.4 - 8.4 % of total mRNA copies from the SPIRE1 gene) 
and mitoSPIRE1 (4.3 - 18.2 % of total mRNA copies from the SPIRE1 gene) expression 
compared to the corresponding amount of SPIRE1 (78.6 - 92.2 % of total mRNA copies from 
the SPIRE1 gene) copy numbers. mitoSPIRE1 was most highly expressed in the kidney (2453 
mRNA copies / 50 ng total RNA, 41 % of total mRNA copies from the SPIRE1 gene), whereas 
SPIRE1-E9 has its expression hot spot in the brain (1266 mRNA copies / 50 ng total RNA, 
8.4 % of total mRNA copies from the SPIRE1 gene). Compared to the expression of SPIRE1 
and SPIRE2, we identified only very low expression of SPIRE1-E9 and the mitochondria 
associated mitoSPIRE1 in most organs. In summary, we found SPIRE1 most highly expressed 
in the brain, whereas SPIRE2 shows a high expression in the digestive tract and testis. 
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Figure 11 - Tissue specific SPIRE gene expression. (A) Absolute SPIRE mRNA copy 
numbers in various mouse tissues were determined by quantitative real time PCR employing 
cDNA preparations from total RNA isolations and presented in a bar diagram. Each bar 
represents mean mRNA copy numbers of three independent experiments. Cloned cDNAs 
corresponding to respective genes were used as copy number standards for absolute 
quantification. Error bars represent SEM. n = 3 experimental repeats. (B) Absolute 
quantification of tissue specific SPIRE1-E9 and mitoSPIRE1 mRNA copy numbers is shown 
in a bar diagram to improve visualization of expression differences. Error bars represent SEM. 
n = 3 experimental repeats. (C) Amount of determined SPIRE copy numbers in distinct tissues 
is shown and the percental distribution of splice variant expression from the SPIRE1 gene is 
noted in brackets. Expression analysis of SPIRE1, SPIRE1-E9 was already done in the master 
thesis. Graph is complemented by the expression pattern of SPIRE2 and mitoSPIRE1. qPCR 
for mitoSPIRE1 was done in the master thesis as well, but was repeated here, because the 
specific mitoSPIRE1 primer pair used in the master thesis was laying on the same exon. Parts 
of Figure 11 were already published in Kollmar, Welz, Straub et al., 2019. 
 
3.2 Similar expression patterns of SPIRE1 and mitoSPIRE1 in the mouse brain  
The previous expression analysis revealed that the actin nucleator SPIRE is highest expressed 
in cells of the brain. In this context, the reported phenotype in fear conditioning experiments of 
SPIRE1 mutant mice is most likely associated with neuronal dysfunctions (Pleiser et al., 2014). 
MitoSPIRE1 is only expressed at low levels in the mouse brain, but even a low number of 
mitoSPIRE1 proteins could significantly influence neuronal functions and neuronal processing 
of SPIRE1 mutant mice. For this reason, it is important to know which brain areas (anatomical 
overview of mouse brains is shown in Figure 12, A) express the SPIRE1 gene, especially if fear 
related brain areas express the mitoSPIRE1 splice variant. SPIRE1 mRNA was already detected 
by in situ hybridizations in the hippocampus, the dentate gyrus, and the cerebellum 
(Schumacher et al., 2004; Pleiser et al., 2010). Here we used a mitoSPIRE1 specific probe 
(exon 13 of SPIRE1) to localize regions of mitoSPIRE1 expression by in situ hybridization in 
the mouse brain. A pronounced expression of mitoSPIRE1 was detected in the hippocampal 
formation (Figure 12, B). Additional areas, including the cortex, amygdala, and the 
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hypothalamus, showed weak expression of mitoSPIRE1 (results not shown). However, because 
of limited mouse brains and brain slice numbers, these data are very preliminary and await 
further investigations.  
 
Figure 12 - Brain specific in situ hybridization of mitoSPIRE1. SPIRE1 and mitoSPIRE1 
mRNA detection on coronal adult mouse brain sections by in situ hybridization using an 
antisense SPIRE1 CT or mitoSPIRE1 (exon 13) riboprobe. (A) Anatomical overview of adult 
mouse brains visualized by a coronal brain section from the Allen Mouse Brain Atlas (The Allen 
Mouse Brain Atlas contains in situ hybridization data for approximately 20,000 distinct mouse 
genes; Mouse, P56, Coronal, image 65 of 132; CTX, cerebral cortex; HPF, hippocampal 
formation; TH, thalamus; HY, Hypothalamus). Scale bar represents 2000 µm. (B) A high 
hybridization signal for SPIRE1 CT (upper panel) and mitoSPIRE1 (lower panel) was detected 
in the hippocampal formation. The SPIRE1 CT riboprobe detects all SPIRE1 splice variants and 
was therefore used as a positive control for specific mitoSPIRE1 visualization by the 
mitoSPIRE1 (exon 13) riboprobe. Scale bar represents 200 µm. 
 
3.3 Subcellular localization of SPIRE proteins  
Based on the knowledge that expression of SPIRE isoforms differs in distinct tissues, it was 
analyzed whether the protein products of each splice variant have specific subcellular 
localizations as well. It is well characterized that SPIRE proteins are targeted to intracellular 
membrane structures by the FYVE-type zinc-finger, and that the SPIRE1 and the SPIRE2 
protein are located on vesicle membranes (Kerkhoff et al., 2001; Dietrich et al., 2013; Tittel et 
al., 2015). In addition, a mitochondria-specific localization for mitoSPIRE1 was already 
described in 2015. The alternatively spliced exon 13 targets the mitoSPIRE1 protein to the outer 
mitochondrial membrane (Manor et al., 2015). In contrast, a role for the alternatively spliced 
exon 9 in protein function or subcellular localization has not been described thus far. 
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Considering the very low expression levels of all four SPIRE isoforms, it is challenging to 
analyze the intracellular protein localization at endogenous expression levels by staining with 
specific antibodies. For this reason, subcellular localization and potential colocalizations of all 
four SPIRE proteins were investigated by transient co-expression of plasmids encoding 
c-Myc-epitope or GFP tagged SPIRE proteins in HeLa cells. The colocalization of the different 
SPIRE proteins was analyzed by fluorescence microscopy, and subsequently quantified by 
determining the Pearson’s correlation coefficient (PCC) of the two proteins co-expressed. The 
PCC indicates the colocalization rate as a statistical measure to unravel a linear correlation 
between the intensity of different fluorescent signals. Our studies revealed a high correlation 
for colocalization of SPIRE1 to SPIRE1-E9 and SPIRE2 at vesicular membranes (Figure 13, 
A). The unique 14 amino acids spanning alternatively spliced exon 9 do not target the splice 
variant to a specific subcellular localization different from that of SPIRE1. On the contrary, the 
mitoSPIRE1 protein does not colocalize with vesicular SPIRE1, but does colocalize with 
mitochondria; as indicated by MitoTracker co-staining (Figure 13, A). The colocalization of 
tagged proteins was quantified for the indicated co-expressions by determining their PCC using 
ImageJ as shown in a bar diagram (Figure 13, B). The PCC between SPIRE1 and SPIRE1-E9 
or SPIRE2 is significantly higher (PCC > 0.75) than the PCC of SPIRE1 / mitoSPIRE1 
colocalization (PCC 0.1). Furthermore, valued colocalization between MitoTracker and 
mitoSPIRE1 (PCC 0.7) has the same tendency as the PCC of SPIRE1 to SPIRE1-E9 or SPIRE2 
(PCC 0.75 - 0.9; Figure 13, B). 
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Figure 13 - SPIRE splice variants show different subcellular localization. (A) Myc-epitope 
(SPIRE1; red) and GFP (AcGFP1; SPIRE1-E9, mitoSPIRE1, SPIRE2; green) tagged SPIRE 
proteins are transiently co-expressed in HeLa cells. Deconvoluted images show the localization 
of SPIRE1, SPIRE1-E9 and SPIRE2 at vesicular membranes. mitoSPIRE1 is localized at 
mitochondria membranes as indicated by the colocalization with a mitochondrial stain 
(MitoTracker Orange; MitoTracker; red). Colocalization is indicated by overlapping punctae 
(yellow). Scale bar represents 5 μm. At least 3 cells were recorded for each condition and the 
channel overlap of one representative cell is presented here. (B) The colocalization of tagged 
proteins and MitoTracker, respectively, as described in (A) was quantified for the indicated 
conditions by determining its Pearson’s correlation coefficient (PCC) and shown in a bar 
diagram. Each bar represents the mean PCC value for at least 3 cells analyzed. Error bars 
represent SEM. One-way ANOVA has been performed; Tukey-Kramer test has been performed 
as post-hoc analysis: *** = p < 0.001. Figure 13 was already published in Kollmar, Welz, Straub 
et al., 2019. 
 
3.4 Interaction of mitoSPIRE1 with the outer mitochondrial membrane 
It is published (Manor et al., 2015) and confirmed by the previous experiment that the unique 
58 amino acid spanning alternatively spliced exon 13 of mitoSPIRE1 targets the protein to 
mitochondria. In the original manuscript of the discovery of mitoSPIRE1, the N-terminus of 
the mitochondria-localized mitoSPIRE1 protein is described to remain in the cytosol, where it 
could directly interact with formins to facilitate the actin nucleation processes. On the other 
hand, published data suggest that the C-terminal end of mitoSPIRE1 reaches into the 
mitochondrial intermembrane space (IMS) and does not face the cytosol. However, these 
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experiments are only preliminary (Manor et al., 2015), and as such, it remains unclear if the 
C-terminal end of mitoSPIRE1 is located in the IMS of mitochondria (Figure 14, A). To identify 
the localization of the mitoSPIRE1 C-terminus, the following experiment was designed. As a 
first step, we had a closer look at the predicted secondary protein structure of the alternatively 
spliced exon 13, analyzed by the online tool PHYRE 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). The exon 13 is predicted to have 
two alpha helices separated by a loop structure and could therefore form a hairpin structure 
which would allow the mitoSPIRE1 C-terminus to be located in the cytosol (Figure 15, A). 
These findings are only based on a prediction model and do not show reliable structural data. 
To address the localization of the C-terminal end of mitoSPIRE1, a specific antibody (SA-2133, 
rabbit polyclonal, Schumacher et al., 2004) against the C-terminal end of SPIRE1 was used 
(Figure 14, A). As SPIRE proteins are expressed at low levels, it is not possible to specifically 
stain endogenous SPIRE proteins with this antibody. That is why a GFP tagged mitoSPIRE1 
protein in HeLa cells was transiently expressed. Following fixation, HeLa cells were treated 
with either Triton X-100 or Digitonin to permeabilize membranes for subsequent antibody 
staining. The unspecific permeabilizer Triton X-100 permeabilizes all membranes of a cell. In 
contrast, Digitonin specifically targets cholesterol-rich membranes such as the plasma 
membrane, whereas the mitochondria membranes are not affected due to their low 
concentration of cholesterol (Figure 14, B and C). A staining of mitoSPIRE1 with the antibody 
SA-2133 in Digitonin treated cells therefore would indicate that the C-terminal end of 
mitoSPIRE1 is localized in the cytosol. To be sure that the outer mitochondrial membrane 
(OMM) is not permeabilized by Digitonin, which would allow the entry of the antibody into 
the IMS, an antibody staining for cytochrome C was used. The antibody used against 
cytochrome C targets a part of the cytochrome C protein, which is located in the IMS. 
Therefore, only if the OMM is permeabilized an antibody staining of cytochrome C is possible. 
In the experiment, both, Triton X-100- and Digitonin-treated cells show a bright signal for the 
expressed GFP-mitoSPIRE1, cytochrome C, and the anti-SPIRE1 (SA-2133) antibody staining 
(Figure 15, B). Triton X-100 and Digitonin permeabilized cells show a high colocalization of 
GFP tagged mitoSPIRE1 to the anti-SPIRE1 (SA-2133) antibody staining, resulting in the same 
PCC value (PCC 0.94; Figure 15, B, C (i)). However, Digitonin permeabilized cells show a 
cytochrome C antibody staining which has a significantly lower colocalization to mitoSPIRE1 
(PCC 0.25) than cells treated with Triton X-100 (PCC 0.82; Figure 15, B, C (ii)), which could 
indicate that the OMM of Digitonin treated cells is still intact. In summary, this experiment 
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indicates that the C-terminus of mitoSPIRE1 is likely in the cytosol and not in the IMS or the 
matrix of mitochondria. 
 
Figure 14 - Experimental setup to determine the localization of the C-terminal end from 
mitoSPIRE1. To clarify the question if the C-terminal end from mitoSPIRE1 faces the cytosol 
or localizes in mitochondria an experiment using two different permeabilizers was performed. 
In this experiment, Digitonin is used after cell fixation to permeabilize cell membrane but not 
the outer mitochondrial membrane, while Triton X-100 is used to permeabilize the cell 
membrane and organelle membranes as well. An antibody staining of mitochondrial 
intermembrane space (IMS) located proteins is therefore only possible when Triton X-100 is 
used. (A) The C-terminal end of mitoSPIRE1 might localizes in the cytosol (A (i)) or in the 
mitochondrial IMS (A (ii)). A specific anti-SPIRE1 antibody (C-terminal anti-SPIRE1 
antibody, highlighted in cyan) is used to report the C-terminal end of expressed GFP tagged 
mitoSPIRE1 (mitoSPIRE1 has an N-terminal GFP tag (GFP-mitoSPIRE1), highlighted in 
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green). (B) Antibody staining of mitochondria located cytochrome C was used as a control that 
outer mitochondrial membrane is still intact after Digitonin treatment (mitochondrial outer 
membrane stays intact after Digitonin treatment and inhibits the entry of antibodies in the IMS, 
while a staining of IMS located proteins fail, indicated by the light grey color of the IMS). The 
antibody used against cytochrome C targets a part of the cytochrome C protein, which is located 
in the IMS. (C) In contrast, Triton X-100 treated cells show permeabilized mitochondrial 
membranes and allow therefore an antibody staining of cytochrome C proteins (indicated by 
the red color of the IMS). IMS, intermembrane space. 
 
Figure 15 - The C-terminal end of mitoSPIRE1 might be located in the cytosol. Predicted 
secondary protein structure of the alternatively spliced exon 13 from the SPIRE1 gene and 
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specific antibody staining were analyzed to evaluate localization from the C-terminal end of 
mitoSPIRE1. (A) Predicted secondary protein structure of the SPIRE1 alternatively spliced 
exon 13. The sequence of 58 amino acids of the alternatively spliced exon 13 from mouse 
SPIRE1 was analyzed by the secondary protein structure prediction software PHYRE. The 
exon 13 is predicted to form two alpha helices (helix 1 highlighted in red and helix 2 highlighted 
in cyan) separated by a loop structure (highlighted in yellow) and therefore should be able to 
build a hairpin structure with two transmembrane domains in the mitochondrial outer 
membrane. N-terminal (N) and C-terminal (C) end of the exon 13 are distinguished. Sequence 
for exon 13 isolated from XM_006526204.3 (aa: 521 - 578). (B) GFP (AcGFP1; mitoSPIRE1, 
green) tagged mitoSPIRE1 proteins are transiently expressed in HeLa cells. Deconvoluted 
images show the localization of transiently expressed mitoSPIRE1 proteins (green) at 
mitochondria. In addition, the deconvoluted images show an antibody staining of the C-terminal 
end of mitoSPIRE1 visualized by SA-2133 C-terminal anti-SPIRE1 antibody (cyan) and an 
IMS antibody staining of cytochrome C (red; antibody used against cytochrome C targets a part 
of the cytochrome C protein, which is located in the IMS). Fixed cells were permeabilized for 
antibody staining by Triton X-100 or by the mild permeabilizer Digitonin. Both, Digitonin and 
Triton X-100 permeabilized cells show a bright fluorescence signal of mitoSPIRE1 (green), 
cytochrome C (red) and the SA-2133 antibody (cyan). Comparison of merge pictures from 
mitoSPIRE1 (green) and cytochrome C (red) shows colocalization differences between 
cytochrome C and mitoSPIRE1 within groups of Digitonin and Triton X-100 treated cells. At 
least 10 cells were recorded for each condition and the channel overlap of one representative 
cell is presented here. Scale bar represents 5 μm. (C) The colocalization of GFP tagged 
mitoSPIRE1 proteins to stained cytochrome C or C-terminal stained SPIRE1 (SA-2133), 
respectively, as described in (B) was quantified by determining its Pearson’s correlation 
coefficient (PCC) and shown in a bar diagram. Each bar represents the mean PCC value for at 
least six cells analyzed. (i) The PCC for mitoSPIRE1 (green) to C-terminal stained SPIRE1 
(SA-2133; cyan) does not differ between Triton X-100 and Digitonin permeabilized cells. 
Mann-Whitney-U-test has been performed as post-hoc analysis: ns = not significant. Error bars 
represent SEM. (ii) In contrast, Digitonin permeabilized cells show a significantly lower 
colocalization of cytochrome C (red) to mitoSPIRE1 (green) than cells permeabilized by Triton 
X-100. T-test has been performed as post-hoc analysis: *** = p < 0.001. Error bars represent 
SEM. These experiments indicate that the C-terminal end of mitoSPIRE1 might localize in the 
cytosol. 
	
3.5 mitoSPIRE1 targets FMN subfamily formin proteins towards mitochondria  
A functional actin nucleator complex on vesicle membranes facilitates 
microtubule-independent long-range transport of exocytic vesicles (Schuh et al., 2011). In this 
transport mechanism, the actin nucleator complex is formed by SPIRE1 or SPIRE2 proteins 
interacting strongly with FMN1 and FMN2 subfamily formins (Pechlivanis et al., 2009; Schuh 
et al., 2011). The functional complex of SPIRE and FMN benefits from its ability to nucleate 
and elongate actin filaments (Quinlan and Kerkhoff, 2008; Kerkhoff, 2011). A direct interaction 
of SPIRE and FMN proteins is mediated by an acid cluster in the N-terminal KIND domain of 
SPIRE and a basic cluster in the C-terminal FSI sequence of FMN proteins (Pechlivanis et al., 
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2009; Zeth et al., 2011). Interestingly, these functional actin nucleator complexes have never 
been described for mitoSPIRE1 and FMN subfamily proteins. 
In the following experiments, the potential colocalization of mitoSPIRE1 and formins, 
including different point and deletion mutants of formins was investigated. Positive 
colocalization between mitoSPIRE1 and formins at mitochondria would point towards the 
formation of a functional actin nucleator complex at mitochondrial membranes. Fluorescent 
protein tagged mitoSPIRE1 (mStrawberry-mitoSPIRE1), SPIRE1 exon 13 
(mStrawberry-exon 13), FMN1 (GFP-FMN1A-FL, GFP-FMN1C-FL), FMN2 
(GFP-FMN2-FL, GFP-FMN2-FH2-FSI, GFP-FMN2-FH2-C1493, 
GFP-FMN2-FH2-FSI-K1571A) and Inverted formin 2 (INF2; GFP-INF2-FL-CAAX, 
GFP-INF2-FL-NonCAAX) proteins are transiently co-expressed in HeLa cells and analyzed by 
fluorescence microscopy (Figure 16, A-H). The extend of colocalization from co-expressed 
proteins was quantified by determining the respective Pearson´s correlation coefficient (PCC; 
Figure 16, I-K). Single expression of fluorescent protein tagged FMN1, FMN2 and INF2 
proteins each show a distinct subcellular or cytoplasmic localization, but do not localize at 
mitochondria (results are not shown). Single expression of mStrawberry tagged mitoSPIRE1 
and SPIRE1 exon 13 show localization in mitochondria (results are not shown). 
All tested FMN1 proteins showed a similar high colocalization with mitoSPIRE1 (PCC 
0.9 - 0.91; Figure 16, B, C, I) as GFP-FMN2 proteins containing the FSI (PCC 0.82 - 0.84; 
Figure 16, D, E, I, K). The transiently co-expressed mStrawberry tagged exon 13 of SPIRE1 is 
a mitochondrial marker and does not colocalize with GFP-FMN1A-FL; indicated by a PCC of 
0.31 (Figure 16, A, J). In contrast, the mStrawberry tagged mitoSPIRE1 protein has a 
significantly higher colocalization to co-expressed GFP-FMN1A-FL (PCC 0.9; Figure 16, B, 
J), which shows that the mitoSPIRE1 protein translocates the GFP-FMN1A-FL towards 
mitochondria. 
The N-terminal fluorescence tagged FMN2-FL or FMN2-FH2-FSI proteins highly colocalize 
with mitoSPIRE1 at mitochondrial membranes and show a PCC of 0.82 - 0.84 (Figure 16, D, 
E, I, K). A loss of the functional FSI peptide either by mutation (FMN2-FH2-FSI-K1571A) or 
truncation (FMN2-FH2-C1493) leads to a rather random colocalization of the affected FMN2 
proteins with mitoSPIRE1 (PCC 0.12 - 0.13), and therefore to a significant difference in PCC 
values to FSI containing FMN2 proteins (Figure 16, E, F, K). 
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INF2 proteins generally showed a low rate of colocalization with mitoSPIRE1 
(PCC 0.18 - 0.29); independent of whether they include the CAAX motif or not (Figure 16, 
G-I). In this context, the CAAX motif determines the subcellular localization of INF, because 
the CAAX motif contains a C-terminal prenyl group and is therefore stably bound to the 
endoplasmic reticulum membrane. The INF2 splice variant without the CAAX motif displays 
a web-like cytoplasmic appearance that is distinct from the endoplasmic reticulum 
(Ramabhadran et al., 2011).  
In summary, FMN full-length proteins colocalize with mStrawberry-mitoSPIRE1 at 
mitochondria (PCC 0.84 - 0.91), while FMN2 proteins without a functional FSI motif and INF2 
proteins only showed a significantly lower colocalization with mitoSPIRE1 (PCC 0.12 - 0.29; 
Figure 16). 
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Figure 16 - mitoSPIRE1 colocalizes with formin proteins at mitochondrial membranes. 
Fluorescent protein tagged mitoSPIRE1 (mStrawberry-mitoSPIRE1), SPIRE1 exon 13 
(mStrawberry-exon 13), FMN1 (GFP-FMN1A-FL, GFP-FMN1C-FL), FMN2 
(GFP-FMN2-FL, GFP-FMN2-FH2-FSI, GFP-FMN2-FH2-C1493, 
GFP-FMN2-FH2-FSI-K1571A) and INF2 (GFP-INF2-FL-CAAX, GFP-INF2-FL-NonCAAX) 
proteins are transiently expressed as well as co-expressed in HeLa cells and analyzed by 
fluorescence microscopy. (A-H) Deconvoluted images of co-expressed proteins show 
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representative colocalization of full-length FMN1, FMN2 and INF2 proteins to full-length 
mitoSPIRE1 (mStrawberry-mitoSPIRE1, red) or SPIRE1 exon 13 (mStrawberry-exon 13, red). 
GFP tagged FMN1 (GFP-FMN1A-FL, green; GFP-FMN1C-FL, green) and GFP tagged FMN2 
(GFP-FMN2-FL, green) proteins show considerable overlap with mitochondrial mitoSPIRE1 
(mStrawberry-mitoSPIRE1, red), whereas endoplasmic reticulum and cytoplasmic AcGFP1 
tagged INF2 (GFP-INF2-FL-CAAX, green; GFP-INF2-FL-NonCAAX, green) proteins are 
almost exclusively localized from mitoSPIRE1. GFP tagged FMN1A (GFP-FMN1A-FL, 
green) does not colocalize with SPIRE1 exon 13 (mStrawberry-exon 13, red). Scale bars 
represent 5 µm; FL, full-length. (I-J) The colocalization of tagged proteins as described in 
(A-H) was quantified for the indicated co-expressions by determining their Pearson´s 
correlation coefficient (PCC) as shown in a bar diagram. Each bar represents mean PCC values 
for at least six cells analyzed, error bars represent SEM. (I) All FMN full-length (FL) proteins 
show a significant higher PCC (0.84 - 0.91) to mitoSPIRE1 than INF2 FL proteins 
(PCC 0.18 - 0.29). (J) GFP-FMN1A-FL shows a significant higher colocalization with 
mitoSPIRE1 than with the exon 13 of SPIRE1, which indicates that mitoSPIRE1 translocates 
GFP-FMN1A-FL towards mitochondria. (K) mStrawberry-mitoSPIRE1 was transiently 
co-expressed with GFP-FMN2-FH2-FSI, GFP-FMN2-FH2-C1493 or 
GFP-FMN2-FH2-FSI-K1571A and colocalization of tagged proteins was quantified for the 
indicated co-expressions by determining their Pearson´s correlation coefficient (PCC) as shown 
in a bar diagram. GFP tagged FMN2-FH2-FSI proteins containing the FSI motif show a 
significant higher PCC (0.82) than FMN2 proteins affected by a loss of the functional FSI 
peptide either by mutation (FMN2-FH2-FSI-K1571A; PCC 0.13) or truncation 
(FMN2-FH2-C1493; PCC 0.12), indicating that the FSI motif is necessary for colocalization 
between mitoSPIRE1 and FMN2 proteins. For I - K One-way ANOVA has been performed; 
Tukey-Kramer test has been performed as post-hoc analysis: ns = not significant, 
*** = p < 0.001. 
  
3.6 mitoSPIRE1 targets MYO5 actin motor proteins towards mitochondria 
Motility of mitochondria is mediated by motor and adapter proteins, which facilitate 
mitochondrial transport along cytoskeletal components (Hollenbeck and Saxton, 2005). In 
contrast to mitochondrial transport along microtubules, the molecular transport mechanism 
mediated by actin filaments and myosin motor proteins has been poorly understood until now. 
In this respect, it is still unclear how myosin motor proteins are translocated towards 
mitochondria, and how they influence mitochondrial motility. In 2016, it was reported that 
SPIRE proteins contain the conserved globular tail domain binding motif (GTBM) which 
directly interacts with the globular tail domain of myosin 5 (MYO5) motor proteins (Pylypenko, 
Welz et al., 2016). Since all SPIRE1 proteins contain the GTBM, mitoSPIRE1 could contribute 
to targeting MYO5 function towards mitochondria. In an initial colocalization study, we 
co-expressed a GFP tagged C-terminal MYO5A or an mStrawberry tagged MYO5B protein 
containing coiled-coil regions and a globular tail domain (MYO5A-CC-GTD, 
MYO5B-CC-GTD) with GFP or mStrawberry tagged isolated SPIRE1 exon 13 or full-length 
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mitoSPIRE1, respectively. The truncated MYO5 proteins were used, because the expression of 
MYO5 full-length proteins is only hardly tolerated by cells due to the actin filament binding of 
the myosin motor domain. The isolated SPIRE1 exon 13 showed a localization at mitochondria 
but did not show a notable colocalization with MYO5A-CC-GTD (PCC 0.14; Figure 18, A). In 
contrast, mitoSPIRE1 localized at mitochondria as well and showed a remarkable 
colocalization with MYO5A-CC-GTD (PCC 0.71; Figure 18, A). MYO5B-CC-GTD 
colocalized, as did MYO5A, with mitoSPIRE1 but not with the isolated exon 13. In this context, 
the PCC of MYO5B / mitoSPIRE1 is significantly different from the PCC of MYO5B / exon 13 
(results are not shown). 
In collaboration with Prof. Dr. Dori Woods and Hannah (Sheehan) Alberico from Northeastern 
University of Boston, MA, USA, we further analyzed the presence of endogenous MYO5A 
proteins at the surface of mitochondria from immortalized mouse embryonic fibroblasts by a 
novel technique called fluorescence-activated mitochondria sorting (FAMS). FAMS is an 
innovative technique based on the principles of a fluorescence-activated cell sorting (FACS) 
machine that allows the operator to sort and analyze small organelles like mitochondria. Briefly, 
a modified FACS cytometer, including a ‘hybrid’ dual-forward scatter mechanism consisting 
of a photomultiplier tube and a diode, enables the user to distinguish between small particles, 
debris, and background instrument noise (MacDonald et al., 2019). In our experiment, 
mitochondria were stained by MitoTracker Red CMXRos (MTR), which enables the 
identification of mitochondria via flow cytometry by size and positive fluorescence staining. In 
summary, FAMS facilitates the sorting of mitochondria, in order to analyze mitochondrial size, 
and to determine the presence of mitochondrial surface molecules by the use of specific 
fluorophore-conjugated antibodies (Figure 17; MacDonald et al., 2019). Using FAMS with a 
PE-Cy7 conjugated antibody against MYO5A, we measured the number of MYO5A positive 
mitochondria from SPIRE1 mutant and wild type mice. Here, we used immortalized mouse 
embryonic fibroblasts (iMEFs) of SPIRE1 mutant mice, which means that iMEFs lack the 
expression of all functional SPIRE1 including mitoSPIRE1 proteins, and iMEFs from wild type 
mice as a control. In this context, iMEFs were generated by immortalization of pMEFs using 
the SV40 large T-antigen (Andritschke et al., 2016). SPIRE1 lacking iMEFs of SPIRE1 mutant 
mice showed 12.06 % MYO5A positive mitochondria, whereas wild type iMEFs have a 
significantly higher number of MYO5A positive mitochondria (30.23 % MYO5A positive 
mitochondria; Figure 18, B (i)). In the corresponding FAMS histogram, PE-Cy7 intensity 
(horizontal axis) is plotted against the number of mitochondria (vertical axis; Figure 18, B (ii)). 
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It shows that iMEFs from SPIRE1 mutant mice have fewer mitochondria with a high PE-Cy7 
fluorescence intensity compared to mitochondria from wild type iMEFs. This indicates a 
function of SPIRE1 proteins in mitochondrial targeting of MYO5A motor protein function. 
 
 
Figure 17 - Number of MYO5A positive mitochondria can be determined by fluorescence 
conjugated anti-MYO5A antibodies in FAMS. Fluorescence-activated mitochondria sorting 
(FAMS) is basically used to sort mitochondria, to analyze mitochondrial size and to determine 
the presence of mitochondrial surface molecules. For these analyzes, a modified 
fluorescence-activated cell sorting (FACS) machine is used, which is able to distinguish 
between fluorescence colored organelles and unstained organelles. In addition, the modified 
FACS machine recognizes surface molecules on fluorescent mitochondria, which are visualized 
by specific fluorophore conjugated antibodies. In the here presented cartoon mitochondria are 
stained red by MitoTracker Red and MYO5A proteins are visualized by a specific anti-MYO5A 
antibody conjugated to a green fluorescent dye (we used in our experiment PE-Cy7, deep red). 
In this case, the FACS machine enables both to differentiate between mitochondria (red signal) 
and all other unstained organelles and to differentiate between MYO5A positive (red and green 
signal) and MYO5A negative (red signal only) mitochondria. 
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Figure 18 - mitoSPIRE1 targets MYO5 proteins towards mitochondrial membranes. (A) 
Fluorescent tagged mitoSPIRE1 (mStrawberry-mitoSPIRE1), exon 13 of mitoSPIRE1 
(mStrawberry-exon 13) and C-terminal MYO5A (GFP-MYO5A-CC-GTD) proteins are 
transiently co-expressed in HeLa cells. (i) mStrawberry tagged isolated exon 13 sequences 
(exon 13, red) shows mitochondrial localization as was shown by fluorescence microscopy. In 
contrast, GFP tagged C-terminal MYO5A proteins containing coiled-coil regions and globular 
tail domain (MYO5A-CC-GTD, green) show a typical vesicular localization as expected and 
which is distinct from mitochondria. (ii) Co-expression of mStrawberry tagged full-length 
mitoSPIRE1 (mitoSPIRE1, red) and GFP tagged MYO5A-CC-GTD (green) proteins show 
mitochondrial localization of mitoSPIRE1, as expected, and targeting of MYO5A-CC-GTD to 
mitochondrial membranes in contrast to (i). (iii) The extend of colocalization of 
MYO5A-CC-GTD with isolated exon 13 and full-length mitoSPIRE1 proteins, respectively, 
was further quantified by determining the Pearson´s correlation coefficient (PCC) as shown in 
a bar diagram. Each bar represents the mean PCC values for each co-expression, error bars 
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indicate SEM. At least 6 cells were analyzed per condition. T-test has been performed as 
post-hoc analysis: *** = p < 0.001. (B, (i)) The percentage of myosin 5A positive mitochondria 
was determined in wild type and SPIRE1 mutant immortalized mouse embryonic fibroblasts 
(iMEFs) by fluorescence-activated mitochondria sorting (FAMS). SPIRE1 mutant iMEFs show 
significantly fewer MYO5A positive mitochondria compared to mitochondria isolated from 
wild type iMEFs. MYO5A proteins at the mitochondria surface were marked by staining with 
specific antibodies which are fluorescently tagged with PE-Cy7. T-test as post-hoc analysis: 
** = p < 0.01. (ii) PE-Cy7 intensity (horizontal axis) against normalized mitochondrial counts 
(vertical axis) from iMEFs of SPIRE1 mutant (orange) and wild type (blue) mice of the FAMS 
experiment (B (i)) is plotted in a histogram. The histogram shows that iMEFs from SPIRE1 
mutant mice have fewer mitochondria with a high PE-Cy7 fluorescence intensity compared to 
mitochondria from wild type iMEFs. This indicates that a reduced number of mitochondria 
from SPIRE1 mutant iMEFs have MYO5A on their surface compared to wild type 
mitochondria. Data are normalized and K-S probability > 99.9 %. RFU, relative fluorescence 
units; a.u., arbitrary units. 
 
3.7 Generation of a mitoSPIRE1 knockout mouse model 
The previous experiments have shown that mitoSPIRE1 is able to target FMN subfamily 
formins and MYO5 proteins towards mitochondrial membranes. A complex at vesicle 
membranes formed by RAB11, MYO5B, SPIRE1, 2 and FMN2 proteins coordinates actin 
filament nucleation and myosin 5 dependent force generation in vesicle transport processes in 
mouse oocytes (Schuh et al., 2011; Pylypenko, Welz et al., 2016). Thus, it was intriguing to 
speculate that a similar protein complex initiated by mitoSPIRE1 might be formed at 
mitochondrial membranes which could influence mitochondrial dynamics, including 
mitochondrial transport processes. To address the function of mitoSPIRE1 in more detail at the 
cellular level, but also at the behavioral level, we looked for an adequate model to study 
mitoSPIRE1 function. We decided that a knockout mouse model would be the best choice. 
Previously, in 2014, a murine SPIRE1 mutant model was generated. Unfortunately, given the 
gene-trap approach in this mouse knockout model, there is no specific deletion of the 
mitoSPIRE1 protein, but the expression of all functional SPIRE proteins from the SPIRE1 gene 
is inhibited (Pleiser et al., 2014). In this system, it is hard to investigate the specific function of 
mitoSPIRE1, because a potential effect in SPIRE1 mutant mice could always be caused by the 
absence of other vesicular SPIRE isoforms. The SPIRE1 mutant mouse model is therefore not 
sufficient to specifically unravel mechanisms of mitoSPIRE1. For this reason, and in 
collaboration with Prof. Dr. Cord Brakebusch and Dr. Javier Martín Gonzalez from the 
University of Copenhagen, we generated a mouse model that specifically lacks the expression 
of mitoSPIRE1 without affecting the expression of SPIRE1 and SPIRE1-E9 - the mitoSPIRE1 
knockout mouse. The mitoSPIRE1 knockout mouse was generated in embryonal stem cells of 
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a C57BL/6N mouse background by the use of the CRISPR / Cas9 gene editing technology. Two 
targeting constructs have been designed to knockout the exon 13 of the SPIRE1 gene, each 
containing a SPIRE1 exon 13 flanking guide RNA (gRNA) and the Cas9 nuclease protein. The 
two flanking gRNAs are highlighted in red of Figure 19, and direct the nuclease Cas9 to two 
distinct locations that are located directly before and after exon 13 of the SPIRE1 gene. Cas9 
activity results in a double strand break at the gRNA defined regions and results consequently 
in the loss of the genomic SPIRE1 exon 13 sequence (Figure 19). The DNA double-strand 
breaks are fixed by the DNA repair mechanisms of the cell. We confirmed the loss of exon 13, 
both at the genomic DNA level and at the mRNA level, using specific primer pairs (Figure 19, 
B (i) and (ii)). In detail, we used a primer pair starting in the SPIRE1 intron 12 and ending in 
the belonging intron 13 sequence to confirm the absence of genomic SPIRE1 exon 13. If 
exon 13 is included in the SPIRE1 gene, the mentioned primer pair, when used in a PCR 
reaction and analyzed by gel electrophoresis, a band of 749 base pairs is generated, as was 
shown for the homozygous and heterozygous wild type controls (Figure 19, B (i)). In contrast, 
the specific primer pairs generate a 575 base pair DNA fragment when exon 13 is absent, like 
it is shown for the mitoSPIRE1 knockout and the heterozygous wild type control (Figure 19, B 
(i)). The absence of SPIRE1 exon 13 encoding mRNA was confirmed by two specific primer 
pairs. The first primer pair binds specifically to exon 8 and exon 13 of SPIRE1 and generates 
only a 687 base pair PCR fragment from cDNA preparations if the exon 13 exists, as is shown 
for wild type controls (Figure 19, B (ii)). The second primer flanks the exon 13 of SPIRE1 by 
specifically binding to exon 12 and exon 14. A PCR product band from cDNA preparations is 
therefore generated in both the absence and presence of exon 13, but the PCR products differ 
in size. Here, the presence of exon 13 generates a 295 base pair fragment, while the absence of 
exon 13 produces a shorter 121 base pair long PCR-product. Our gene expression analysis 
confirmed a specific loss of the exon 13 transcript in mitoSPIRE1 knockout mice (Figure 19, B 
(ii)). We were not able to test whether the mitoSPIRE1 protein is absent, as there is no specific 
mitoSPIRE1 antibody to distinguish between the different SPIRE isoforms from the SPIRE1 
gene. However, by means of GST-pulldown assays from primary mouse embryonic fibroblasts 
using a mouse GST tagged FMN2-eFSI peptide (GST-FMN2-eFSI) and GST as control, we 
confirmed that SPIRE proteins from the SPIRE1 gene are still translated in mitoSPIRE1 
knockout mice at similar levels compared to wild type mice (Figure 19, B (iii)). 
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Figure 19 - Generation of the mitoSPIRE1 knockout mouse. (A) Schematic representation 
of the mouse mitoSPIRE1 protein domains and the respective predicted exon structure. 
Numbers on the protein structure indicate amino acid boundaries. The genomic exon 13 DNA 
sequence is shown (capital letters) as well as the surrounding intron sequences (lowercase 
letters). We have generated the mitoSPIRE1 knockout (mitoSPIRE1 KO) mice by using the 
CRISPR / Cas9 gene editing technology. Selected guide RNAs to direct the Cas9 nuclease to 
the genomic region of interest are highlighted in red. Primer which are used to verify the 
exclusion of exon 13 at DNA and mRNA level are illustrated as dotted arrows (DNA 
primer = black, mRNA primer = green and red). KIND, kinase non-catalytic C-lobe domain; 
WH2, Wiskott-Aldrich-Syndrome protein homology 2; GTBM, globular tail domain binding 
motif; SB, SPIRE-box; FYVE, FYVE-type zinc-finger; Mm, Mus musculus. (B) Analysis of 
genomic SPIRE1 exon 13 presence as well as mRNA and protein expression in mitoSPIRE1 
KO mice. (i) Absence of genomic SPIRE1 exon 13 in mitoSPIRE1 KO mice was confirmed by 
PCR analysis using genotyping primer (black dotted arrow, (A)). DNA of wild type mice was 
used as a control. (ii) PCR analysis of cDNA preparations from wild type and mitoSPIRE1 KO 
primary embryonic fibroblasts (pMEFs) reveals the absence of the alternatively spliced exon 
13 at mRNA levels. Two different primer pairs were used (red and green dotted arrows as in 
(A) for PCR fragments SPIRE1 (E8-E13) and SPIRE1 (E12E13E14), respectively). (iii) The 
expression of SPIRE proteins from the SPIRE1 gene in wild type and mitoSPIRE1 KO pMEFs 
was confirmed by a GST-pulldown assay with purified GST-mm-FMN2-eFSI 
(GST-FMN2-eFSI) from pMEF cell lysates. mitoSPIRE1 KO pMEFs specifically lack the 
expression of alternatively spliced SPIRE1 exon 13 but still express SPIRE proteins from the 
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SPIRE1 gene. GST was used as control and Ponceau S staining shows equal amounts of GST 
tagged proteins. WT, wild type; KO, mitoSPIRE1 knockout; WB, Western blotting. 
 
3.8 Mitochondria integrity in mouse SPIRE knockout models 
In general, mitochondria are highly dynamic organelles which divide, fuse and move to distinct 
intracellular regions where they provide energy in the form of ATP. The dynamics and the 
function of these highly complex organelles are regulated and affected by a multitude of 
different intra- and extracellular factors (Chen and Chan, 2009; Sheng, 2014). In this respect, a 
huge number of proteins are known to affect mitochondrial dynamics. One of these proteins is 
the actin nucleator protein mitoSPIRE1 which is located at the mitochondrial outer membrane 
and influences mitochondrial dynamics (Manor et al., 2015). By the use of our novel 
mitoSPIRE1 knockout mouse model, we investigated the influence of the absence of 
mitoSPIRE1 on mitochondrial integrity, including mitochondrial morphology, functionality, 
and motility. 
 
3.8.1 Influence of SPIRE absence on mitochondrial morphology 
Mitochondrial morphology is mainly regulated by the balance between the dynamic processes 
of mitochondrial fission and fusion. An unbalanced number of fission and fusion events causes 
fragmented or elongated mitochondria and can therefore influence the functional integrity of 
these organelles. Dysfunctional mitochondria often lead to cellular dysfunctions and can cause 
severe consequences for the whole organism (Chen and Chan, 2009; van der Bliek et al., 2013). 
It is reported that fission processes are not only dependent on several regulatory proteins, but 
also from the actin cytoskeleton (Korobova et al., 2013, 2014; Hatch et al., 2014; Li et al., 
2015). As a consequence, we asked if mitoSPIRE1 serves as an actin nucleator in mitochondrial 
fission processes, and if mitochondrial morphology is changed as a result of mitoSPIRE1 
absence. We therefore had a closer examination of the mitochondrial morphology. In the 
following experiments, we determined mitochondrial morphology of wild type, SPIRE1 mutant 
and mitoSPIRE1 knockout mouse embryonic fibroblasts by fluorescence-activated 
mitochondria sorting (FAMS) and live cell fluorescence microscopy (Figure 20). Mitochondria 
morphology was measured in a 3-dimensional approach by forward scatter photomultiplier tube 
(FSC PMT) and side scatter (SSC) by FAMS and was done in collaboration with Prof. Dr. Dori 
Woods and Hannah (Sheehan) Alberico at Northeastern University in Boston. The flow 
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cytometry approach allowed us to analyze a high number of mitochondria from wild type and 
SPIRE1 mutant immortalized mouse embryonic fibroblasts (iMEFs). These data showed that 
iMEFs without SPIRE proteins from the SPIRE1 gene had an overall higher number of small 
mitochondria, and a lower number of large mitochondria compared to the wild type cells 
(Figure 20, A (i)). The same morphological phenotype was detected for mitochondria of 
mitoSPIRE1 knockout primary mouse embryonic fibroblasts (pMEFs) compared to control 
mitochondria from wild type pMEFs (Figure 20, A (ii)). In addition, the average length 
measured from 2-dimensional fluorescence microscopy pictures of MitoTracker Orange stained 
mitochondria from SPIRE1 mutant and mitoSPIRE1 knockout pMEFs revealed a significant 
difference compared to the length of wild type mitochondria. In this context, wild type 
mitochondria show an average length of 3.07 µm, while the length of SPIRE1 mutant (1.89 µm) 
and mitoSPIRE1 knockout mitochondria (1.62 µm) is significantly reduced (Figure 20, B). 
Interestingly, cells of all investigated mouse lines contain elongated, normal and fragmented 
mitochondria (Figure 20, C). 
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Figure 20 - mitoSPIRE1 regulates mitochondria size in mouse fibroblasts. (A) Size analysis 
of MitoTracker Red CMXRos stained mitochondria by fluorescence-activated mitochondria 
sorting (FAMS) of immortalized mouse embryonic fibroblasts (iMEFs; (i)) and primary mouse 
embryonic fibroblasts (pMEFs; (ii)). Fibroblasts are isolated from wild type mice, SPIRE1 
mutant mice lacking both, expression of vesicular and mitochondrial SPIRE1 proteins and 
mitoSPIRE1 knockout mice lacking only mitochondrial mitoSPIRE1. Forward scatter 
photomultiplier tube area (FSC PMT-A) and the more sensitive side scatter area (SSC-A) are 
used to determine mitochondria size. Both, SPIRE1 mutant iMEFs (orange) (i) and 
mitoSPIRE1 KO pMEFs (red) (ii) show a higher number of small mitochondria and a lower 
number of large mitochondria than cell specific wild type controls (blue and green). Data shown 
represent one out of three experimental repeats (results of experimental repeats were similar). 
n indicates number of sorted mitochondria. (B) The length of MitoTracker Orange stained 
mitochondria was quantified for living pMEFs isolated from wild type (n = 85), SPIRE1 mutant 
(n = 160) and mitoSPIRE1 KO (n = 18) mice. The mean mitochondrial length is shown in a bar 
diagram. Error bars represent SEM. One-way ANOVA has been performed; a significant 
difference between species was detected; proofed effect size (η² = 0.056); 
Mann-Whitney-U-test has been performed as post-hoc analysis: ns = not significant, 
*** = p < 0.001. (C) Representative pMEF cells with MitoTracker Orange stained 
mitochondria reveal differences in mitochondrial length between wild type, SPIRE1 mutant and 
mitoSPIRE1 KO pMEFS as including long (arrow first panel), short (arrow second panel) and 
fragmented (arrow third panel) mitochondria as shown by fluorescence microscopy. 
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3.8.2 Influence of SPIRE1 absence on mitochondrial respiration  
As already described above, the functional integrity of mitochondria is essential for cellular 
homeostasis, and therefore, mitochondrial dysfunction can cause severe diseases (Chen and 
Chan, 2009). For this reason, we investigated the mitochondrial functionality of SPIRE1 mutant 
cells by staining mitochondria with the cell-permeable dye tetramethylrhodamine-methylester 
(TMRM). TMRM accumulates in active mitochondria with an intact membrane potential and 
thus, shows a bright signal in healthy cells with functional mitochondria. In contrast, 
non-functional mitochondria often have a loss of their membrane potential, and therefore 
TMRM accumulation is inhibited leading to a decreased or abolished fluorescence signal. 
Mitochondria of both SPIRE1 mutant cells and wild type pMEFs showed a bright TMRM 
signal. The TMRM staining was shown to be independent of mitochondrial morphology and 
was thus observed in both fragmented and tubular mitochondria of SPIRE1 mutant and wild 
type pMEFs (Figure 21, A). In order to obtain additional information about the mitochondrial 
function in SPIRE1 lacking cells, we analyzed these organelles in a specific stress test. For this 
purpose, we used a Seahorse Mito Stress Test assay in which mitochondria are treated with 
different bioenergetic modulators to trigger functional mitochondrial reactions. The induced 
mitochondrial reactions consume a specific amount of oxygen which can be measured as 
oxygen consumption rate (OCR) by the Seahorse Analyzer. In the mentioned Mito Stress Test 
assay pMEFs of SPIRE1 mutant and wild type mice were successively treated with oligomycin, 
carbonilcyanide p-triflouromethoxyphenylhydrazone (FCCP) and antimycin A / rotenone. 
Oligomycin blocks the proton channel of the ATP synthase, thus the mitochondrial proton 
gradient cannot be degradated. As a consequence of oligomycin treatment the mitochondrial 
ATP production-related OCR can be determined. In contrast, FCCP uncouples the oxidative 
phosphorylation (OXPHOS) by collapsing the mitochondrial proton gradient resulting in a 
maximal OCR of complex IV. The bioenergetic modulators antimycin A and rotenone shut 
down the OXPHOS by blocking complex III (blocked by antimycin A) and complex I (blocked 
by rotenone) of the electron transport chain. The treatment of mitochondria with the mentioned 
bioenergetic modulators determined the OCR of mitochondrial basal respiration, ATP-linked 
respiration, maximal respiration and further parameters. None of the treatments resulted in a 
significant difference of OCR between wild type and SPIRE1 mutant mitochondria (Figure 21, 
B). 
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Figure 21 - Absence of mitoSPIRE1 does not influence mitochondrial respiration rate in 
response to bioenergetic modulators. (A) Tetramethylrhodamine-methylester (TMRM) 
stained mitochondria of wild type and SPIRE1 mutant pMEFs are shown. TMRM accumulates 
in active mitochondria with intact membrane potentials and indicates healthy mitochondria. 
There was no detectable difference between stained mitochondria of wild type and SPIRE1 
mutant pMEFs. Both cell types contain both, tubular and fragmented mitochondria, which are 
both active and intact. Scale bar represents 15 µm and 5 µm (insets). (B) A bar diagram shows 
the oxygen consumption rate (OCR) which was measured using a Seahorse XFp Flux Analyzer 
with the Mito Stress Test kit under following conditions: Primary MEFs (pMEFs) from wild 
type and SPIRE1 mutant mice were successively treated with oligomycin, carbonyl 
cyanide-p-triflouromethoxyphenylhydrazone (FCCP) and antimycin A / rotenone. Oligomycin 
inhibits oxygen consumption rate of mitochondria by blocking the ATP synthase, while FCCP 
stimulates mitochondrial respiration to its maximum by uncoupling the electron transport chain. 
Antimycin A and rotenone are shutting down oxidative phosphorylation completely by 
blocking complex III and complex I of the electron transport chain. None of the treatments 
resulted in a significant difference in OCR between wild type and SPIRE1 mutant mitochondria. 
The non-mitochondrial oxygen consumption didn´t show any differences between groups as 
well. Each bar represents mean values, error bars represent SEM. with n = 4 experimental 
repeats. One-way ANOVA has been performed, no significant differences were found, ns = not 
significant. 
 
3.8.3 Function of mitoSPIRE1 in mitochondrial motility 
Intracellular trafficking of different cargo is an essential mechanism to establish cell function, 
morphology and polarization, as well as for the sophisticated communication within animal 
cells. Dysfunctions in specific intracellular transport systems can cause severe diseases like 
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spastic paraplegia (mutated KIF5A; Chevalier-Larsen and Holzbaur, 2006), or the Griscelli 
syndrome (Huizing et al., 2008). In general, the movement of cargo in animal cells is organized 
along microtubules and actin filament tracks, and driven by distinct motor proteins (Rogers et 
al., 2000). In mouse oocytes, SPIRE proteins are recruited to RAB11 vesicles and interact with 
the FMN2 subfamily formin in nucleating actin filaments at the surface of RAB11 vesicle 
membranes in order to generate an oocytic actin meshwork. This actin meshwork is used by 
MYO5B actin motor proteins to drive an actin dependent long-range transport of RAB11 
vesicles towards the oocyte cortex (Schuh et al., 2011). In a similar mechanism, RAB27A is 
reported to recruit SPIRE1 to melanosomes in melanocytes to organize an actin nucleator 
complex with FMN1. The resulting cytoplasmic actin mesh subsequently facilitates an MYO5A 
dependent peripheral melanosome transport in mouse melanocytes (Alzahofi, Robinson, Welz 
et al., 2018). 
SPIRE, myosin 5, and FMN proteins interact and regulate local actin / myosin networks at 
vesicle membranes. Based on the previous experiments, we know that mitoSPIRE1 is able to 
colocalize with FMN formins and with MYO5 motor proteins at the outer mitochondrial 
membrane. As a consequence, we asked if the cooperation of SPIRE / MYO5 / FMN proteins 
at membranes is a conserved mechanism, and mitoSPIRE1 influences the transport of 
mitochondria. We therefore analyzed the motility of mitochondria in primary mouse embryonic 
fibroblasts (pMEFs) of SPIRE1 mutant, mitoSPIRE1 knockout and wild type mice by live cell 
fluorescence microscopy. To measure distinct parameters of single mitochondrial movements, 
we used IMARIS software with a custom particle tracking-mask. IMARIS tracked the motility 
of each MitoTracker Orange stained mitochondrion over time and analyzed associated track 
parameters (Figure 22, B). We defined moving mitochondria as mitochondria which cover a 
distance greater than 4 μm per 20 seconds. Figure 22, A presents that pMEFs of wild type mice 
showed a significantly lower number of moving mitochondria per 20 seconds compared to 
mitochondria without mitoSPIRE1. In more detail, wild type pMEFs showed 1.56 %, SPIRE1 
mutant pMEFs 3.12 % and mitoSPIRE1 knockout 3.38 % moving mitochondria per time 
interval (Figure 22, A (i)). In addition, wild type mitochondria showed shorter average track 
lengths of moving mitochondria (5.42 μm) than mitoSPIRE1 deficient mitochondria 
(6.09 - 6.12 μm; Figure 22, A (ii)). Furthermore, the maximal track length of mitoSPIRE1 
deficient motile mitochondria (10.89 - 12.46 μm) was significantly higher compared to the wild 
type, with a maximal track length of 7.36 μm (Figure 22, A (iii)). In line with this, the 
mitoSPIRE1 deficient mitochondria showed a significant increase in the maximal velocity 
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(0.96 - 1.04 μm/s) compared to mitochondria from wild type pMEFs (0.85 μm/s; Figure 22, 
A (iv)). As a summary, mitoSPIRE1 deficient pMEFs of SPIRE1 mutant and mitoSPIRE1 
knockout mice do not show any significant differences in measured parameters of mitochondria 
motility between each other, but they show in all measured parameters mitochondria with 
increased motility compared to the wild type control (Figure 22). 
 
Figure 22 - mitoSPIRE1 influences mitochondria motility. Motility of mitochondria was 
measured in a time range of 20 seconds in wild type, SPIRE1 mutant and mitoSPIRE1 KO 
primary mouse embryonic fibroblasts (pMEFs), respective migratory tracks were detected and 
analyzed via a custom tracking-mask by IMARIS software. Motility of mitochondria was 
grouped according to the measured track length into three different classifications: fixed, wiggle 
and moving mitochondria. Only moving mitochondria were used for further motility analysis. 
(A) The absence of mitoSPIRE1 increases the motility of mitochondria in pMEFs. (i) pMEFs 
without the mitoSPIRE1 protein showed a significantly increased number of moving 
mitochondria. (ii) The average mitochondria track length and (iii) the maximal track length of 
moving mitochondria in pMEFs of SPIRE1 mutant and mitoSPIRE1 KO mice was increased 
compared to wild type. (iv) Furthermore, in absence of mitoSPIRE1, the maximal transport 
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velocity of moving mitochondria was significantly increased. Each bar represents respective 
mean values, error bars represent SEM. The numbers of cells and embryos used are shown in 
Table 4. One-way ANOVA has been performed; for each parameter a significant difference 
between species was detected; proofed effect size [(i): η² = 0.249; (ii): η² = 0.054; 
(iii): η² = 0.279; (iv): η² = 0.112]; Tukey-Kramer test has been performed as post-hoc analysis: 
ns = not significant, * = p < 0.05, *** = p < 0.001. None of the investigated parameters showed 
a significant difference between SPIRE1 mutant and mitoSPIRE1 knockout pMEFs. (B) 
Representative cells with MitoTracker Orange stained mitochondria including individual 
mitochondrial motility tracks for wild type (left panel), SPIRE1 mutant (middle panel) and 
SPIRE1 mutant pMEFs overexpressing mitoSPIRE1 protein (right panel) are shown. Track 
color code represents timepoints of mitochondrial movement. Mitochondria of SPIRE1 mutant 
cells show a higher maximal track length compared to wild type mitochondria. Overexpression 
of mitoSPIRE1 leads to a significant reduction in mitochondrial motility. 	
3.8.4 Overexpression of mitoSPIRE1 influences mitochondrial motility  
The previous experiments revealed that the absence of mitoSPIRE1 causes an increase in 
mitochondrial motility in pMEFs. Based on that, we repeated the experimental set up trying to 
rescue the motility phenotype by transient expression of AcGFP1 tagged mitoSPIRE1 proteins. 
Transient expression of AcGFP1 served as a control. In all tested cell lines, the mitochondrial 
motility was significantly reversed for all measured parameters by transient overexpression of 
mitoSPIRE1 (Figure 23). In more detail, the expression of mitoSPIRE1 in SPIRE1 mutant and 
mitoSPIRE1 knockout pMEFs reduced the number of moving mitochondria significantly to 
0.53 - 0.93 % compared to the native state control (3.12 - 3.38 % of moving mitochondria; 
Figure 23, A and 22, B). The transient expression of mitoSPIRE1 in wild type pMEFs showed 
a significantly lower number of moving mitochondria (0.41 %) than the belonging native state 
control (1.56 %; Figure 23, A). Furthermore, the average track length in both mitoSPIRE1 
deficient cell lines was reduced significantly to 3.1 - 3.41 μm in comparison with the native 
state control (6.09 - 6.12 μm; Figure 23, B). In addition, the average track length of wild type 
mitochondria was significantly reduced to 2.23 μm after transient overexpression of 
mitoSPIRE1 compared to the native state control (5.42 μm; Figure 23, B). The maximal track 
length is reduced by transient expression of mitoSPIRE1 in all three cell lines significantly 
(transient overexpression of mitoSPIRE1: wild type: 2.32 μm; SPIRE1 mutant: 3.18 μm; 
mitoSPIRE1 knockout: 3.77 μm; Figure 23, C) compared to the belonging native state 
(untransfected native state: wild type: 7.36 μm; SPIRE1 mutant: 10.89 μm; mitoSPIRE1 
knockout: 12.46 μm; Figure 23, C). In line with that, the maximum velocity of mitochondria 
from all cell lines was reduced to 0.61 - 0.71 μm/s compared to native state control groups 
(0.85 - 1.04 μm/s; Figure 23, D). The transient expression of AcGFP1 did not significantly 
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affect the motility of mitochondria in any cell line. In summary, the transient overexpression of 
mitoSPIRE1 reverses all measured parameters significantly, independent from the genotype 
and therefore impairs mitochondrial motility. 
	
Figure 23 - Overexpression of mitoSPIRE1 influences mitochondria motility in pMEFs. 
Motility of mitochondria was measured in a time range of 20 seconds in wild type, SPIRE1 
mutant and mitoSPIRE1 KO primary mouse embryonic fibroblasts (pMEFs) following 
respective transfections, mitochondria tracks were detected and analyzed by IMARIS software 
with a custom tracking-mask. Motility of mitochondria was grouped according to the measured 
track length into three different classifications: fixed, wiggle and moving mitochondria. Only 
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moving mitochondria were used for further motility analysis. (A) The number, (B) the average 
track length, (C) the maximal track length and (D) the maximal velocity of moving 
mitochondria are shown in bar diagrams for pMEFs isolated from wild type (blue), SPIRE1 
mutant (yellow) and mitoSPIRE1 KO (red) mice. For each cell type analysis data are presented 
for the native state (untransfected control) and following overexpression of AcGFP1 or 
full-length mitoSPIRE1 proteins, respectively (refer to transgene expression). The transient 
overexpression of mitoSPIRE1 reverses all measured parameters significantly, independent 
from the genotype and therefore impairs mitochondrial motility. Between native states and 
following transient overexpression of AcGFP1 for none cell type a significant difference was 
detected. Each bar represents mean values, error bars represent SEM. The number of cells and 
embryos used are shown in Table 4. Two-way ANOVA with 1 factor species 3 levels and 1 
factor expression 3 levels has been performed; in all cases of expression a significant difference 
was detected; proofed effect size (η²P > 0.9); Tukey-Kramer test has been performed as post-hoc 
analysis: ** = p < 0.01, *** = p < 0.001. For all cell types, only differences in the native state 
(untransfected controls) and following overexpression of full-length mitoSPIRE1 proteins are 
shown in bar diagrams. 	
Expression wild type SPIRE1 mutant mitoSPIRE1 knockout 
Non-
transfected 
control 
(native state) 
72 6 39 3 49 4 
AcGFP1 29 5 12 2 15 3 
mitoSPIRE1 47 6 26 3 26 4 
       
 number of cells  number of embryos  
Table 4 - Number of cells (ocher) and embryos (blue) used in experiments of Figure 
22 / 23.		
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4. Discussion 
Mitochondria contribute to a multitude of intracellular processes, where they, for example, 
function as Ca2+ storage for neurotransmission (Medler and Gleason, 2002) or produce 
precursors for macromolecules (Spinelli and Haigis, 2018), but their major task is to provide 
energy in the form of ATP. The intracellular energy supply requires a sophisticated spatial and 
temporal regulation, which is facilitated by different aspects of mitochondrial dynamics in order 
to adjust to diverse intracellular situations. Thus misregulated mitochondrial dynamics 
including fission, fusion and motility are associated with severe neurodegenerative diseases like 
the peripheral neuropathy Charcot-Marie-Tooth type 2A (Chen and Chan, 2009). 
Mitochondrial motility is mediated by a complex intracellular transport system (Hollenbeck 
and Saxton, 2005), in which mitochondria are specifically transported to distinct cellular 
compartments. Until recently, mainly the microtubule transport of mitochondria via kinesin and 
dynein motor proteins was analyzed (Hollenbeck and Saxton, 2005; Chen and Chan, 2009; 
Sheng, 2014), but in the last years accumulating evidence was generated for a potential role of 
actin filaments in mitochondria motility as well (Pathak et al., 2010; Gutnick et al., 2019; 
Rangaraju et al., 2019). The mitochondrial transport machinery is highly complex, and it is still 
unknown how actin filaments affect mitochondrial motility, and how this process is regulated 
at the molecular level. The present thesis identified the actin nucleation factor mitoSPIRE1 as 
an adapter between mitochondrial membranes and FMN subfamily formins as well as myosin 
5 (MYO5) actin motor proteins. Consistently, the present thesis shows that mitoSPIRE1 
influences mitochondrial movement. These findings open the possibility that mitoSPIRE1 
cooperates with FMN subfamily formins to build a functional actin nucleator complex and to 
generate a local actin meshwork at mitochondrial surfaces, which can subsequently be used by 
MYO5 motors to anchor mitochondria at certain intracellular positions (Figure 24). 
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Figure 24 - Model for mitoSPIRE1 function in mitochondria transport. Mitochondria are 
transported along microtubules over long distances via kinesin and dynein motor proteins. In 
contrast, myosin 5 (MYO5) actin motor proteins might drive short-range local mitochondria 
transport along actin networks. In addition, MYO5 could influence the processivity of 
microtubule-based long-range transport of mitochondria. In the here presented model, exon 13 
drives localization of mitoSPIRE1 to the outer mitochondrial membrane which facilitates 
translocation of MYO5 and FMN subfamily formin proteins towards mitochondria. Moreover, 
based on the known SPIRE-KIND / FMN-FSI interaction a mitochondrion associated 
mitoSPIRE1 / FMN protein complex might be able to generate actin filaments directly at the 
mitochondrial surface. In summary, a protein complex, including mitoSPIRE1, FMN subfamily 
members and MYO5 actin motors, could generate a local mitochondrial actin network, which 
could ultimately be used by MYO5 to anchor mitochondria at actin filaments. The here 
described mitochondrial anchor system driven by mitoSPIRE1, FMN subfamily formins and 
MYO5 proteins could therefore influence mitochondria motility. 
 
4.1 Expression of SPIRE splice variants in mouse tissues  
Nearly two decades ago studies revealed that the mammalian genome encodes for two SPIRE 
genes (Schumacher et al., 2004). To understand the role of SPIRE proteins in distinct tissues 
and organs, several experiments specified the expression of these two genes in the following 
years. In this context, in situ hybridizations showed that the SPIRE1 gene is mainly expressed 
in the developing central nervous system and in specific brain regions in adult mice 
(Schumacher et al., 2004; Pleiser et al., 2010). In addition, Northern blot analyzes also revealed 
high SPIRE1 expression in the adult mouse brain and these experiments detected a weak 
expression of SPIRE1 in spleen and kidney (Schumacher et al., 2004; Pleiser et al., 2010). Using 
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the same method SPIRE2 was mainly detected in tissues of the digestive tract, the brain and in 
testis (Pleiser et al., 2010). Subsequently, the expression of SPIRE1 and SPIRE2 genes was 
analyzed in more detail by means of quantitative real time PCR (qPCR) which possesses much 
higher sensitivity. SPIRE1 was most highly expressed in oocytes, brain and in testis, whereas 
SPIRE2 was highly expressed in the same tissues as SPIRE1 but showed additionally a high 
expression in the digestive tract (Pfender et al., 2011; Pleiser, 2012). 
More recently, two additional SPIRE1 isoforms were described; which result from alternative 
splicing. The mammalian SPIRE1 gene carries two alternatively spliced exons, and therefore 
encodes, in summary, for three different SPIRE1 proteins, namely SPIRE1, SPIRE1-E9 and 
mitoSPIRE1. The SPIRE1-E9 protein contains 14 unique amino acids encoded by exon 9, 
whereas the mitoSPIRE1 protein contains a sequence of 58 amino acids encoded by the 
alternatively spliced exon 13. To get an overview of the expression of all known SPIRE1 splice 
variants, a quantitative real time PCR of mouse tissues was performed in the present thesis in 
order to obtain absolute mRNA copy numbers. The use of specific primer pairs for each SPIRE 
splice variant revealed a distinct expression pattern for SPIRE mRNAs. Absolute quantification 
by qPCR of SPIRE1 and SPIRE1-E9 was already done in my master thesis and the respective 
results are presented in the same graph (Figure 11). 
All tested organs show expression of at least two SPIRE1 splice variants and SPIRE2. The 
highest expression of SPIRE1 was detected in the brain, whereas a high expression of SPIRE2 
was found in testicle as well as in the small and large intestine. Those results are in line with 
previous data from Northern blot analysis (Schumacher et al., 2004; Pleiser et al., 2010). 
However, qPCR analysis in the present thesis showed SPIRE expression in tissues, which was 
not detected by Northern blot analysis previously (Schumacher et al., 2004; Pleiser et al., 2010). 
This is likely due to a sensitivity difference of the methods. Anyhow, absolute quantification 
by qPCR shows results with a similar tendency as analysis of SPIRE1 and SPIRE2 expression 
with relative quantification by qPCR (Pfender et al., 2011; Pleiser, 2012). 
Relative quantification of SPIRE1 and SPIRE2 revealed already in 2011 that SPIRE genes are 
only expressed at low levels (Pfender et al., 2011; Pleiser, 2012). The measured expression of 
SPIRE1-E9 and mitoSPIRE1 in the present thesis was even lower than the expression of the 
already minimally expressed SPIRE1 and SPIRE2 mRNAs. Given the low mRNA expression 
levels, we should be critical about the importance of SPIRE1-E9 and mitoSPIRE1 proteins at 
endogenous levels in intracellular processes. Nevertheless, based on the expression data, 
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mitoSPIRE1 might have a role in kidney, testicle and in the brain, whereas SPIRE1-E9 could 
have a role in the brain. However, these experiments show that SPIRE splice variants are 
generally expressed at low mRNA levels, but do not allow conclusions about protein 
concentrations. For this reason, the mRNA expression data do not describe the number of 
SPIRE proteins in the cell, which could be higher or lower than the indicated mRNA level by 
the belonging SPIRE splice variant due to different protein translation and stability. The 
presented expression pattern shows that SPIRE2 is preferentially expressed in the testicle and 
the large and small intestine, while SPIRE1 splice variants are mainly expressed in the brain, 
pointing that the splice variants have distinct importance in tissues. The mitochondrial 
mitoSPIRE1 is mainly expressed in the kidney, which could be explained by the high energy 
consumption of the organ in filtration processes. 
 
4.2 Similar expression patterns of SPIRE1 and mitoSPIRE1 in the mouse brain 
SPIRE1 mutant mice lack the expression of any functional SPIRE1 protein and show an 
increased fear-related behavior in contextual and cued fear conditioning experiments compared 
to wild type mice (Pleiser et al. 2014). One explanation for the altered fear behavior might be 
the loss of mitoSPIRE1 proteins particularly in the brain, in which we found mitoSPIRE1 
expression (Figure 11). In this respect, especially the absence of mitoSPIRE1 in brain areas 
involved in fear learning could influence the mouse behavior. The expression of the SPIRE1 
gene was already detected by in situ hybridizations in the hippocampus, dentate gyrus and in 
the cerebellum of mice (Schumacher et al., 2004; Pleiser et al., 2010). The in situ data of the 
present thesis confirm the expression of the SPIRE1 gene in the hippocampal formation. 
Furthermore, a strong positive signal for mitoSPIRE1 could be detected in the hippocampal 
formation as well (Figure 12). The expression of mitoSPIRE1 in the hippocampal formation 
seems to be important, because the hippocampus may be involved in contextual fear learning 
(Gewirtz et al., 2000). In addition, a low level of mitoSPIRE1 expression was detected in the 
cortex, hypothalamus and the amygdala (data not shown). Interestingly, amygdala lesions in 
both humans and rodents influencing the recognition of fearful stimuli (Janak and Tye, 2015).  
The absence of mitoSPIRE1 in the hippocampus and the amygdala could induce an organ 
dysfunction and influence fear related behavior. However, as the brain is a very complex organ 
with a multitude of interconnected regions, it might well be that neuronal dysfunctions in cells 
of any brain area could finally influence animal behavior. In summary, the in situ hybridization 
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data shown here are very preliminary, because of limited brain slice numbers and therefore 
those experiments need to be repeated. 
 
4.3 Subcellular localization of SPIRE proteins 
SPIRE proteins contain highly conserved domains each serving specific functions. The 
FYVE-type zinc-finger interacts with negatively charged membranes and targets the protein 
towards intracellular membrane structures (Kerkhoff et al., 2001; Tittel et al., 2015). As a 
consequence, the subcellular localization targets SPIRE function directly to distinct organelles. 
SPIRE proteins facilitate the generation of actin filaments, and are able to recruit both MYO5 
actin motors and FMN subfamily formins (Pechlivanis et al., 2009; Pylypenko, Welz et al., 
2016; Alzahofi, Robinson, Welz et al., 2018). The resulting protein complex of 
SPIRE / MYO5 / FMN was shown to mediate the motility of RAB11 vesicles in oocytes and 
melanosome transport in melanocytes (Schuh, 2011; Alzahofi, Robinson, Welz et al., 2018). 
The subcellular localization of SPIRE proteins is therefore important for vesicles and 
organelles, which can be directly influenced by SPIRE and its associated MYO5 / FMN 
functions. Our results show, in line with the literature, that SPIRE1 and SPIRE2 proteins 
localize at vesicles and do not show any other subcellular localization (Figure 13; Kerkhoff et 
al., 2001; Schuh et al., 2011; Dietrich et al., 2013; Tittel et al., 2015). We also confirmed that 
the mitoSPIRE1 protein does not colocalize with vesicular SPIRE proteins, but instead is 
localized to mitochondria. The mitochondrial localization of mitoSPIRE1 is mediated by the 
alternatively spliced exon 13 (Manor et al., 2015). In contrast to exon 13, the 14 amino acid 
spanning sequence encoded by the alternatively spliced exon 9 does not change the vesicular 
localization of SPIRE1-E9, as SPIRE1-E9 colocalizes with SPIRE1 proteins (Figure 13). 
Potentially, the exon 9 encoded sequence is able to interact with yet unknown proteins, but the 
identification of those proteins requires further investigations. In our experiments, the 
overexpression of proteins can also cause accumulation effects, which is why it cannot be 
excluded that SPIRE1-E9 proteins also may have a specific vesicular membrane localization. 
However, in transient overexpression studies SPIRE1, SPIRE1-E9 and SPIRE2 proteins show 
a vesicular and mitoSPIRE1 a mitochondrial localization. Thus, SPIRE function is available at 
vesicular and mitochondrial membranes, and could in general influence the motility of these 
organelles.  
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4.4 Interaction of mitoSPIRE1 with the outer mitochondrial membrane 
Vesicular SPIRE proteins use the FYVE-type zinc-finger at their C-terminal end to anchor at 
vesicle membranes. As a consequence, the whole protein except some amino acids of the 
hydrophobic turret loop from the FYVE-type zinc-finger is located in the cytosol and conserved 
domains are free to interact with cooperation partners (Kerkhoff, 2011; Tittel et al., 2015). In 
contrast, the C-terminal end of mitoSPIRE1 was described to be localized in the mitochondrial 
intermembrane space (IMS). It was reported that the alternatively spliced exon 13 encoded 
sequences are predicted to integrate directly into the outer mitochondrial membrane to localize 
the protein to mitochondria, whereas all C-terminal sequences following the exon 13 are 
localized inside the mitochondrial IMS and do not face the cytosol (Manor et al., 2015). In this 
predicted localization of mitoSPIRE1, the SPIRE-box and the FYVE-type zinc-finger are 
located in the IMS of mitochondria and could probably not interact with potential cooperation 
partners. 
However, the experiments performed here, through cell stainings using specific antibodies and 
cell permeabilization protocols (Figure 14, 15), indicate that the C-terminal end of mitoSPIRE1 
is located inside the cytosol and not in the IMS. In this work, the secondary amino acid structure 
of the alternatively spliced exon 13 encoded sequences was predicted by the PHYRE software 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) as it was already described by 
Uri Manor in 2015 (Figure 15, A; Manor et al., 2015). The prediction reveals two α-helices 
separated by a loop sequence which could form a hairpin structure in the mitochondrial 
membrane and as a consequence, the C-terminal end might also face the cytosol. Both helices 
contain hydrophobic amino acids, which could facilitate helix integration in the hydrophobic 
lipid double layer of the polar membrane. Furthermore, both helices are long enough (15 - 20 
residues) to span the mitochondrial outer membrane (Manor et al., 2015). In addition, 
fluorescence microscopy data of this thesis show evidence that the mitoSPIRE1 C-terminus is 
located in the cytosol (Figure 15). In this experiment, an antibody staining against an IMS 
located part of cytochrome C was used as negative control to make sure that the mitochondrial 
outer membrane is still intact and not permeabilized by the mild permeabilizer Digitonin. Both, 
Triton X-100- and Digitonin-permeabilized cells show a high colocalization of GFP tagged 
mitoSPIRE1 proteins to the C-terminal SPIRE1 antibody staining (anti-SPIRE1, SA-2133). In 
contrast, cells permeabilized by Digitonin show a significantly reduced colocalization of 
antibody stained cytochrome C to mitochondria-localized GFP-mitoSPIRE1 compared to the 
same colocalization in Triton X-100-permeabilized cells. This indicates that in the Digitonin 
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permeabilized cells the antibody is impaired to bind to mitochondria localized cytochrome C. 
The differences in antibody staining of cytochrome C between Digitonin and Triton X-100 
treated cells on one hand, and the identical antibody staining of the mitoSPIRE1 protein by 
SA-2133 on the other hand, indicate that the C-terminal end of mitoSPIRE1 rather faces the 
cytosol. Our experiments accumulate evidence that the C-terminal end of mitoSPIRE1 is 
located in the cytosol, which, however, awaits further confirmation in future experiments. 
The cytosolic C-terminal localization could explain how mitoSPIRE1 is anchored in 
mitochondrial membranes. In this theory, the exon 13 encoded sequences could determine the 
specific localization at the outer mitochondrial membrane and the FYVE-type zinc-finger could 
stabilize anchoring of the whole protein at the selected membrane by interaction with negatively 
charged lipids of the outer mitochondrial membrane. Furthermore, the C-terminal end including 
the SPIRE-box could interact with mitochondria specific RAB GTPases. Anyhow, there is a 
chance that a mitoSPIRE1 splice variant is expressed, which is truncated and does not contain 
the C-terminal end. In this case exon 13 could work as a single membrane anchor. 
 
4.5 mitoSPIRE1 targets FMN subfamily formin proteins towards mitochondria 
The present colocalization study of fluorescently tagged mitoSPIRE1 and formin proteins 
shows that transiently expressed mitoSPIRE1 proteins can specifically translocate FMN 
subfamily formins but not INF2 proteins towards mitochondrial membranes. In addition, the 
experiments reveal that FMN subfamily formins need the C-terminal FSI motif to colocalize 
with mitoSPIRE1 (Figure 16). 
SPIRE proteins fail to process profilin-actin monomers, which are used for actin polymerization 
in cells (Montaville et al., 2014). In a well described model, FMN subfamily formins cooperate 
with SPIRE proteins to provide free actin monomers, which can be used subsequently by SPIRE 
WH2 domains to initiate actin filament polymerization (Figure 3). Anyhow, the cooperation 
between FMN and SPIRE proteins illustrates an efficient machinery to create actin filaments 
(Pechlivanis et al., 2009; Pfender et al., 2011; Schuh et al., 2011; Alzahofi, Robinson, Welz et 
al., 2018). The present colocalization study indicates that mitoSPIRE1 might be able to 
translocate FMN1 and FMN2 towards mitochondria at endogenous levels. A protein complex 
formation of mitoSPIRE1 and FMN subfamily formins at mitochondria could induce actin 
filament generation directly at mitochondria surfaces and these newly generated actin filaments 
could influence mitochondrial dynamics. In this context, it is already reported in the literature 
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that actin filaments influence mitochondrial fission events (Manor et al., 2015), and 
mitochondria motility (Gutnick et al., 2019; Rangaraju et al., 2019). 
INF2 enriches the amount of actin filaments at mitochondria (Korobova et al., 2013), and was 
described to interact directly with mitoSPIRE1 (Manor et al., 2015). In this context, INF2 
facilitates the translocation of the floppy ER towards mitochondria to finally induce a 
constriction at mitochondrial fission sites (Manor et al., 2015). The endoplasmic reticulum 
associated isoform of INF2 - INF2-CAAX, and its cytoplasmic correlate INF2-NonCAAX both 
do not significantly colocalize with mitoSPIRE1 in our transient expression studies, compared 
to FMN1 and FMN2 (Figure 16). This indicates that both INF2-CAAX and INF2-NonCAAX 
do not interact strongly with mitoSPIRE1 at an endogenous level. The reported binding strength 
for the INF2-CAAX / SPIRE1 KIND interaction is very low (Kd: 25 - 30 μM; Manor et al., 
2015), which in addition to the here presented colocalization study indicates that it is rather 
unlikely that these two proteins interact at an endogenous protein level. If both proteins would 
interact strongly, a colocalization would be expected in over-expression studies as it is shown 
for FMN subtype formins (Figure 16). However, it cannot be excluded despite the weak 
interaction that INF2 and mitoSPIRE1 both contribute to the formation of a larger multimeric 
protein complex at mitochondrial surfaces, which finally serves to induce constriction of 
mitochondrial fission sites. 
 
4.6 mitoSPIRE1 targets MYO5 actin motor proteins towards mitochondria 
Myosin proteins are actin-based motor proteins that are involved in many functional processes, 
such as muscle contraction, cytokinesis, signal transduction and intracellular transport 
processes of organelles and other components (Hartman and Spudich, 2012). Especially the 
unconventional class 5 and class 6 myosins are associated with transport mechanisms of distinct 
organelles (Sellers, 2000; Kneussel and Wagner, 2013). In this regard, class 5 myosins mediate 
transport towards the actin filament barbed end (plus-end) whereas class 6 myosins move 
towards the minus end of polarized actin filaments (Wells et al., 1999; Sakamoto et al., 2000). 
Our colocalization studies show that C-terminal MYO5A and MYO5B proteins colocalize with 
full-length mitoSPIRE1 at mitochondria but not with the isolated exon 13 of mitoSPIRE1 
(Figure 18, A). In general, the interaction of myosins to their cargo is facilitated by adapter 
proteins (Yu et al., 2009) or the myosin protein interacts directly with the cytoplasmic portion 
of transmembrane molecules from its cargo (Fagarasanu et al., 2009). Like all SPIRE proteins, 
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the used GFP tagged full-length mitoSPIRE1 protein contains the globular tail domain binding 
motif (GTBM), which allows a direct interaction to the globular tail domain (GTD) of MYO5 
motor proteins. The difference of the colocalization between isolated exon 13 encoded 
sequences and full-length mitoSPIRE1 to the truncated MYO5A or MYO5B protein is therefore 
most likely caused by the GTBM of SPIRE proteins. The here presented colocalization study 
shows that, at least under transient over-expression conditions, the mitochondria-localized 
mitoSPIRE1 is able to translocate MYO5 proteins from vesicles to mitochondria. 
A mitochondrial mitoSPIRE1 / MYO5 protein complex is further supported by the fact that 
fibroblasts having a mutated SPIRE1 gene and therefore lack all functional SPIRE1 proteins 
show a lower number of MYO5A-positive mitochondria compared to wild type fibroblasts in 
fluorescence-activated mitochondria sorting (FAMS) analysis (Figure 18, B). Furthermore, the 
FAMS results indicate that MYO5 proteins are also recruited to mitochondrial surfaces by 
mechanisms different from SPIRE, given the fact that even in SPIRE1 mutant cells there is still 
a considerable amount of MYO5A proteins present at mitochondrial membranes. Nevertheless, 
reduced MYO5A-positive mitochondria of SPIRE1 mutant fibroblasts can also be caused by 
the loss of SPIRE1 or SPIRE1-E9, because SPIRE1 and SPIRE1-E9 could be involved in the 
transport of MYO5A proteins towards mitochondria. 
However, the mitoSPIRE1 mediated recruitment of MYO5 to mitochondria could be an 
important mechanism for the mitochondrial transport machinery. In this context, MYO5 could 
use mitoSPIRE1 generated actin filaments to drive mitochondrial movement, as it is already 
described for RAB11 vesicles in oocytes or melanosome transport (Schuh et al., 2011; 
Pylypenko, Welz, et al. 2016; Alzahofi, Robinson, Welz et al., 2018). In addition, the 
mitoSPIRE1 generated actin filaments could be used by MYO5 to anchor mitochondria at a 
certain position in the cell. 
 
4.7 Generation of a mitoSPIRE1 knockout mouse model 
Genetically modified mice have become a useful tool for scientists to study the biological role 
of specific genes, because single genes can be targeted and modified at the genomic level. In 
this context, knockout models describe mice which are genetically modified by a certain 
inactivation of an individual gene. The targeting of a specific gene often results in a distinct 
phenotype, which provides conclusive evidence for the functional role of the gene product (Hall 
et al., 2009). However, it also happens frequently that the interference with a specific gene does 
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not induce significant phenotypes or any phenotype at all. By employing CRISPR / Cas9 editing 
technology the genomic modification of embryonal stem cells (ES cells) works with a high rate 
of success (Yang et al., 2014). By injection of the modified totipotent ES cells into a mouse 
blastocyst, the genetically modified ES cells differentiate into all cell subtypes in a chimeric 
mouse. Final crossbreeding of chimeric mice, which carry the gene modification in their 
germline, results in mice containing the desired targeted gene modification (Hall et al., 2009). 
In the present thesis, a knockout mouse was generated using the CRISPR / Cas9 gene editing 
technology in ES cells in order to inactivate the alternatively spliced exon 13 of the SPIRE1 
gene (Figure 19). The inactivation of exon 13 is expected to result in a mouse model which is 
able to express SPIRE1 and SPIRE1-E9 but not the mitoSPIRE1 protein. The successful 
inactivation of exon 13 was confirmed by DNA analysis checking the absence of SPIRE1 
exon 13 in mitoSPIRE1 knockout mice. In addition, the genetically modified mice did not 
express mRNAs containing the alternatively spliced exon 13 of the SPIRE1 gene (Figure 19). 
The endogenous protein levels of mitoSPIRE1 are extremely low, and given that a specific 
mitoSPIRE1 antibody is not available today, it is impossible to confirm the absence of 
mitoSPIRE1 proteins by immunoblot. However, considering that both the genomic DNA and 
mRNA exon 13 sequences are missing in the mitoSPIRE1 knockout mouse we assume that the 
mice cannot express any mitoSPIRE1 protein. Nevertheless, by means of GST-pulldown assays 
using GST tagged FMN2-eFSI peptides, we confirmed that mitoSPIRE1 knockout mice still 
express SPIRE1 (and presumably SPIRE1-E9) proteins. These experiments verify that we have 
generated a knockout mouse that is specifically lacking the expression of mitoSPIRE1 proteins. 
The novel mitoSPIRE1 knockout mouse carries the gene modification in every single cell and 
can therefore be used to analyze the role of mitochondrial mitoSPIRE1 at the subcellular, 
cellular and organismic level. 
Mice which lack the expression of any functional SPIRE1 splice variant are more fearful in 
contextual and cued fear conditioning experiments (Pleiser et al., 2014). Until now it is unclear 
whether the deficiency of a single splice variant of the SPIRE1 gene is sufficient to cause this 
phenotype or if the combined absence of all three SPIRE1 encoded proteins is necessary. In this 
respect, it would be indispensable to test whether the mitoSPIRE1 knockout mice have a fear 
related phenotype, which would support a role for mitoSPIRE1 in fear related behavior. 
The newly generated mitoSPIRE1 knockout mouse is furthermore a valuable tool to get a 
deeper insight into the cellular role of the mitoSPIRE1 protein. In future experiments, any type 
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of cell can be isolated, cultured and analyzed for mitoSPIRE1 dependent alterations. In this 
context, neuronal cells could be analyzed for neurotransmitter release of oxytocin, which 
influences fear behavior (Knobloch et al., 2012). In addition, the mitoSPIRE1 knockout mouse 
could be investigated for abnormalities in mouse behavior experiments. 
 
4.8.1 Influence of SPIRE absence on mitochondrial morphology 
The morphology of mitochondria is a result of the precisely regulated balance between 
mitochondrial fission and fusion processes. As a consequence of these dynamic events, 
mitochondria have the ability to adjust their size to intracellular alterations, which allows 
mitochondria to fulfill their functions in an appropriate way for cellular requirements (Chen 
and Chan, 2009). The importance of dynamic mitochondrial fission and fusion events is 
highlighted by the fact that failure of these events not only influences the mitochondrial 
morphology, but also affects function and motility of mitochondria, and can therefore cause 
severe diseases or even death (Amiott et al., 2008; Ishihara et al., 2009; Chen and Chan, 2009; 
Lenaers et al., 2012). 
By means of employing fluorescence microscopy, the length of mitochondria from fibroblasts 
isolated from SPIRE1 mutant mice, which do not express any functional SPIRE protein from 
the SPIRE1 gene, mitoSPIRE1 knockout mice and wild type mice was analyzed in this thesis 
(Figure 20, B). In addition, 3-dimensional measurements of the mitochondria size from 
fibroblasts were performed for the same genotypes by flow cytometry (fluorescence-activated 
mitochondria sorting; FAMS) experiments (Figure 20, A). During flow cytometry, the 
combination of forward scatter photomultiplier tube area (FSC PMT-A) and the more sensitive 
side scatter area (SSC-A) was used to determine the 3-dimensional mitochondrial size. In this 
context, SSC-A provides information about the internal complexity of a mitochondrion, while 
the FSC PMT-A describes the mitochondrial diameter. Both fluorescence microscopy and 
FAMS experiments show that fibroblasts from all tested genotypes contain large, intermediate 
and fragmented mitochondria. The quantification of mitochondrial length by 2-dimensional 
microscopy revealed that mitochondria from primary mouse embryonic fibroblasts (pMEFs) 
lacking mitoSPIRE1 or all SPIRE1 proteins, respectively, show a reduced mitochondrial length 
compared to wild type mitochondria. Furthermore, 3-dimensional size measurements of 
mitochondria by FAMS show that fibroblasts lacking functional SPIRE1 proteins or only 
mitoSPIRE1, respectively, have a higher number of small mitochondria and lower number of 
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large mitochondria compared to wild type fibroblasts. For the 3-dimensional size analysis, 
SPIRE1 mutant mitochondria were analyzed in immortalized mouse embryonic fibroblasts 
(iMEFs), while mitoSPIRE1 knockout mitochondria were analyzed in pMEFs. In this aspect, 
the determined mitochondria size by FSC PMT-A of wild type mitochondria from iMEFs and 
pMEFs differ, which could be explained by the general differences between the two cell lines 
used. In summary, these results indicate that mitochondria of fibroblasts are smaller in the 
absence of the mitoSPIRE1 protein compared to wild type mitochondria, which is, however, 
not in line with the literature (Manor et al., 2015). 
In 2015, it was published that mitoSPIRE1 is required for the process of mitochondrial fission. 
In this context, mitoSPIRE1 was alleged to interact with the ER-localized INF2 protein to 
mediate mitochondrial constriction at fission sites via actin assembly mechanisms. However, it 
was reported that a mitoSPIRE1 knockdown increases the length of mitochondria in U2OS cells 
(Manor et al., 2015). As we know from the present thesis mitoSPIRE1 expression is extremely 
low. A temporary reduction of mRNA levels by an RNA interference knockdown might be 
irrelevant for the physiological effect of mitoSPIRE1, because mitoSPIRE1 proteins could be 
stable and therefore they could be still present in cells affected by the knockdown. However, in 
the study of 2015, the length of mitochondria was only determined by 2-dimensional 
microscopy analysis and not more than mitochondria of 25 cells per group were measured. In 
addition to the low number of investigated mitochondria, microscopy length analysis of 
organelles can be easily biased for example by the operator, because mostly nice- and 
healthy-looking cells are recorded. After we found controversial mitochondrial lengths in our 
SPIRE knockout cell lines by microscopy analysis, we measured in FAMS the size of more 
than 15,000 mitoSPIRE1 knockout, 18,900 SPIRE1 mutant and 7600 wild type mitochondria. 
In this connection, FAMS allows a 3-dimensional unbiased determination of mitochondrial 
size, because pooled fibroblasts of each cell line are lysed, and mitochondria are selected 
randomly for size measurements by a fluorescence-activated cell sorting (FACS) machine. 
At least it seems that mitoSPIRE1 somehow influences the mitochondrial size. This might be 
caused by direct or indirect involvement of mitoSPIRE1 in mitochondrial fission or fusion 
events. A direct influence of mitoSPIRE1 could shift the balance towards either mitochondrial 
fission or fusion events and could therefore result in a morphological phenotype and severe 
dysfunction of mitochondria. An indirect influence on the complex processes underlying 
mitochondrial fission and fusion events might be caused by an alteration of mitochondria 
motility (Chen and Chan, 2009). In this context, the motility of mitochondria could be modified 
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by newly generated actin filaments mediated by mitoSPIRE1 in cooperation with FMN 
subfamily formins at mitochondrial surfaces. However, the morphological phenotype observed 
at absence of mitoSPIRE1 was not detected in all cells, which indicates that mitoSPIRE1 does 
not have a severe influence on fission and fusion events. In contrast, a homozygous knockout 
of the mitochondrial fission-associated protein dynamin-related protein 1 (Drp1) in mice is 
already lethal at an embryonic stage (Manczak et al., 2012) and embryonic Drp1-/- fibroblasts 
contain extensive mitochondrial networks, which highlights the importance of Drp1 for 
mitochondrial fission events (Wakabayashi et al., 2009). To investigate the effects of 
mitoSPIRE1 on mitochondrial morphology in more detail, further experiments must be done. 
The frequency of fission and fusion events would be important to quantify in mitoSPIRE1 
knockout cells compared to wild type cells in order to consider a potential direct effect from 
mitoSPIRE1 on mitochondrial morphology. 
 
4.8.2 Influence of SPIRE1 absence on mitochondrial respiration 
Mammalian cells generate energy under physiological conditions mainly by mitochondrial 
respiration (oxidative phosphorylation; OXPHOS) and only to a small extent by anaerobic 
glycolysis. The highly efficient mitochondrial respiration processes molecules like NADH or 
succinate to convert energy into ATP, while using oxygen molecules as a terminal electron 
acceptor. In summary, during mitochondrial respiration oxygen molecules are consumed and 
ATP molecules are produced (Bonora et al., 2012; Smolina et al., 2017; Castellanos and 
Lanning, 2019). However, the highly motile mitochondria are transported to all cell areas in 
order to provide the whole cell with an adequate amount of energy in the form of ATP 
(Hollenbeck and Saxton, 2005). The interference with ATP supply is associated to severe 
diseases like diabetes or heart failure (Mogensen et al., 2007; Ingwall, 2009). Furthermore, the 
inadequate supply of energy, especially in neuronal cells, can alter the local protein synthesis 
during synaptic plasticity (Rangaraju et al., 2019) and therefore potentially the behavior of the 
whole organism. In this regard, limited ATP supply to specific cell areas can be caused by 
dysfunctions in the mitochondria transport system (Guo et al., 2005), but also by an impaired 
mitochondria respiration capacity (Smolina et al., 2017). In summary mitochondrial respiration 
is an irreplaceable process which enables the cell to drive energy consuming processes to finally 
ensure survival and functioning of mammalian cells. 
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In the present thesis, we measured the oxygen consumption rate (OCR) from isolated 
mitochondria of SPIRE1 mutant and wild type fibroblasts in vitro to evaluate mitochondrial 
functionality (Figure 21, B). In this context, the OCR indicates how much oxygen is required 
by mitochondria to convert ADP into ATP. The treatment of fibroblasts with different 
biologically active modulators triggers functional mitochondrial reactions and provides a 
specific readout of mitochondrial parameters like the OCR for maximal or basal respiration. 
The results show that mitochondria in cells without having functional SPIRE1 proteins do not 
significantly differ in the OCR in induced stress situations compared to mitochondria of wild 
type cells. For the maximal respiration rate, the OCR tends to be slightly reduced in 
mitochondria from SPIRE1 mutant cells, but which is probably not relevant in a physiological 
environment. These results strongly indicate that proteins encoded by the SPIRE1 gene do not 
severely influence mitochondrial respiration, and mitochondria of SPIRE1 mutant mice are 
therefore functional and not restricted in OXPHOS. These results are confirmed by a bright 
mitochondrial TMRM staining of SPIRE1 mutant fibroblasts (Figure 21, A), because the 
TMRM dye only accumulates in cells with functional mitochondria. Initially, we suggested that 
mitochondria of SPIRE1 mutant cells show also a functional phenotype, as morphological 
changes of mitochondria often influence mitochondrial function as well (Chen and Chan, 2009). 
In the present thesis, it was shown that the absence of the mitoSPIRE1 protein induces 
morphological alterations of mitochondria, which was also reported before (Manor et al., 2015). 
However, the described morphological changes do not measurably alter mitochondrial 
respiration. 
 
4.8.3 Function of mitoSPIRE1 in mitochondrial motility 
Mitochondrial motility is an important aspect of mitochondrial dynamics. The essential 
mitochondrial transport system allows the supply of an adequate amount of energy in the form 
of ATP to all cell areas (Chen and Chan, 2009). The main transport of mitochondria is facilitated 
by kinesin and dynein motor proteins along rigid and polarized microtubules (Heidemann et 
al., 1981; Baas et al., 1988, 1989; Sheng, 2014). Our experiments revealed that fibroblasts 
without the mitochondrial actin nucleator mitoSPIRE1 contain a higher percentage of moving 
mitochondria compared to wild type fibroblasts. Furthermore, the mitochondria of mitoSPIRE1 
deficient fibroblasts move faster and over longer distances than mitochondria from wild type 
fibroblasts (Figure 22). In our experiments, pMEFs lacking exclusively the mitoSPIRE1 protein 
present the same motility phenotype as pMEFs of SPIRE1 mutant mice lacking the expression 
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of all functional proteins of the SPIRE1 gene. This indicates that the motility effect is not caused 
by SPIRE1 or SPIRE1-E9 proteins but by mitoSPIRE1 as pMEFs from both genetically 
modified mice show an identical mitochondrial phenotype. In summary, we can conclude that 
mitochondria in pMEFs not expressing the mitoSPIRE1 protein are more motile than 
mitochondria in wild type cells. 
As a proof of concept, the transient overexpression of mitoSPIRE1 reverses the mitochondrial 
motility phenotype dramatically in all pMEF cell lines investigated (Figure 23). Overexpression 
of mitoSPIRE1 significantly reduces the number of moving mitochondria and mitochondria are 
transported slower and over shorter distances than mitochondria from control cells. Significant 
differences in the experiment indicate that the actin nucleator mitoSPIRE1 might cooperate 
with MYO5 / FMN at mitochondria surfaces to influence mitochondrial motility. 
These experiments clearly show that mitoSPIRE1 is involved in the molecular mechanisms to 
regulate the motility of mitochondria in pMEFs. As mentioned above, mitochondria are mainly 
transported along microtubules, but there is also accumulating evidence that actin filaments 
play an important role in the transport machinery of mitochondria (Hollenbeck and Saxton, 
2005; Gutnick et al., 2019; Rangaraju et al., 2019). It is still unclear how mitochondrial 
transport is influenced by actin filaments. In 2010, it was published that mitochondria of 
neuronal cells in Drosophila melanogaster show higher motility in the absence of MYO5 actin 
motor proteins (Pathak et al., 2010). Years later it was further reported that mitochondria in 
axons of mammalian hippocampal neurons show an increased motility following actin filament 
polymerization is blocked by latrunculin A (Gutnick et al., 2019). Furthermore, a rapid calcium 
induced actin polymerization at the endoplasmic reticulum by Inverted formin 2 leads to 
transient immobilization of organelles (Wales et al., 2016). In combination with the knowledge 
that SPIRE proteins cooperate with FMN subfamily formins to facilitate actin filament 
polymerization (Quinlan and Kerkhoff, 2008; Dietrich et al., 2013; Alzahofi, Robinson, Welz 
et al., 2018), it is not surprising that mitoSPIRE1 influences mitochondrial motility. The 
influence of mitoSPIRE1 on mitochondrial motility might be explained by a local actin network 
at mitochondria produced by mitoSPIRE1 and FMN subfamily proteins. To understand in detail 
how these local actin filaments could influence the transport of mitochondria, further 
investigations are necessary. In addition, the experiments performed in pMEFs to investigate 
mitochondrial motility have to be repeated in neuronal cells. This would also clarify if we 
detected a cell specific effect of mitoSPIRE1 or if mitoSPIRE1 might play a much larger 
systemic role by finally influencing the integrity of neuronal networks. 
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4.9 Model for mitoSPIRE1 function in mitochondrial transport processes 
The transport of mitochondria along cytoskeletal components enables the cell to provide all 
intracellular compartments with energy in the form of ATP (Hollenbeck and Saxton, 2005). 
Besides their movement, the target-oriented anchoring of mitochondria at synapses or other cell 
areas which have a high demand of energy seems to be important as well (Li et al., 2004; Sheng, 
2014; van Bergeijk et al., 2016; Ashrafi and Ryan, 2017; Rangaraju et al., 2019).  
Transport, replenishment, and reuptake of synaptic vesicles are highly energy consuming 
processes, which are impaired by an insufficient supply with ATP (Sheng, 2014). However, 
stationary mitochondria pools at active pre-synaptic boutons in axons facilitate a constant ATP 
supply, while motile mitochondria passing through the active synapses only provide a 
temporary ATP supply, which reduces synaptic energy levels. To avoid a depleted ATP supply, 
motile mitochondria can become stationary (Sheng, 2014). In line with axonal synapses the 
function of dendritic spines is also dependent on local stationary mitochondria pools. In this 
context, it was shown that stable mitochondrial compartments fuel local translation during 
induced neuronal plasticity (Rangaraju et al., 2019). To immobilize mitochondria in axonal 
compartments the syntaphilin protein anchors the organelle directly at microtubules (Kang et 
al., 2008; Chen et al., 2009). Not surprisingly, the absence of syntaphilin in hippocampal 
neurons increases the general axonal mitochondria motility and mitochondria fail to stop at 
activated pre-synapses. Nevertheless, mitochondria of dendrites are not affected by the loss of 
syntaphilin and are still recruited to active synapses (Chen and Sheng, 2013). However, it is 
hypothesized that stationary mitochondria of both dendritic post-synaptic spines and axonal 
pre-synaptic sites are anchored to actin filaments (Gutnick et al., 2019; Rangaraju et al., 2019). 
Those facts indicate that the mitochondrial transport system is highly complex and has several 
mechanisms to stop and anchor motile mitochondria at specific intracellular positions. 
From the work presented in this thesis, we conclude that the mitochondrial mitoSPIRE1 protein 
might be able to cooperate with FMN subfamily formins and MYO5 motor proteins at the 
mitochondrial surface. Furthermore, the loss of mitoSPIRE1 increases the motility of 
mitochondria in pMEFs. Based on these results and on the present literature we propose a model 
in which the mitoSPIRE1 protein interacts with FMN formins to produce a local actin 
meshwork at mitochondrial membranes (Figure 24). Furthermore, we propose that mitoSPIRE1 
translocates the myosin 5 actin motor protein function towards mitochondria to provide 
anchoring to the actin cytoskeleton by the interaction of myosin motor domains with the actin 
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network. In our model, the functional protein complex of SPIRE, FMN and MYO5 provides a 
mitochondrial anchor system, which facilitates mitochondria to be spatially stationary. The 
mitoSPIRE1 protein might therefore function similarly to its vesicular counterpart in organizing 
local actin / myosin networks, but the mitoSPIRE1 generated actin meshwork seems to facilitate 
mitochondria positioning and not mitochondria transport. The number of actin motor proteins 
on an individual organelle / vesicle might differentiate between motility and anchoring. This 
model is in line with the observation that the absence of mitoSPIRE1 increases mitochondrial 
motility in pMEFs. 
The model proposed herein for mitochondrial transport describes that mitoSPIRE1 is able to 
cooperate with FMN subfamily formins to produce a local actin meshwork at mitochondria, as 
it was already described for the transport of RAB11 vesicles and melanosomes (Schuh, 2011; 
Alzahofi, Robinson, Welz et al., 2018). In contrast to RAB11 vesicles and melanosomes, we 
propose that these actin filaments are not used for transport but rather to anchor the 
mitochondria at specific positions. In this context, the positioning of mitochondria could be 
facilitated by an actin meshwork containing randomly oriented actin filaments. As a 
consequence, myosin motor proteins could walk along polarized actin filaments in distinct 
directions, block each other in forward movement and would finally stabilize the mitochondria 
at a specific position. Myosin motor proteins could also just bind the actin filament and freeze 
in a certain position to block mitochondria movement and work finally as an anchor. It is most 
likely that MYO5 motors are involved in these processes, because these proteins colocalize 
with mitoSPIRE1 and MYO5 is already associated to arrest kinesin-driven cargoes in the axon 
initial segment, which is an actin-rich region (Janssen et al., 2017). Finally, our predicted 
mitochondrial transport model is supported by the fact that myosin motors are reported before 
to participate in the tethering and positioning of many other organelles at actin filaments 
(Venkatesh et al., 2019). 
However, the hypothesized mitochondria anchoring system organized by mitoSPIRE1 seems 
to be highly energy consuming compared to immobilization of mitochondria by syntaphilin. 
The anchor mechanism mediated by syntaphilin seems to be an area specific system for 
neuronal axons and anchors mitochondria at microtubules but not at actin filaments (Kang et 
al., 2008; Chen et al., 2009). Actin filaments have been proposed to aid transport processes 
within cell areas where rigid microtubules are not available (Kneussel and Wagner, 2013). This 
would explain why the cell needs an actin dependent anchor system for organelles. In agreement 
with syntaphilin, it could be that there is an unknown protein / (complex) which immobilizes 
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mitochondria at actin filaments as well. Furthermore, actin rich regions have been suggested to 
inhibit cargo movement by itself (Venkatesh et al., 2019) and it is an additional option to explain 
the mitoSPIRE1 influence on mitochondria motility. In this context, the enrichment of actin 
filaments synthesized by a mitoSPIRE1 / FMN complex at mitochondria act as an 
insurmountable obstacle for mitochondrial transport, and mitochondria are captured at their 
current position until actin filaments are depolarized. Nevertheless, our results and 
accumulating evidence from other scientists indicate that actin filaments serve as an anchor 
system in the mitochondrial transport machinery, and not as transport tracks (Pathak et al., 
2010; Gutnick et al., 2019; Rangaraju et al., 2019). The absence of the actin based 
mitochondrial anchor system facilitated by mitoSPIRE1 could influence the stationary 
mitochondria pools in synapses and therefore impair neuronal plasticity. Impairments in 
synaptic plasticity interfere with learning processes and memory formation and thus could 
finally influence the behavior of the whole organism and explain the fear conditioning 
phenotype of SPIRE1 mutant mice, lacking the expression of proteins from the SPIRE1 gene. 
Furthermore, the loss of actin-based stationary mitochondria pools could influence pre-synaptic 
neurotransmitter release and therefore the behavior of an organism, may explain the fear 
phenotype of SPIRE1 mutant mice as well. 
To confirm the existence of a mitoSPIRE1 mediated anchor system of mitochondria at actin 
filaments, further experiments are necessary. In this context, mitochondria motility assays of 
mitoSPIRE1 knockout neurons have to be done. In addition, the novel mitoSPIRE1 knockout 
mouse has to be tested in fear conditioning experiments to investigate if the in vitro phenotypes 
influence animal behavior. 
The actin nucleators SPIRE and FMN subfamily formins directly interact strongly with each 
other and form a functional actin nucleator complex at intracellular membranes (Pechlivanis et 
al., 2009; Pfender et al., 2011; Schuh, 2011; Alzahofi, Robinson, Welz et al., 2018). Based on 
this, it seems counterintuitive that SPIRE1 mutant and FMN2 knockout mouse models display 
different phenotypes in fear conditioning experiments (Peleg et al., 2010; Pleiser et al., 2014; 
Agís-Balboa et al., 2017). Further analysis needs to be done to clarify why these mouse models 
show a difference in fear behavior. 
Based on our results presented in this thesis and on the present literature, we propose a novel 
model for mitochondria anchoring at actin filaments mediated by the mitochondria associated 
actin nucleator mitoSPIRE1. In conclusion, the here-hypothesized mitoSPIRE1-mediated 
Discussion 
 102 
actin-based anchor system of mitochondria might be important for several neurological 
functions, including neuroplasticity or neurotransmitter release, and could therefore especially 
influence fear behavior.
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6. Supplement 
6.1 Overview of used materials 
All materials used in this thesis are systematically listed in this chapter. Materials for 
experiments not done primarily by myself (like CRISPR / Cas9 experiments, protein 
purification or embedding brain in paraffin blocks and cutting brain sections from paraffin 
blocks) are not listed here, because experiments were done by our collaboration partners or by 
Kerkhoff laboratory members. Most cloning experiments were done by Dr. Tobias Welz and 
Annette Samol-Wolf from the Kerkhoff laboratory, why all needed endonucleases for cloning 
of used plasmids are listed here. 
 
6.1.2 Chemicals and reagents 
Article Quantity Company Order Number 
Acetic acid, Rotipuran, 100 %, p.a. 1 l Carl Roth 3738.1 
Albumin standard (2 mg/ml) 10 × 1 ml ThermoFisher 23209 
Ammoniumpersulfat 100 g Sigma-Aldrich A3678 
Ampicillin sodium salt 25 g Sigma-Aldrich A9518-25G 
Blood bank saline 10 l ThermoFisher 23-312-651 
BM-Purple 100 ml Roche 11442074001 
Boric acid 1 kg Sigma-Aldrich B0252-1KG 
Bovine serum albumin 1 Vial Sigma-Aldrich A8531 
Bromophenol blue sodium salt 10 g Carl Roth A512.1 
Citric acid 100 g Sigma-Aldrich 251275 
cOmplete Mini, EDTA-free 25 tabs Roche 11836170001 
Coomassie Plus Protein Assay, 
Reagent for Bradford assays 950 ml ThermoFisher 1856210 
D-MEM (HG) W/O NA PYR (CE) 500 ml ThermoFisher 41965-062 
dATP 100 μM  NEB N0440S 
dCTP 100 μM  NEB N0441S 
Denhardt´s Solution 50x 5 ml Sigma-Aldrich D2532 
Dextran sulfate 50 g Sigma-Aldrich D8906 
dGTP 100 μM  NEB N0042S 
Digitonin 100 mg Sigma-Aldrich D141 
Dimethyl sulfoxide (DMSO), Hybri-Max 5 × 10 ml Sigma-Aldrich D2650 
DL-Dithiothreitol (DTT) 5 g Sigma-Aldrich D0632-5G 
dTTP 100 μM  NEB N0443S 
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Ethanol > 99.8 % + 1 % MEK 2.5 l Carl Roth K928.1 
Ethanol > 99.8 %, p.a. 2.5 l Carl Roth 9065.2 
Ethidiumbromide solution, 0.5 % 15 ml Carl Roth HP46.1 
Ethylenediaminetetraacetic acid 
tetrasodium salt hydrate (EDTA) 500 g Sigma-Aldrich E5134-500G 
Fetal bovine serum 50 ml Merck F2442 
Formamide 1 l Carl Roth 6749.1 
Formamide deionized 250 ml Carl Roth P040.1 
GeneRuler 1 kb DNA 5 × 50 μg ThermoFisher SM0311 
GeneRuler 100 bp DNA 5 × 50 μg ThermoFisher SM0241 
Glutathione Sepharose 4B 10 ml GE Healthcare Life Sciences 17-0756-01 
Glycerine-solution for microscopy 1 vessel Leica 11513872 
Glycerol 100 ml Merck G5516 
Glycine, 99 % 5 kg Carl Roth 3790.3 
Hydrochloric acid, Rotipuran, 25 % 1 l Carl Roth 6331.1 
Immersion liquid, Type F 1 vessel Leica 11513859 
Isopropanol, > 99.5 % 2.5 l Carl Roth 9866.5 
Kanamycin B sulfate salt 250 mg Sigma-Aldrich B5264-250MG 
LB-Medium (Luria/Miller; 10 g/l NaCl) 5 kg Carl Roth X968.4 
Levamisole hydrochloride 5 g Sigma-Aldrich L9756 
LuminataTM Forte Western HRP 
Substrate 
100 ml Merck-Millipore WBLUF0100 
Magnesium chloride hexahydrate 100 g Sigma-Aldrich M2670-100G 
Methanol, LiChrosolv 2.5 l Merck-Millipore 1.06007.2500 
Milk powder 500 g Carl Roth T145.2 
MitoTracker Orange CMTMRos 20 × 50 μg ThermoFisher M7510 
MitoTracker Red CMXRos 20 × 50 μg ThermoFisher M7512 
MOWIOL 4-88 Reagent 100 g Merck 475904 
N-propyl-gallate 100 g Sigma-Aldrich P3130 
Nonidet P 40 Substitute 1 l Merck 74385 
Nonidet P-40 BioChemica (NP-40) 500 ml AppliChem A1694,0500 
Opti-MEM I (1X) 100 ml ThermoFisher 31985-062 
Paraformaldehyde 250 g Carl Roth 0335.1 
PBS buffer (10x, powder) 10 l AppliChem A0965,9010 
Phenylmethylsulfonylfluorid, PMSF 5 g Sigma-Aldrich P-7626-5G 
Ponceau S, practical grade 50 g Sigma-Aldrich P3504-50G 
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Precision Plus Protein Dual Color 
Standards 500 μl Bio-Rad 161-0374 
Protease and Phosphatase Inhibitor 
Cocktail 1 package Abcam ab201119 
RNAlater™ Stabilization Solution 100 ml ThermoFisher AM7020 
RNase AWAY 475 ml Carl Roth 7002 
Rotiphorese Gel 30, Acrylamid/Bis-
Acrylamid solution 1 l Carl Roth 3029.1 
Salmon sperm DNA 1 ml Agilent Technologies 201190 
Select agar 1 kg Sigma-Aldrich A5054 
Sodium chloride, > 98 % 1 kg Sigma-Aldrich S3014-1KG 
Sodium citrate tribasic dihydrate 100 g Sigma-Aldrich C8532 
Sodium dodecyl sulfate (SDS) 500 g Sigma-Aldrich L4390-500G 
Sodium hydroxide pellets 1 kg Merck 1064621000 
TEMED 100 ml Sigma-Aldrich T9281 
TMRM 5 × 100 μl ThermoFisher I34361 
Tris-EDTA (TE) buffer solution 100 ml Merck 93283 
Triton X-100, for molecular biology 100 ml Sigma-Aldrich T8787-100ML 
Trizma base (Tris) 5 kg Sigma-Aldrich T1503-5KG 
Trypsin-EDTA solution (0.05 %) 100 ml ThermoFisher 25300054 
Tween 20, BioChemica 500 ml AppliChem A1389,0500 
UltraPureTM Agarose 100 g ThermoFisher 16500100 
Xylol 2.5 l Carl Roth 9713.3 
Yeast t-RNA 100 mg Merck 10109517001 
β-Mercaptoethanol (12.8 M) 100 ml Carl Roth 4227.3 
Table 5 - Overview on used chemicals and reagents. 
 
6.1.3 Cell culture media, reagents and supplements 
Article Quantity Company Order Number 
DMEM (1X) Dulbecco´s Modified Eagle 
Medium 500 ml ThermoFisher 41965-039 
Dulbecco’s Phosphate Buffered Saline 
(1X; 1x PBS) 500 ml ThermoFisher 14190-094 
HyClone FetalClone III Serum (FCS III) 500 ml 
GE 
Healthcare 
Life Sciences 
SH30109.03 
L-Glutamine; 200 mM 100 ml ThermoFisher 25030024 
LipofectamineTM 2000 reagent 1.5 ml ThermoFisher 11668019 
Penicillin/Streptomycin solution 100 ml ThermoFisher 15140122 
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Poly-L-Lysine 50 ml Sigma-Aldrich P4707 
Trypan Blue solution (0.4 %, 
sterile-filtered, suitable for cell culture) 100 ml Sigma-Aldrich T8154-100ML 
Trypsin-EDTA (0.05 %) 100 ml ThermoFisher 25300054 
Water, sterile filtered, BioReagent, 
suitable for cell culture 1 l Sigma-Aldrich W3500-1L 
Table 6 - Overview on used cell culture media, reagents and supplements. 
 
6.1.4 Buffers, solutions and media 
Buffer, solution or media ingredients 
100 mg/ml tRNA - 100 mg in 10 ml Millipore-H2O - aliquots at -20 °C 
200 mM Levamisole - 2.4 g of levamisole in 50 ml of Millipore-H2O 
20x SSC 
- 175.3 g NaCl 
- 88.2 g sodium citrate tribasic dihydrate 
- 800 ml Millipore-H2O 
- adjust pH to 8.0 with 1 M citric acid 
- fill to 1 l with Millipore-H2O 
- 1 ml of DEPC 
- autoclave 
- solution is stored at room temperature 
5 % (w/v) Milk powder 
blocking solution 
- 50 g dry milk powder in 1 l 1x PBST 
- freeze 50 ml aliquots at -20 °C 
7.5 % SDS polyacrylamide 
separation gel 
- 5.7 ml Millipore-H2O 
- 1.3 ml 3 M Tris-HCl pH 9.0 
- 2.6 ml Acrylamide30 solution 
- 50 μl 20 % SDS 
- 10 μl TEMED 
- 50 μl 10 % APS 
Agar selection plates for 
bacterial culture 
 
- 25 g LB medium (Luria/Miller) 
- 13 g select agar 
- fill up with Millipore-H2O to 1 l 
- autoclave for 20 min at 121 °C, cool to approx. 42 °C 
- add antibiotics 
Agarose solution for gel 
electrophoresis 
- dissolve desired amount of agarose in 0.5x TBE by 
boiling and shaking (1 - 2.5 %) 
Ampicillin solution (10 %)  - 1 g Ampicillin sodium salt in 10 ml Millipore-H2O - filter sterile and store aliquots at 4 °C 
APS solution (10 %) - 10 % Ammoniumpersulfat (w/v) in Millipore-H2O - store at 4 °C 
Blocking buffer  
- 0.2 % BSA  
- 2 % fetal bovine serum  
- 1x PBS 
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Cell lysis buffer 
- 25 mM Tris-HCl pH 7.4 
- 150 mM NaCl 
- 5 mM MgCl2 
- 10 % (v/v) glycerol 
- 0.1 % (v/v) Nonidet P-40 
- 1 mM PMSF 
- protease inhibitor cocktail 
Coomassie staining solution 
- 10 % acetic acid 
- 40 % ethanol 
- 0.6 % (w/v) Coomassie brilliant blue G250 
- 0.6 % (w/v) Coomassie brilliant blue R250 
DEPC-H2O - add 1 ml of DEPC to 1 l of Millipore-H2O - autoclave and store at room temperature 
DNA loading dye (6x) 
- 10 mM Tris-HCl, pH 7.6 
- 0.03 % bromophenol blue 
- 60 % glycerol 
- 60 mM EDTA 
FACS buffer  
- 0.5 % BSA 
- 2 mM EDTA 
- 1x PBS pH 7.2  
FCSIII for cell culture - inactivate at 56 °C (waterbath) for 30 min - store 50 ml aliquots at -20 °C 
Full Medium for cell culture 
- DMEM 
- 10 % FCSIII 
- 2 mM L-glutamine 
- 100 units/ml Penicillin 
- 100 μg/ml Streptomycin 
Hybridization mixture 
- Prehybridization buffer  
- add 15 μl of specific DIG-labeled RNA (final 
concentration of 2 ng/μl) 
Hypo-osmotic buffer  
- 10 mM NaCl 
- 1.5 mM MgCl2  
- 10 mM Tris-HCl (pH 7.6) 
Kanamycin stock solution 
- dissolve Kanamycin monosulfate in Millipore-H2O         
(25 mg/ml) 
- filter sterile and store 2 ml aliquots at -20 °C 
LB medium (Luria/Miller) - dissolve 25 g/l in Millipore-H2O - autoclave for 20 min at 121 °C 
Mowiol solution 
- 15 g Mowiol 4-88 in 70 ml Millipore-H2O 
- 30 ml glycerol 
- 2.5 % (w/v) n-propylgallat 
- centrifuge at 17,300 × g for 15 min 
- store 1 ml aliquots at -20 °C 
NTE buffer  
- 100 ml 5 M NaCl 
- 10 ml 1 M Tris pH 7.5 
- 10 ml 0.5 M EDTA to 880 ml of Millipore-H2O 
- store solution at 4 °C 
NTMT buffer 
- 20 ml 5 M NaCl 
- 50 ml 1 M MgCl2 
- 100 ml 1 M Tris pH 9.5 to 830 ml of Millipore-H2O 
- 1 ml Tween 20  
- store solution at 4 °C 
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Paraformaldehyde solution 
(3.7 %) 
- 7.4 g paraformaldehyde in 100 ml 1x PBS  
- 2 drops 10 M NaOH 
- incubate at 60 °C for at least 30 min  
- 100 ml 1x PBS, adjust to pH 7.4  
- store 10 ml aliquots at -20 °C 
PBS (10x) - dissolve 95.5 g PBS powder in 1 l Millipore-H2O 
PBST (1x; 0.05 % Tween20)  - add 0.05 % Tween20 to 1x PBS 
PMSF stock solution (0.1 M)  - dissolve in ethanol - store 2 ml aliquots at -20 °C 
Ponceau S staining solution  - 5 % acetic acid - 0.1 % (w/v) Ponceau S 
Prehybridization buffer 
- 50 % deionized formamide 
- 1x Denhardt´s solution 
- 10 mM DTT 
- 4x SCC 
- 10 % Dextran sulfate 
- 1 mg/ml yeast t-RNA and 1 mg/ml salmon sperm DNA 
Proteinase K (10 mg/ml) - 10 mg proteinase K to 1 ml proteinase K buffer - store aliquots at -20 °C  
Proteinase K buffer 
- 20 ml 1 M RNase-free Tris pH 7.5  
- 2 ml 0.5 M EDTA/DEPC pH 8.0 
- 978 ml DEPC-H2O 
- store at room temperature 
Pulldown buffer 
- 25 mM Tris-HCl, pH 7.4 
- 150 mM NaCl 
- 5 mM MgCl2 
- 0.1 % NP-40 
- 10 % glycerol 
SDS polyacrylamide stacking 
gel 
- 2.6 ml Millipore-H2O 
- 420 μl 1 M Tris-HCl pH 6.8 
- 550 μl Acrylamide30 solution 
- 17 μl 20 % SDS 
- 5 μl TEMED 
- 33 μl 10 % APS 
SDS protein sample buffer 
(5x) Laemmli buffer 
- 100 mM Tris-HCl, pH 6.8 
- 50 % glycerol (v/v) 
- 15 % SDS (w/v) 
- 25 % β-Mercaptoethanol (v/v) 
- 0.025 % bromophenol blue (w/v) 
- store 1 ml aliquots at -20 °C 
SDS-PAGE-buffer (10x)  
- 250 mM Tris 
- 1.9 M glycine 
- 1 % SDS (w/v) 
TBE buffer (10x)  
- 890 mM Tris 
- 890 mM boric acid 
- 20 mM EDTA, pH 8.0 
TBST (10x) 
- 0.5 M Tris 
- 1.5 M NaCl 
- 0.5 % Tween20 
- adjusted to pH 7.4 with HCl 
- store at room temperature 
Transfer buffer (10x) - 250 mM Tris - 1.92 M glycine 
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Transfer buffer (1x)  
- 25 mM Tris 
- 192 mM glycine 
- 20 % methanol 
Tris-EDTA, pH 8.0 for 
plasmid DNA storage 
- 20 mM Tris  
- 1 mM EDTA 
- adjust pH to 8.0 with HCl 
- autoclave 
Triton X-100 (0.2 %)  - 0.2 % in 1x PBS 
Tween20 (10 %)  - dilute Tween20 in 1x PBS 
β-Mercaptoethanol solution 
(12.8 M) - mix stock solution with Millipore-H2O to obtain 12.8 M 
Table 7 - Overview on used buffers, solutions and media. 
 
6.1.5 Disposable materials 
Article Company Order Number 
Autoclave indicator tape (120 °C) A. Hartenstein STKD 
BD MicrolanceTM 3 (0.9 × 40 mm) Becton Dickinson 301300 
Biosphere Filter Tip 100 Sarstedt 70.760.212 
Blotting papers, Grade 3 MM Chr Whatman 3030.917 
Cell culture dish (100 × 20 mm) Greiner Bio-One 664160 
Cell culture plate (6-well) Greiner Bio-One 657160 
Cellstar reaction tubes, conical (15 ml) Greiner Bio-One 188 271 
Cellstar reaction tubes, conical (50 ml) Greiner Bio-One 227 261 
CryoTube Vials (1 ml) Nunc 366656 
Embedding casette Carl-Roth E478.1 
Microscope cover glasses, 15 mm A. Hartenstein DKR2 
Microscope slides, Menzel-Gläser, 
Superfrost® Plus ThermoFisher  J1800AMNZ 
Needles, BD Microlance 3, 20G × 1.5“ BD Biosciences 301300 
Nitrocellulose transfer membrane, 
PROTAN® BA85, 0.45 μm pore size Whatman 10401196 
Parafilm® “M” Laboratory Film Pechiney Plastic Packaging PM-996 
Pasteur pipettes A. Hartenstein PP07 
PCR SoftTubes (0.2 ml) Biozym Scientific GmbH 710920 
Petri dishes (94 × 16 mm) A. Hartenstein PP90 
Pipette tips, blue (100 - 1000 μl) Axygen T-1000-B 
Pipette tips, white (0.5 - 10 μl) Axygen T-300 
Pipette tips, yellow (2 - 200 μl) Sarstedt 70.760.002 
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qPCR reaction tubes (Strip Tubes and 
Caps, 0.1 ml (250)) Qiagen 981103 
Reaction tubes (1.5 ml) A. Hartenstein RK1G 
Reaction tubes (2.0 ml) A. Hartenstein RK2G 
Sapphire Filter Tip (10 μl) Greiner Bio-One 771261 
Scalpel Megro 147222 
Syringe with needle, 1 ml 26G × 3/8“, Luer BD Biosciences 300015 
T25 cell culture flask (25 cm2, 50 ml) Sarstedt 83.1810.002 
T75 cell culture flask (75 cm2, 250 ml) Sarstedt 83.1813.002 
TissueRuptor Disposable Probes Qiagen 990890 
Transfection tubes (5 ml, 75 × 12 mm) Sarstedt 55.476.013 
Ventilation cap tubes (14 ml) Sarstedt 62.515.006 
Videoprinter paper VWR PEQRCD80E1091 
WillCo-Dish (Glass-bottom dish; 40 mm) WillCo Wells B.V. GWSt-5040 
Table 8 - Overview on used disposable materials. 
 
6.1.6 Kits 
Article Company Order Number 
DIG RNA Labeling Kit Merck 11175025910 
NucleoSpin Gel and PCR Clean-up Macherey-Nagel REF 740609.50 
NucleoSpin RNA Kit Macherey-Nagel 740955.50 
PE/Cy7 Conjugation Kit - Lightning Link Abcam ab102903 
QIAGEN Plasmid Maxi Kit (25) Qiagen 12163 
QIAprep Spin Miniprep Kit (250) Qiagen 27106 
QIAxcel RNA QC Kit v2.0 Qiagen 929104 
QuantiNova Reverse Transcription Kit Qiagen 205411 
QuantiNova SYBR Green PCR Kit (100) Qiagen 208052 
RNeasy Midi Kit Qiagen 75144 
Seahorse XFp Cell Mito Stress Kit Agilent Technologies 103010-100 
Table 9 - Overview on used kits. 
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6.1.7 Antibodies 
6.1.7.1 Primary antibodies 
Article Species / Clonality Purpose Company 
Order 
Number 
anti-c-Myc (9E10) mouse, monoclonal Immunostain 
Santa Cruz 
Biotechnology sc-40 
anti-cytochrome C mouse, monoclonal Immunostain ThermoFisher 33-8200 
anti-Digoxigenin-AP sheep, polyclonal in situ Merck 11093274910 
anti-MYO5A (G-4) mouse, monoclonal FAMS 
Santa Cruz 
Biotechnology sc-365986 
anti-SPIRE1            
(SA-2133) 
rabbit, 
polyclonal 
Immunostain, 
Western blot 
Schumacher 
et al., 2004 - 
Table 10 - Overview on used primary antibodies. 
 
6.1.7.2 Secondary antibodies 
Article Species Purpose Company Order Number 
Amersham ECL anti-
rabbit IgG, HRP-linked donkey Western blot 
GE 
Healthcare 
Life 
Sciences 
NA934-1ML 
anti-mouse TRITC donkey Immunostain Dianova 715-025-151 
anti-rabbit Cy5 donkey Immunostain Dianova 711-175-152 
Table 11 - Overview on used secondary antibodies. 
 
6.1.8 Enzymes 
6.1.8.1 Restriction endonucleases 
Restriction endonuclease Concentration / Volume Company Order Number 
BamHI-HF 20,000 units/ml NEB R3136S 
BclI-HF 20,000 units/ml NEB R3160S 
EcoRI-HF 20,000 units/ml NEB R3101L 
HindIII-HF 20,000 units/ml NEB R3104S 
KpnI-HF 20,000 units/ml NEB R3142L 
NheI 20,000 units/ml NEB R3131S 
SalI 20,000 units/ml NEB R0138S 
XbaI 20,000 units/ml NEB R0145S 
XhoI 20,000 units/ml NEB R0146L 
Table 12 - Overview on used restriction endonucleases. 
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6.1.8.2 DNA polymerases 
Polymerase Concentration / Volume Company Order Number 
AccuPrimeTM Pfx DNA 
Polymerase 2.5 units/μl ThermoFisher 12344-024 
Pfu DNA Polymerase 500 u Promega M7745 
Q5® High-Fidelity DNA 
Polymerase 2000 units/ml NEB M0491S 
Taq DNA Polymerase 5000 units/ml NEB M0273L 
Table 13 - Overview on used DNA polymerases. 
 
6.1.8.3 Additional enzymes 
Enzyme Concentration / Volume Company Order Number 
Calf Intestinal Alkaline 
Phosphatase (CIP) 10,000 units/ml NEB M0290L 
Proteinase K (genotyping) 30 units/mg Carl Roth 7528.1 
Proteinase K (in situ) 2 units/mg Merck 03115836001 
RNase A 7000 units/ml Qiagen 19101 
T4 DNA Ligase 400,000 units/ml NEB M0202L 
Table 14 - Overview on additional enzymes. 
 
6.1.9 Primer (PCR / qPCR) 
Primer name  Tm (°C) Product size  Purpose Primer sequence (5´ à 3´) 
SPIRE1-FW 60.03 
149 bp PCR, qPCR 
AGGATGAAGGGTACGAGGCT 
SPIRE1-REV 58.85 CTGATAATGATTGGGTGCCTCC 
SPIRE1-E9-
FW 58.63 129 bp PCR, qPCR 
GGCCACTTAGCATGTCTCAC 
SPIRE1-E9-
REV 58.67 CGCTCAGCCCATTTTCTTTTG 
mitoSPIRE1-
FW 
57.71 
 113 bp PCR, qPCR 
TCTGTTTGAGAGAGCTTTTACCA 
mitoSPIRE1-
REV 59.78 GGACCTGACGGATGTGCAT 
SPIRE2-FW 61.5 
133 bp PCR, qPCR 
ACACTGCACGAGAAGATCCT 
SPIRE2-REV 64.3 ACTTGATGTCCCCAGAGCAG 
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genoS1-FW 
 
 
 
58.6 
269 bp (WT 
shows a specific 
PCR-product, 
SPIRE1 mutant 
does not show a 
specific PCR-
product) 
Geno- 
typing 
(SPIRE1 
WT / 
SPIRE1 
mutant) 
GCATGACTCTTTGGAGAGCATT
AGC 
genoS1-REV 60.8 AGGCTACAAGAACTGGTCTCCAAGC 
genoS1-FW 58.6 142 bp (SPIRE1 mutant shows a 
specific PCR-
product, WT 
does not show a 
specific PCR-
product) 
Geno-
typing 
(SPIRE1 
WT / 
SPIRE1 
mutant) 
GCATGACTCTTTGGAGAGCATT
AGC 
geno 
S1mutant-
REV 
56.2 ATAAACCCTCTTGCAGTTGCATC 
genomito 
SPIRE1-FW 55.82 749 bp (WT), 575 bp 
(mitoSPIRE1) 
Geno-
typing 
(SPIRE1 
WT / 
mitoSPI
RE1 
knockout
) 
 
 
 
 
TCCCTCCAACCAAAAATGTC 
 
 
 
 
genomito 
SPIRE1-REV 57.57 TCAGCAGTCAAAAGCAAAGTG 
SPIRE1-
E8E13-FW 58.18 687 bp (when 
exon 13 of 
SPIRE1 is 
present)  
PCR 
(absence 
of exon 
13 on 
mRNA 
levels) 
GCCAGAAAACTGAAACCAACC 
SPIRE1-
E8E13-REV 59.32 CCCAAACATGGCTGCTTCAA 
SPIRE1-
E12E14-FW 59.9 
295 bp 
(including the 
exon 13 of 
SPIRE1), 121 
bp (when exon 
13 of SPIRE1 is 
absent) 
PCR 
(absence 
of exon 
13 on 
mRNA 
levels) 
ACGAACGTGAGGCAGTTTCT 
SPIRE1-
E12E14-REV 59.78 GGACCTGACGGATGTGCAT 
Table 15 - Overview on used primer for PCR and qPCR. 
 
6.1.10 Mouse lines 
Mouse line Company 
C57BL/6J Charles River 
C57BL/6N Charles River 
mitoSPIRE1 (background: C57BL/6N) in this thesis developed mouse model 
SPIRE1 mutant (background: C57BL/6J) Pleiser et al., 2014 
Table 16 - Overview on used mouse lines. 
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6.1.11 Machines and equipment 
Article Company 
AF6000LX fluorescence microscope (HCX PL APO 
63x/1.3 GLYC objective, DFC7000 GT digital camera) Leica 
AM TIRF MC microscope (HCX PL APO 100x/1.47 
oil objective, Hamamatsu EM-CCD C9100-02 digital 
camera) 
Leica, Hamamatsu 
BD FACS Aria III (fitted with a PMT detector for 
forward light scatter of a 488 nm laser) Becton Dickinson 
Cell counting chamber (Neubauer, depth: 0.1 mm; 
0.0025 mm2) Paul Marienfeld GmbH & Co. KG 
Centrifuge, 5417 R, refrigerated Eppendorf 
Centrifuge, 5424 Eppendorf 
Centrifuge, Multifuge 1 s-r, refrigerated Heraeus 
Digital-pH-Meter Knick 
Dumont forceps Nr. 5 Dumont, (neoLab) 
E-Box 3026 WL-26M (UV-Transilluminator) PeqLab 
Eppendorf Research plus 0.1 - 2.5 μl variable Pipette  Eppendorf 
Eppendorf Research plus 0.5 - 10 μl variable Pipette  Eppendorf 
Eppendorf Research plus 10 - 100 μl variable Pipette  Eppendorf 
Eppendorf Research plus 100 - 1000 μl variable 
Pipette  Eppendorf 
Eppendorf Research plus 2 - 20 μl variable Pipette  Eppendorf 
Eppendorf Research plus 20 - 200 μl variable Pipette  Eppendorf 
Forma Orbital Shaker, 37 °C ThermoFisher 
Forma Orbital Shaker, refrigerated ThermoFisher 
Humidity Chamber Plus BioLegend 
ImageQuant LAS 4000 GE Healthcare Life Sciences 
KIMBLE Dounce tissue grinder set Sigma-Aldrich 
Leica DMIL (Tissue Culture Microscope) Leica 
Leica DMR microscope (PL Fluotar 
10x/0.30 objective, DFC320 digital camera) Leica 
Mastercycler ep gradient S Eppendorf 
micro-scissors Megro 
Mini Trans-Blot® Cell Bio-Rad 
Mini-Sub Cell GT Cell (electrophoresis system) Bio-Rad 
Nanophotometer P300  Implen 
POWER PAC 300 (power supply) Bio-Rad 
PowerPacTM 300 Bio-Rad 
PowerPacTM Basic Power Supply Bio-Rad 
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QIAxcel Advanced System Qiagen 
Rotor-Gene Q 2plex HRM Platform Qiagen 
Seahorse Flux Analyzer Agilent Technologies 
TissueRuptor Qiagen 
Water bath Memmert 
Table 17 - Overview on used machines and equipment. 
 
6.1.12 Eukaryotic expression vectors 
6.1.12.1 pAcGFP1-C1 (Clontech) 
The pAcGFP1-C1 vector was used to generate SPIRE1, SPIRE1-E9, mitoSPIRE1, SPIRE1 
exon 13, SPIRE2, FMN1, FMN2 and INF2 N-terminal AcGFP1 tagged plasmids for expression 
in HeLa cells. The cDNA expression of the vector is regulated by the strong CMV promoter 
and the vector has a kanamycin resistance for bacterial selection. Vector and restriction map 
are available in the world wide web (https://www.addgene.org/vector-database/1663/). 
 
6.1.12.2 pcDNA3 (Invitrogen) 
The pcDNA3 vector was used to generate a SPIRE1 N-terminal c-Myc-epitope tagged plasmid 
for expression in HeLa cells. The protein expression of the vector is regulated by the strong 
CMV promoter and the vector has an ampicillin resistance for bacterial selection. Vector and 
restriction map are available in the world wide web 
(https://www.addgene.org/vector-database/2092/). 
 
6.1.12.3 pEGFP-C1 (Clontech) 
The pEGFP-C1 vector was used to generate FMN2 N-terminal GFP tagged plasmids for 
expression in HeLa cells. The plasmid expression of the vector is regulated by the CMV 
promoter and the vector has a kanamycin resistance for bacterial selection. Vector and 
restriction map are available in the world wide web 
(https://www.addgene.org/vector-database/2487/). 
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6.1.12.4 pEGFP-C2 (Clontech) 
The pEGFP-C2 vector was used by our collaboration partner to generate a MYO5A N-terminal 
GFP tagged plasmid and I used it for expression in HeLa cells. The plasmid expression of the 
vector is regulated by the CMV promoter and the vector has a kanamycin resistance for bacterial 
selection. Vector and restriction map are available in the world wide web 
(https://www.addgene.org/vector-database/2488/).  
 
 6.1.12.5 pmStrawberry-C1 
The pmStrawberry-C1 expression vector is based on the pAcGFP1-C1 vector and was 
generated by substituting the AcGFP1 cassette by an mStrawberry cassette. This vector was 
used to generate mitoSPIRE1, SPIRE1 exon 13 and MYO5B N-terminal mStrawberry tagged 
plasmids for expression in HeLa cells. The cDNA expression of the vector is regulated by the 
strong CMV promoter and the vector has a kanamycin resistance for bacterial selection. 
 
6.1.12.6 List of used constructs 
Construct name Plasmid 
Internal 
Plasmid 
Number 
Boundaries 
(restriction 
sites) 
Purpose 
GFP (AcGFP1; 
(*)) pAcGFP1-C1 # 201 - 
mitochondrial 
motility study 
GFP-exon 13 pAcGFP1-C1-mm-SPIRE1-exon 13 # 615 
aa 521 - 578 
(HindIII / EcoRI) colocalization 
GFP-FMN1A-FL pAcGFP1-C1-mm-FMN1A-fl # 967 
aa 2 - 1430 
(EcoRI / KpnI) colocalization 
GFP-FMN1C-FL pAcGFP1-C1-mm-FMN1C-fl # 976 
aa 2 - 1204 
(HindIII / KpnI) colocalization 
GFP-FMN2-FH2-
C1493 
pAcGFP1-C1-mm-
FMN2-FH2-C1493 # 631 
aa 1135 - 1493 
(KpnI / BamHI) colocalization 
GFP-FMN2-FH2-
FSI 
pAcGFP1-C1-mm-
FMN2-FH2-FSI # 628 
aa 1135 - 1578 
(KpnI / XbaI) colocalization 
GFP-FMN2-FH2-
FSI-K1571A 
pEGFP-C1-mm-FMN2-
FH2-FSI-K1571A # 351 
aa 1135 - 1578 
(KpnI / XbaI) colocalization 
GFP-FMN2-FL pEGFP-C1-mm-FMN2-fl # 417 
aa 1 - 1578 
(KpnI / BclI) colocalization 
GFP-INF2-FL-
CAAX 
pAcGFP1-C1-hs-INF2-
CAAX-fl # 916 
aa 1 - 1249 
(XhoI / EcoRI) colocalization 
GFP-INF2-FL-
NonCAAX 
pAcGFP1-C1-hs-INF2-
NonCAAX-fl # 923 
aa 2 - 1240 
(EcoRI / KpnI) colocalization 
GFP-mitoSPIRE1 pAcGFP1-C1-mm-mitoSPIRE1-fl # 626 
aa 2 - 788 
(KpnI / BamHI) 
PCR, qPCR, 
mitochondrial 
motility study, 
colocalization 
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GFP-MYO5A-
CC-GTD (*) 
pEGFP-C2-mm-
MYO5A-CC-GTD # 589 
aa 1260 - 1853 
(EcoRI / SalI) colocalization 
GFP-SPIRE1 pAcGFP1-C1-mm-SPIRE1 # 500 
aa 2 - 730 
(KpnI / BamHI) 
PCR, qPCR, 
colocalization 
GFP-SPIRE1-E9 pAcGFP1-C1-mm-SPIRE1-exon 9 # 679 
aa 2 - 745 
(KpnI / BamHI) 
PCR, qPCR, 
colocalization 
GFP-SPIRE2 pAcGFP1-C1-mm-SPIRE2 # 502 
aa 2 - 718 
(KpnI / BamHI) 
PCR, qPCR, 
colocalization  
GST-FMN2-eFSI pGEX-4T1-NTEV-mm-FMN2-eFSI # 255 
aa 1523 - 1578 
(BamHI / XhoI) 
GST-
pulldown 
mStrawberry-
exon 13 
pmStrawberry-C1-mm-
SPIRE1-exon 13 # 613 
aa 521 - 578 
(HindIII / EcoRI) colocalization 
mStrawberry-
mitoSPIRE1 
pmStrawberry-C1-mm-
mitoSPIRE1 # 627 
AcGFP1 in 
# 626 
substituted by 
mStrawberry 
(NheI / XhoI) 
colocalization 
mStrawberry-
MYO5B-CC-GTD 
pmStrawberry-C1-hs-
myosin-5B-CC-GTD # 321 
aa 904 - 1848 
(HindIII / XbaI) colocalization 
Myc-SPIRE1 pcDNA3-Myc-hs-SPIRE1 # 14 
aa 2 - 742 
(BamHI / XhoI) colocalization 
Table 18 - Overview on used eukaryotic expression vectors. (*), these expression vectors 
were bought from companies or generated by other laboratories and kindly provided by them. 
All other expression vectors were generated in the Kerkhoff laboratory (mostly by Annette 
Samol-Wolf and Dr. Tobias Welz); aa, amino acid. 
 
6.1.13 Sequence related data 
Protein Name Species NCBI Number 
FMN1A Mus musculus XM_011239294.1 
FMN1C Mus musculus NM_001285459.1 
FMN2 Mus musculus NM_019445.2 
INF2 (CAAX) Homo sapiens NM_022489.3 
INF2 (NonCAAX) Homo sapiens NM_001031714.3 
mitoSPIRE1 Mus musculus XM_006526204.3 
MYO5A Mus musculus NM_010864 
MYO5B Homo sapiens NM_001080467 
SPIRE1 Homo sapiens NM_020148.2 
SPIRE1 Mus musculus XM_006526207.3 
SPIRE1-E9 Mus musculus XM_006526205.1 
SPIRE2 Mus musculus AJ459115.1 
Table 19 - Overview on used proteins and respective cDNA accession numbers. 
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6.2 Amino acids, one letter code 
A alanine C cysteine D aspartic acid E glutamic acid F phenylalanine 
G glycine H histidine I isoleucine K lysine L leucine 
M methionine N asparagine P proline Q glutamine R arginine 
S serine T threonine V valine W trypotophan Y tyrosine 
Table 20 - One letter code of amino acids. 
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7. List of abbrevations 
a.u.      arbitrary units 
aa      amino acid  
ANOVA     analysis of variance  
ATP      adenosine triphosphate  
Bio-Rad     Bio-Rad Laboratories, Inc 
CIP     Calf Intestinal Alkaline Phosphatase 
CT     cycle threshold 
DIG     Digoxigenin  
Dm      Drosophila melanogaster  
Drp1     dynamin-related protein 1  
ER      endoplasmic reticulum  
ES cells    embryonic stem cells 
FACS     fluorescence-activated cell sorting 
FAMS     fluorescence-activated mitochondria sorting 
GBD      GTPase binding domain 
FCCP carbonylcyanide-p-
triflouromethoxyphenylhydrazone  
FH1     formin homology domain 1  
FH2     formin homology domain 2 
FL     full-length 
FSC     forward scatter 
FSC PMT     forward scatter photomultiplier tube 
FSC PMT-A     forward scatter photomultiplier tube area 
FSI      formin-SPIRE Interaction 
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FYVE      FYVE-type zinc-finger  
gRNA      guide RNA 
GS     Griscelli syndrome 
GTBM     globular tail domain binding motif 
GTD      globular tail domain 
Hs     Homo Sapiens 
ID      intellectual disability  
iMEFs     immortalized mouse embryonic fibroblasts 
IMM      inner mitochondrial membrane  
IMS      intermembrane space 
INF2     Inverted formin 2  
KIND      kinase non-catalytic C-lobe domain 
Mfn1     mitofusin 1  
Mfn2     mitofusin 2  
MLPH     melanophilin  
Mm     Mus musculus 
mtDNA     mitochondrial DNA 
MTR     MitoTracker Red CMXRos  
MYO5     myosin 5 
MYO5A     myosin 5A 
MYO5B     myosin 5B 
MYO5C     myosin 5C 
NEB     New England Biolabs  
OCR      oxygen consumption rate  
OMM      outer mitochondrial membrane 
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OPA1     optic atrophy 1 
OXPHOS     oxidative phosphorylation  
PAM     protospacer adjacent motif 
PCC      Pearson’s correlation coefficient  
PCR      polymerase chain reaction 
pMEFs    primary mouse embryonic fibroblasts 
qPCR      quantitative real-time PCR 
RFU      relative fluorescence units 
RPE cells    retinal pigment epithelial cells 
SB      SPIRE-box  
SHD      Slp homology domain 
SMART    Simple Modular Architecture Research Tool  
SSC     side scatter  
SSC-A     side scatter area 
ThermoFisher    Thermo Fisher Scientific Inc. 
TIRF      total internal reflection fluorescence  
TMRM     tetramethylrhodamine-methylester  
WH2     Wiskott-Aldrich-Syndrome protein homology 2 
η²       eta squared  
η²P      partial eta squared 
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